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SUMMARY
Genetic toxicology assays have been used to investigate the mechanisms and 
modes of actions, both in vitro and in vivo, of a novel class of chemicals namely the 
diazo- and nitroso-peptides.
The Salmonella typhimurium/mecoamol^ein. microsome mutagenicity assay 
showed that most were direct acting mutagens. The nitrosopeptide, N-acetyl 
y  prolileiN-nitrosog^ptide (APNG) was taken as representative of the class. APNG
was mutagenic in an m vivo rat bone marrow metaphase assay and a mouse 
micronucleus assay, after intraperitoneal (ip) treatments. In the mouse dominant 
lethal assay, after ip treatment, a high incidence of late deaths and malformations, 
was observed with no increase in early deaths. A host-mediated assay in mice, 
with the Salmonella typhimurium  strain TAIOO, demonstrated that APNG was 
active after oral, as well as ip, treatment and provided a pharmacokinetic profile 
of the compound. The in vitro unscheduled DNA synthesis (UDS) assays 
demonstrated that APNG damaged DNA. A similar effect was seen in vivo and 
demonstrated that APNG was absorbed orally. Finally ^^ P post-labelling studies 
estabhshed that APNG formed stable adducts in rat hver and kidneys,after oral 
treatment.
These results led to the supposition that APNG may be a carcinogen. This 
was confirmed in a restricted long-term mouse study where a variety of mahgnant 
tumour types were seen. It was concluded that the nitrosopeptide, APNG, had 
considerable carcinogenic potential and may cause heritable male germ cell 
damage.
Also demonstrated was that by the careful selection of genetic toxicological studies 
the need for a large, and hence costly, carcinogenicity study was unnecessary.
I l l
ABBREVIATIONS
2AA 2-aminoanthracene
2AAF N-acetyl-2-aminofluorene
9AA 9-aminoacridiiie
APNG N-acetyl prolyl-N-nitrosopeptide
AVNG N-ace1yi valyl-N-nitrosopeptide
BP benzo(a)pyrene
CTX cyclophosphamide
DM 80 dimethylsulphoxide
DoH Department of Health (UK)
DPX coverslip mounting medium
ELISA Enzyme Linked Immuno-Sorbent Assay
G-6-P glucose-6-phosphate
HBSS Hank's balanced salt solution
his gene for histidine
His+ histidine dependent
HMA host mediated assays
HPLC high pressure liquid chromotography
HU hydroxyurea
ip intraperitoneal
iv intravenous
MAFF Ministry of Agriculture, Fisheries and Food
MMC mitomycin C
IV
MNNG N-methyl-N-nitro-N-nitrosoguanidine
NaAz sodium azide
NADP nicotinamide adenine dinucleotide phosphate
NCE normochromatic erythrocytes
2NF 2-nitrofluorene
NG net grain count
NGG diazo-acetylglycine calcium salt
NGGE diazo acelyl glycine ethyl ester
NGGG diazo acetyl glycylglycine calcium salt
NLGE 2-diazo-4-methylpentanoylgylcine ethyl ester
NMU N-nitroso methyl urea
NSGE diazo-2-hydroxypropionylglycine ethyl ester
PBS phosphate buffered saline (pH 7.4)
PCE polychromatic erythrocytes
po per os
S-9 9000 g post-mitochondrial supernatant
sc subcutaneous
SD standard deviation
TCA trichloracetic acid
UDS unscheduled DNA synthesis
UKEMS United Kingdom Enviommental Mutagen Society
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CHAPTER 1
INTRODUCTION
MECHANISMS OF CHEMICAL CARCINOGENESIS
Ionising radiation, genetic determinants and infectious agents (e.g. 
viruses) are recognised to play significant roles in the aetiology of human 
cancer. However, it is suspected that environmental chemical agents are 
causally involved (Doll and Peto, 1981 and Wynder and Gori, 1977) and until 
the past decade, the chemical induction of cancer was the principal 
experimental tool in the understanding of carcinogenesis (Pitot, 1990). It 
since has become clear that an understanding of the process of 
carcinogenesis must involve identification of chemicals causing neoplasia, the 
mechanisms of action of such agents on cells, and finally the process of the 
development of cancer that results after the initial interaction of the agent 
with the cell.
The involvement of chemicals as the cause of cancer has been long 
known. The ability of tobacco, in the form of snuff, to induce nasal polyps 
was first reported in 1761 by Hill and in 1775 Pott associated the occurrence 
of scrotal cancer, in chimney sweeps, to the exposure to soot. Other early 
correlations between chemical agents and cancer include the work of Rehn 
(1895) showing that the aromatic amines involved in the production of 
’aniline' dyes led to urinary bladder cancer, and further confirmation of the 
involvement of soot in scrotal cancer by Butlin in 1892.
The experimental investigation of chemical carcinogenesis probably 
began in 1915 when Yamagawa and Ichikawa produced skin tumours in the 
ears of rabbits treated with coal tar, and since then a large number of both 
synthetic and naturally-occurring agents have been shown to be carcinogenic
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in experimental animal systems. However, it was not until the 1960’s that 
there was any major breakthrough in an understanding of the mechanisms 
involved in chemical carcinogenesis, when it was demonstrated that reactive 
metabohtes of chemicals were critical intermediates in the induction of 
neoplasia (Miller and Miller, 1969). It had been proposed earlier that 
carcinogenesis was a multi-stage procedure (Rous and Kidd, 1941; Mottram,
1944 and Berenblum and Shubik, 1947), but this hypothesis was not 
appreciated by the majority of workers until the 1970’s (Pitot, 1990).
Mechanistic theories of chemical carcinogenesis probably started with 
investigations of the physicochemical considerations on the electronic 
structure and carcinogenic activity of chemicals. These studies related the 
electron density of specific regions of polycycHc hydrocarbons, called the K 
and L regions, with their carcinogenicity (Pullman and Pullman, 1955).
Since that time a number of other methods for the theoretical prediction of 
carcinogenicity based on structure have been proposed. Various mechanisms 
have since been suggested for the induction of the malignant process. These 
include the electrophihcity of chemicals as a determinant of their 
carcinogenicity, whereby chemical carcinogens are, or may be converted by 
metabolism into electron-pair-deficient electrophihc entities that covalently 
interact with cellular macromolecules such as DNA (Miller, 1978).
Model studies with 2-acetamidofluorene led to the proposal that most 
chemical carcinogens are "procarcinogens" which require metabohsm to 
'proximate' and later to "ultimate" carcinogens, the 'ultimate' carcinogen 
being the form which would react with DNA to induce the neoplastic 
transformation and many agents fall into this class.
It has, however, become clear that not all chemicals induce neoplastic 
transformation by mechanisms involving covalent interactions with DNA.
Méthylation of DNA cytosines is probably involved in the heritable 
expression or repression of specific genes in eukaryotic cells (Holliday, 1987)
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Other proposed mechanisms for neoplasia include chemicals capable of 
inhibiting the normal méthylation of some deoiycytidine residues in DNA  
The inhibition of DNA méthylation may occur by several mechanisms, 
including the formation of single strand breaks and covalent adducts in the
 DNA It is also possible to inhibit or deactivate the enzyme DNAS-
adenosylmethionine methyltransferase, which is responsible for normal 
méthylation (Pitot, 1990). As an example, it has been shown that the 
inhibitor of DNA méthylation, 5-azacytidine, is a carcinogen in mice 
(Cavaliere et al.,1987) and can act as a cocarcinogen in chemical 
hepatocarcinogenesis (Denda et aZ.,1985)
The highly reactive chemical intermediates including single electron- 
deficient or free radicals derived from some chemical carcinogens may also 
play a part in neoplasia. The production of these reactive agents may be 
associated with a series of inter-related mechanisms including: the formation 
of reactive oxygen radicals from tissue oxygen, in the redox cycling of free 
radical-reactive intermediates (semiquinones, nitroso-compounds, oxy 
radicals) or the formation of superoxide or peroxide anions and the 
conversion of superoxy anion and peroxide to reactive hydroxyl radicals in 
the presence of iron (Parke and loannides, 1990); DNA damage by hydroxyl 
or other radicals resulting in mutagens (Hsie et al., 1986); epigenetic 
modulation of gene expression by oxidative stress, modifying regulatory 
molecules, oncogene activation and DNA rephcation and the activation of 
endogenous and xenobiotic chemicals by hydrmyl mediated reactions to form 
new mutagens and ultimate carcinogens (Parke and loannides, 1990).
Other mechanisms involve interaction of the chemical or metabolite 
with the Ah or other receptors leading to DNA replication, mitosis and cell 
prohferation (Parke and loannides, 1990); aberrations of DNA repair where 
the repair mechanisms are interferred with, leading to an increased
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incidence of cancer as with xeroderma pigmentosum where individuals 
affected have a marked inabihty to repair DNA caused by ultraviolet light 
(Kraemer, 1980); and mechanisms involving metals which may induce 
infidehty of DNA polymerase during DNA synthesis (Sirover and Loeb,
1976).
It is clear from the study of chemicals causing cancer that many do
not damage DNA, examples of which include naturally-occurring oestrogens
(Liehr et al., 1986) asbestos (Oshimura et al., 1984) and dioxin (Poland and
Glover, 1979). These agents, which are non-genotoxic carcinogens, often
called epigenetic carcinogens, act through mechanisms other than
attachment to the genetic material of the cell. They may act as promoters
of initiated ceUs, cause cell proliferation, be cytotoxic, act as peroxisome
proliferators or through other means (Weisburger, 1990). In addition manv
to be carcinogenic (Legator et a/., 1973) 
clastogenic chemicals such as trimethylphosphate have not been showp( It
is clear that the mechanistic theories of chemical carcinogenesis cannot
totally account for the varied effects of chemicals shown to be carcinogenic;
however, a more integrated picture is beginning to evolve.
MULTISTAGE CARCINOGENESIS
The mechanisms of chemical carcinogenesis, described previously, may 
contribute to the sequence of events that lead to neoplasia. This sequence 
of events is often called the multistage, or multistep, model of carcinogenesis 
and involves at least three stages described as initiation, promotion and 
progression. It is now possible to classify chemical carcinogens by their role 
in effecting one or more stages in the development of neoplasia. Pitot (1990) 
defines these agents as:
Initiating agents (incomplete carcinogens) - chemicals capable of 
initiating cells only.
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Prom oting agents - chemicals capable of causing the expansion of 
initiated cells.
Progresser agents - chemicals capable of converting initiated cells to 
potentially mahgnant ceUs.
Complete carcinogens - chemicals capable of inducing cancer from 
normal cells, having the abihty to act as initiating, promoting and progressor 
agents.
GENETIC TOXICOLOGY
Genetic toxicology is that area of toxicology that is concerned with 
the effects of agents on the hereditary components of hving organisms. The 
agents that produce such alterations to nucleic acids and associated 
components may be classified as genotoxic.
Initially the focus was on the potential impact that mutagens may 
have on germ cells; however the early high correlations (about 90%) 
between mammahan carcinogens and mutagens (Ames, 1979; Bridges, 1976; 
Brusick, 1978; Purchase, 1978; McCann et al., 1975 and Sugimura, 1977) 
stimulated much work related to the investigation of environmental agents 
that may be imphcated in cancer. Such agents have subsequently been 
found to include not only man-made chemicals but natural carcinogens and 
mutagens produced in the cooking process (Sugimura, 1978; Anderson and 
Purchase, 1983 and Rowland et al., 1984). The use of genetic toxicology 
a^ays has also identified nitroso compounds as being mutagenic.
DNA damage falls into two broad categories. Firstly, microlesions, 
where nonvisible changes occur at the nucleotide level and secondly, 
macrolesions, where visible effects occur detectable through cytologic 
analysis of chromosomes. Microlesions may take the form of either base- 
pair substitution mutations, giving qualitative changes in one or more '
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nucleotide pairs, or frameshift mutations giving quantitative changes. 
Macrolesions may be alterations in chromosomal numbers or structural 
changes such as deletions, rearrangements or breaks. These categories of 
damage have been described by Brusick (1989) and are shown below:
Mutation
Microlesions Macrolesions
Base-pair Frameshii 
substitution mutations changes in 
mutations
Numerical Structural
changes in 
chromosomes chromosomes
Microlesions can be detected by using gene mutation assays and the  
macrolesions by chromosomal damage assays. However, it is also possible 
to look for DNA damage indirectly by the use of methods that measure DNA 
damage and repair, usually by the incorporation and measurement of 
radioactive markers (e.g. tritiated thymidine) into the DNA, providing an 
indication of the degree of damage caused by a test agent.
The uses of genotoxicity assays are multi-fold; the prime purpose is 
usually for the screening of compounds to identify potential DNA-damaging 
agents, as it is estabhshed that many human disease states have a genetic 
component. These include inherited tumours, oncogenesis (retinoblastoma 
and familial polyposis, Knudson, 1973), heart disease (Benditt, 1979) and 
teratogenesis (Kalter, 1977).
In addition, as previously stated, damage to somatic cells by mutation 
may give rise to cancers. In the last fifteen years the use of genetic toxicity
6
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tests has shown a good correlation between genotoxic agents and 
carcinogens (McCann et al., 1975, 1976; Purchase, 1978; Sugimura, 1977; 
Ashby and Tennant, 1988; Ashby et al., 1989 and Ashby and Tennant, 1991). 
These assays for detecting genotoxic agents are much used in the 
assessment of mutagenicity.
However, it is worth considering what is involved in the use of short­
term tests, as predictors of carcinogenicity. To predict from such tests the 
potential carcinogenicity of chemicals in man, requires two interspecies 
extrapolations: firstly the prediction of laboratory animal carcinogenicity 
from the results of short term tests and secondly the prediction of human 
carcinogenicity from animal carcinogenicity results. This correlation is 
difficult due, in part, to the paucity of data relating to proven human 
carcinogens. By 1987 the International Agency for Research on Cancer 
(lARC) in Lyon only accepted about 50 chemicals or processes as being 
proven human carcinogens (lARC monograph update. Vol. 1-42, Lyon). 
Nevertheless it appears from these comparisons that nearly aU known 
human carcinogens can be detected from only two short-term assays, the 
Ames test and an assay for the induction of micronuclei or chromosomal 
aberrations in rodent bone marrow cells (Shelby,1988). The picture is less 
clear when comparing the short-term tests with animal carcinogenicity 
results. The use of four of the most regularly used in vitro short-term  
assays, the Ames test, the L5178Y mouse lymphoma assay, and 
investigations of chromosomal aberrations and sister chromatid exchanges 
(SCEs) in Chinese hamster ovary cells, to predict for the carcinogenic 
potential of 73 chemicals proved to be disappointing (Tennant et aZ.,1987).
All four assays had concordances of around 60%, but the individual assays 
exhibited slightly different data profiles, the mouse lymphoma and the SCE 
assays giving more positive results than the Ames or the chromosomal
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assays. Some chemical agents were predicted by all four assays but many
were only positive in one assay and six carcinogens were not positive in any.
These results highlighted the problems associated using the selection of
chemicals, containing known epigenetic agents, and many commentaries and
debates have been reported in the literature discussing the arguments for
and E^ainst the use of standard assays in assessing the potential genotoxicity
of such selected groups (Ashby,1988; Auletta & Ashby, 1988; Piegorsch &
Hoel, 1988 and Trosko, 1988). One of the issues raised was that of the non-
genotoxic carcinogens. If these are excluded from the data set the
predictabihty for carcinogenicity of the remaining genotoxic compounds was
about 80% (Ashby and Tennant, 1988; Ashby, 1989 and Tennant and Ashby,
1991;). This effect argues for a different approach to be made for the non-
genotoxic agents. Some knowledge of the chemical structure of the
compound could be of great importance in identifying potential
genotoxins (Ashby and Morrod, 1991) and Ashby and Tennant (1988) have
proposed a model approach which highlights structural alerts to identify
chemical regions that may cause genotoxicity. Potential non-genotoxic
compounds may then be assessed perhaps using short-term animal studies
for detecting indirect effects on cell division (Ashby and Morrod, 1991).
However, even if an agent is shown to be a genotoxin in an in vitro assay,
with a probabiUty of about 80% for it being a carcinogen, international
regulatory authorities generally still require animal studies for evaluating
to predict human carcinogenicity
mammahan carcinogenicity It may be of more use to investigate in vitro 
genotoxins using further short-term assays that give some indication of the 
modes of action of the agent so that a critical assessment of its potential 
mammalian carcinogenicity may be made. It is possible by following such 
an approach, many long-term carcinogenicity assays may be avoided with the
8
S.D.Blowers - PhD Thesis Introduction
result that fewer animals would be needed and the costs reduced (Ashby and 
Morrod, 1991).
For regulatory purposes, in order to predict carcinogenicity, it has
been usual to employ battery approaches using both in vitro and in vivo
systems. An earher scheme outlined by the 1981 DHSS Mutagenicity
Guidelines and Committee of the Safety of Medicines (1984) proposed that
a system using four categories of assays be employed. Their
recommendations suggested that the following assays were carried out: a
gene mutation assay in bacteria (e.g. Ames Test), with and without
exogenous metabohsm; an assay for chromosomal aberrations in mammahan
cells in vitro (e.g. in human lymphocytes or in a Chinese hamster ovary cell
line), with and without exogenous metabohsm; a test for gene mutation in
a eukaiyotic system (e.g. hypoxanthine-guanine- phosphoribosyl transferase
assay in Chinese hamster ovary ceU lines) and a test for genetic damage in
vivo (e.g. bone marrow metaphase, micronucleus or dominant lethal test in
rodents). The battery approach has been recently reviewed by those
working in the field and the basic package been altered in the UK to a tier
system. This approach was first suggested by Bridges in 1974 and there is
now more emphasis on the in vitro assays. The Department of Health
(DoH) now requires two or three in vitro studies with a more investigative
approach being asked for. The DoH are mindful of the need to reduce
for most agents
animal studies and suggest that/the in vivo assays should only be used to 
investigate whether mutagenic potential indicated in vitro is expressed in 
vivo. It should he possible, using well selected in vivo assays, to gain some 
understanding of the mechanisms of action of the agents under investigation 
and to evaluate the relevance of positive results seen in vitro. A breakdown 
of the DOH requirements with the suggested improved methods of assaying 
for genotoxicity are published in the United Kingdom Environmental
9
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Mutagen Society (UKEMS) recommended procedures for basic mutagenicity 
tests (Kirkland, 1990).
GENOTOXICITY AND NITROSO COMPOUNDS
It is now becoming possible to reconcile many of the mechanistic 
concepts of chemical carcinogenesis with its proposed development stages. 
Nevertheless many questions still remain unanswered and many chemicals 
and classes of chemicals work by, as yet, not weU understood mechanisms.
One class of such chemical mutagens and carcinogens includes the nitroso- 
compounds which can act as initiators, promoters or even as complete 
carcinogens. Both diazo- and nitroso-peptides are included in this category 
of chemicals but to the present time there is not a great deal known about 
these particular agents. Some toxicological studies have been carried out on 
the diazopeptides and there is some evidence that they are both mutagenic 
and carcinogenic (Brambilla et al., 1970 and 1972, Banfi et al., 1974 and 
Monti-Bragadin et al., 1974). However, the nitrosopeptides have not been 
investigated for their genotoxic properties and the remainder of this chapter 
discusses nitroso compounds and the relevance of genotoxicity assays in 
assessing the biological properties and modes of action of such agents.
THE FORMATION OF N NITROSO COMPOUNDS
N-Nitroso compounds have been known for well over 100 years. 
However, their biological properties were greatly ignored even though some 
evidence of hver toxicity in humans had been reported by Freund as early 
as 1937. Little interest in these agents was generated until 1954 when 
Barnes and Magee investigated the toxicity of dimethylnitrosamine to 
humans following an accidental poisoning. Subsequently, studies in rats in 
1956 showed that dimethylnitrosamine was able to produce liver tumours
10
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(Magee and Barnes, 1956). Further studies illustrated the fact that not only 
the N-nitrosamines but the N-nitrosamides such as N-methyl-N- 
nitrosourethane and N-methyl-N-nitrosourea were carcinogenic (Schoental,
1960; Druckrey et al. 1961).
The animal carcinogenicity data stimulated further work on the N- 
nitroso compounds, although initially it was not behoved that these agents 
were a carcinogenic hazard outside the laboratory. This behef was probably 
strengthened because of the lack of suitable analytical methods for 
determining N-nitroso compounds and so the analysis of these agents both 
in in vitro studies and in food was not possible.
However, the advent of analytical methods to determine N-nitroso 
compounds, such as gas-hquid chromatography in combination with mass 
spectrometry (Bogorvski and Walker, 1974) made possible the identification 
of N-nitroso compounds in many environmental situations and in a number 
of meat, fish and other food products (Montesano and Bartsch, 1976). Also 
the existence of N-nitrosamines in cigarette smoke, proposed by Druckrey 
and Preussmann in 1962, was subsequently proved (Hoffinan et al. 1974; 
McCormick et al. 1973).
In addition to the exogenous formed N-nitroso compounds endogenous 
formation is also possible as a result of the reaction of nitrite with various 
nitrosatable amines (Montesano and Bartsch, 1976). Nitrite the main 
nitrosating agent in vivo, is used as an additive in meat curing (i.e. in bacon 
or smoked fish) and is present in bacon, for example, in quantities greater 
than 35 m g/kg (MAFF, 1987). Nitrite is also present in many fresh 
vegetables at levels up to 1 mg/kg (more in stored vegetables) and in cheese 
(MAFF, 1987). It is also possible that nitrite may originate from the 
enzymic reduction of nitrate by bacteria in the stomach (Montesano and 
Bartsch, 1976).
11
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Nitrosatable substances that occur in the environment include 
secondary and tertiary amines, quaternary ammonium compounds, urea, 
carbamates and guanidines (Montesano and Bartsch, 1976). Many of these 
occur naturally but some are agricultural chemicals (Sen et al. 1974) or even 
drugs, for example, the anti-helminthic compound, piperazine (Arriaga Alba 
et al. 1988). It is also possible that many amino acids or peptides are 
nitrosatable, and could be formed during the breakdown of proteins (ChaUis, 
1989).
In excess of one hundred and forty N-nitroso compounds have now 
been investigated for carcinogenicity and most have been found to be 
carcinogenic in several species (Lijinsby, 1984). Many studies have also been 
carried out investigating the genotoxicity of these compounds and their 
mutagenicity in short-term tests is discussed in some detail by Rao et al. 
(1984).
The N-nitroso compounds may be divided into three groups including 
the N-nitrosamines, N-nitrosamides and N-nitrosoureas the basic structures 
of which are shown below
N-nitrosamines
Rl
N NO
/
R2
12
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N-nitrosamides
R i ----- C
N -------  NO
R2
N-nitrosoureas
X
R i ------  NH-------- - C
N  NO
RI, R2 = alkyl, aryl or part of a cyclic structure
For the purpose of the following discussion the nitrosoureas are 
considered with the nitrosamides. In general the N-nitrosomines are 
comparatively stable whereas the N-nitrosamides are more reactive agents 
and consequently less stable. These stabihties are probably closely related 
to their biological properties since in in vitro mutagenicity assays the 
nitrosamines require metabohc activation and are weakly mutagenic 
whereas the nitrosamides are direct acting and generally more powerful 
mutagens.
13
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PEPTIDE NITROSATION
As with other amino-containing compounds, peptides react with 
nitrosating agents under varying conditions. Several products are possible. 
However, two general reactions are common to most peptides. The first 
involves deamination of the terminal primary amino group via a diazo- 
derivative, this is illustrated below.
R H R H
NOX ............. _ .. ^ 0 0 ,
HX + H2O+
p.  Path 1 O R *
NuH
R.  H
0  R*
N v . + Ng
R,R1 = alkyl or aiyl group 
Nu = HCl, H A  DNA etc 
X = Carrier compound
The second involves the peptide N-atom which gives rise to an N- 
nitroso derivative that will react with nucleophiles resulting in the cleavage 
of the peptide hnkage, and is illustrated below.
14
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C O -  NOX .
HX + H,  N
P a th  2
H3N CO2H + N;+ H2O
NuH
R,R1 = alkyl or aryl group 
NuH = HCl, H2O, DNA etc 
X = Carrier molecule
Both pathways may lead to DNA interaction and are outlined by 
ChaUis (1989) in his review of nitrosated peptides.
Some peptides undergo additional reactions with nitrosating agents. 
The sulphur-containing amino-acid cysteine can be oxidized via an S-nitroso 
intermediate to generate disulphide (cystine) Unks. The monoamino 
dicarbo]grhc acid amides, asparagine and glutamine, and the diamino- 
monocarboxyhc acids, arginine and lysine may undergo specific deamination 
reactions. The aromatic or heterocychc amino-acids including tryptophan 
and prohne may also form specific Nmitroso derivatives. These reactions 
have been observed, certainly in protected peptides 1 if  not in proteins 
(Bonnett and Nicolaidou, 1977 and ChaUis, 1989).
As an example of the above, proline protected peptides have been 
shown to generate the corresponding N-nitroso-prolyl-peptide, shown below.
15
% " 1  "
r
N
This product may be defined as an a-substituted N-nitrosamine 
(Kubacka et al. 1984 a, b and Tricker et al. 1984).
Few products resulting firom the nitrosation of proteins have been 
described, 3-nitrotyrosine and 3,4,dihydro^-phenylalanine (DOPA) being 
two identified by Knowles et al. (1974).
The reactions described above appear to produce few cytotoxic products 
and their chemical aspects are discussed by Bonnett and Nicolaidou (1974).
FORMATION AND REACTIONS OF DIAZOPEPTIDES 
Synthesis
The deamination of the terminal primary amino groups via the 
diazopeptide is well-characterised, and Curtius (1904) reported this 
reaction for the ethyl ester of tetraglycine using nitrite in aqueous 
acetic acid. The N-(diazacetyl)-triglycine ethyl ester was a ciystalline 
solid. Later the same worker was able to prepare further N- 
(diazoacetyl)-glycine peptides (Curtius and Darapsky, 1906, Curtius 
and Thompson, 1906 and Curtius and Callan, 1910). However, he was 
unable to synthesise products with a terminal carboxylic acid. 
Various improvements to the Curtius method were made including 
the use of additional solvent extraction phases (Looker and 
Carpenter, 1967). Nevertheless, it was not until recently that a 
procedure for synthesising diazopeptides, including free terminal ' 
carboxylic acids, has been developed. This method is described by
16
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Challis et al. (1987) and utilizes aphotic nitrosation by N 2O4 (NOg) in 
organic solvents to avoid the strongly acidic conditions in which 
diazopeptides are very unstable.
Form ation by aqueous nitrite
The pathways deduced for the nitrosation of amino compounds, 
including amino acids should apply to diazopeptide formation. So, in 
acidified nitrite, nitrosation agents such as NgO^ , NOCl or NOSCN 
may react with the neutral peptide. The resultant N-nitroso 
ammonium ion intermediate generates the diazopeptide by the rapid 
loss of HgO^ . However this diazopeption is only transient under the 
reaction conditions. It is possible that in HCl in the presence of 
dilute nitrite (ImM) NOCl will be the principal nitrosating agent and 
it would appear likely that the gastric diazotisation of peptides is 
possible with a first-order dependence on nitrite and neghgible acid 
catalysis below pH 3 (Challis et al. 1987 and 1989). Although these 
diazopeptides are short hved they may be reactive enough to cause 
very rapid damage to hving tissue.
Form ation by gaseous nitrogen oxides
ChaUis (1981) has shown that gaseous nitrogen oxides are 
potent nitrosating agents and it is no surprise that peptides in neutral 
aqueous media, such as saliva or blood, are readily diazotized on 
treatment with such agents (ChaUis et al., 1987a). Since NOg is 
retained on inhalation (Goldstein et al., 1977) and reacts with 
erythrocytes (Doyle and Hoekstra, 1981), diazopeptides might be 
expected to form in the lung or blood and could be of great biological 
significance in smokers or in people living in polluted urban areas.
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For peptides in aqueous buffers at pH 6  and 25 ° C, diazopeptide 
formation is exceedingly rapid (t% = 1  second) on the passage of dilute 
gaseous NOg. There is no evidence of any significant concurrent 
nitrosation of the peptide N-atom (ChaUis et al, 1987a). The 
diazopeptides formed vaiy in stabiUty but are aU generaUy short Uved.
In serum and plasma, gaseous NOg interacts rapidly to generate 
nitrite, and in blood, nitrate. Without addition of peptide no 
formation of diazopeptides is detected. This is probably due to the 
many different possible combinations of peptides, each yielded in very 
low concentrations, thus making detection by conventional means 
impossible. However, after the addition of peptides to both serum 
and whole blood nitrosation can take place and diazopeptides can be 
detected and it would appear that these biological solutions do not 
inhibit the formation of diazopeptides (ChaUis et al., 1987a).
Stability o f diazopeptides
In common with most diazo compounds the diazopeptides are 
relatively unstable especiaUy in acidic media. In aqueous buffers 
their decomposition foUows the equation outUned below and is 
therefore generaUy acid-catalysed (ChaUis et al. 1987a).
Rale = [Diazopeptide] + / c h a [ H A ] |
The diazopeptides decompose rapidly (t V2 = 10 seconds) at pH 
3 and 25 ° C. However they are reasonably stable (t V2 = 0.2-5 hours) 
at pH 7.5. The fastest decomposition rates are observed in 
compounds having electron-donating substituents adjacent to the 
diazo group and consequently the diazo derivatives of glyc yl, seryl
18
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andthreonyl peptides should be amongst the most stable. Moreover Y 
it would appear that the diazopeptides are more stable in serum and 
plasma than in aqueous buffer (ChaUis et al., 1987a). The 
diazopeptides would thus appear to be too unstable in gastric 
conditions to cause biological damage, but in blood, saUva and possibly 
in achlorohydric stomachs, they may be stable enough to cause 
significant biological damage.
Decom position products
The diazopeptides should be powerful alkylating agents 
especiaUy in neutral or acidic conditions. Parodi et al., (1977) 
confirmed this for four N-(diazoacetyl)-glycine derivatives. It may be 
inferred that these agents wQl react rapidly with nucleophUes 
including DNA.
The biological properties o f diazopeptides
Subsequent to the description and isolation of diazopeptides by 
Curtius et al. (1904,1906a,b and 1910) Uttle work was carried out on 
the biological properties of these agents. However in 1966 Baldini 
and BrambUla discovered that these agents had antineoplastic activity 
and were potentiaUy useful agents. Later work has shown that many 
diazopeptides are direct-acting mutagens in the Ames test (Banfi et 
al., 1974 and Monti-Bragadin et al., 1974) and against Chinese 
hamster ovaiy cells (Pani et al., 1980). It was further demonstrated 
that several diazopeptides exhibit other cytotoxic properties such as 
the induction of pulmonary tumours and leukaemias in rats 
(Brambilla et al., 1970 and 1972), anti-tumour activity (Baldini and 
Brambilla, 1966; Sava et al., 1979 and Giraldi and Nisi 1976), and
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metastatic activity (Giraldi et al., 1979). It has also been reported by 
Brambilla et al., (1979) and Parodi et al., (1977) that diazopeptides 
induce DNA damage and unscheduled DNA synthesis in cultured 
mouse cells.
FORMATION AND REACTIONS OF N-NITROSOPEPTIDES
N-Nitrosopeptides were essentially unknown until the early 1980’s.
This relates to the preferential formation of diazo-peptides by nitrosation in 
all but strongly acidic media rather than inherent instabihty. It would 
appear likely that they may be similar to the N-nitrosamides, their closest 
structural analogues. Early studies including those by Bonnett et al. (1975 
and 1979) suggested that the formation of N-nitrosopeptides was unlikely. 
However Chow and Polo (1981 and 1984) prepared some N-acetyl-N-nitroso 
amino acids in solution, which decomposed rapidly on addition of bases and 
this led to the formation of N-nitrosopeptides as described in the fbllowmg 
section.
Synthesis
The first authentic N-nitrosopeptides were synthesised and 
described by Challis et al. (1984a and b) and Garcia et al. (1984). 
Garcia’s compounds were N-nitroso derivatives of several N-protected 
peptide esters and ChaUis’ were N-(N-acetyl- L-prolyl)-N-nitroso 
derivatives of glycine, alanine and phenylalanine, shown below.
NO
CH
R = H,methyl or methyl phenyl
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The N-protected compounds were chosen so as to avoid the 
concurrent diazotization of the terminal amino group observed with 
the non aromatic and heterocychc amino acids. Those compounds 
were nitrosated aproticaUy in organic solvents using NgO^  or dhute 
gaseous NOg.
Form ation by aqueous nitrite
The N-nitrosopeptide formation foUows the equation:
Rate = kg [Peptide] [HNOg]
where the kg values increase with acidity (Challis et al. 1984b). 
Another investigation by Chalhs (1987b) showed that the 
diazotization of dipeptides is approximately 2 0  times faster than 
nitrosation at pH 1  and 37 “ C and even faster at higher pH values.
He concluded that diazotization must be the principal reaction for 
smaU peptides under gastric conditions, although for the end 
protected peptides there is no reason to suspect nitrosopeptides may 
not be generated.
Stability
In aqueous media nitrosopeptides decomposed in a pH- 
dependent way (at 25 °C), rapid decomposition occurring only in 
moderately concentrated acid or base. At pH 1-8 at 25 °C the N- 
nitrosopeptides are relatively stable with a half-life of approximately 
10 hours for the compound with R as hydrogen and 3 hours for the  
compound with R as a methyl group (ChaUis et al. 1984). They are 
also relatively stable in organic solvents.
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The stabüity of N-nitrosopeptides is sufficient for them to 
survive in the gastrointestinal tract and vascular system. On 
decomposition they either generate diazotic acids from
N-nitrosopeptides e.g.:
 ______, _  ,  H 3 O + ,  H0 “  o r  n u c le o p h ile s  f v 0
X = OH, NHR, S R  e tc
or diazopeptides from longer chain N-nitrosopeptides e.g.:
,2
R^
COgH
0  R^ R
^  c o , hO Rl I
X =  O , OH, OR, NH^ e tc
w \^^COX + HjO
o
In this way it may be considered that the N-nitrosopeptides are 
carriers (or precursors) for the possibly more biologically important 
diazopeptides.
The biological properties o f N-nitrosopeptides
The N-nitrosopeptides, being novel compounds,have not been 
investigated for their biological activity or presence in animal or 
human systems. Since N-nitrosopeptides probably decompose to 
either diazotic acids or diazopeptides in vivo, their biological 
properties may well be similar to those of the diazopeptides as 
described previously.
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AIM AND JUSTIFICATION OF THE WORK PRESENTED
It would appear that the reactivities of the peptide terminal amino 
groups towards nitrosation should be similar to diallg^lamines. It may be 
also inferred that diazopeptides should form as readily as N-nitrosamines. 
Furthermore the peptide N-atoms would be expected to be susceptible to 
nitrosation and be similar to amides and ureas. Thus it would seem likely 
that N-nitrosopeptides should form as readily as N-nitrosamides and N- 
nitrosoureas.
As proteins are an essential and large component of diet it is obvious 
that large quantities of peptides are available, both in the gut and 
bloodstream. In fact, there can be little doubt that there are more of these 
compounds available for potential nitrosation than the amines, amides and 
ureas that could form N-nitrosamines, N-nitrosamides and N-nitrosoureas 
respectively. It is surprising therefore that peptide nitrosation has not 
attracted interest comparable to that of the other N-nitroso compounds.
This lack of interest primarily stems from the fact that although the 
diazo and N-nitroso peptides are stable at cellular pH, their lower stability 
compared with other N-nitroso compounds undoubtedly complicates their 
detection and quantification.
Two groups of compounds were synthesised. The first group included 
five diazopeptides, shown below:
N-(2-diazoacetyl)glycine ethyl ester (NGGE)
N-(2 -diazoacetyl)glycylglycine calcium salt (NGGG) 
N-(2 -diazohydroxypropionly)glycine ethyl ester (NSGE)
N-(2-diazoacetyl)glycine calcium salt (NGG) 
N-(2-diazo-4-methylpentanoyl)glycine ethyl ester (NLGE)
Their structures being given in Figure 1.1. The second group of compounds 
included two N-nitroso peptides, their structure and names being shown in
23
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Figure 1.1.
The structure o f the diazopeptides
Compound and  S t r u c t u r e A b b rev  i a t  io n
N - ( 2 - d i a z o a c e t y l ) g l y c i n e  e t h y l  e s t e r  
H H O
I I D
/ \  / \  / \
N? C C O
U / \
O H H
N - ( 2 - d i a z o a c e t y I ) g l y c y ^ l g l y c i n e  c a lc iu m  s a l t
NGGE
H H
2+,C^ N C COO-
/ ^ \  / \  / \  /
N2 C C N
n / \  I
O H a  H
N - < 2 - d l a z o h y d r o x y p r o p i o n y l ) g l y c i n e  e t h y l  e s t e r  
HOCH2 H O
1 I H
B / \  °
o  a  H
N - { 2 - d i a z o a c e t y l ) g l y c i n e  c a l c i u m  s a l t  
H H
NGGG
NSGE
NGG
. C  N COO C a2+
/  \  /  \  /
N2 C C
I / \
O H H
N -( 2 - d i a z o —4—m e t h y l p e n t a n o y l ) g l y c i n e  e t h y l  e s t e r  NLGE 
(CH3)2CH CH2 H O
I I 11
I A  °
o  a  H
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Figure 1.2.
The structure o f the nitrosopeptides
N-acetvl prolvl-N-nitrosoglvcine
A
o  CH,
C — N  C H - COOH
NO
N-acetvl valvl-N-nitrosogIvcine
C H , C H , 
\ /
CH NO
CH3 C  NH CH  C  N C H -  COOH
II
O
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Figure 1 .2 . These N-nitrosopeptides are more stable than the diazo- 
compounds and were easier to synthesize. The N-nitrosopeptides have the 
potential to form diazopeptides and could possibly give rise to active 
products relevant to both groups.
It was decided therefore that the investigation of a single N- 
nitrosopeptide, N-acetyl prolyl-N-nitrosoglycine (APNG) could provide 
information relating to both classes of compounds. However, the initial 
approach was to assess the mutagenicity of APNG in the bacterial 
mutagenicity test of Ames et al. (1975) in addition to studying the effects of 
another N-nitroso peptide, N-acetyl valyl-N-nitrosoglycine (AVNG), and a 
selection of diazopeptides to compare their potential in vitro genotoxicity.
Once it could be estabhshed that these chemicals had similar mutagenic 
profiles in vitro, APNG could be used as a model compound in other assay 
systems.
Thus, it was the aim of this work to assess the genotoxicity of a N- 
nitrosopeptide, APNG, in a variety of genotoxicity assays, both in vitro and 
in vivo, to determine its site and mechanisms of action and its potential 
hazard to biological systems.
Initially APNG was tested in in vitro assays, including the Ames 
SaZTTZoTie/Za/mammahan microsome assay and CHO mutagenicity assays, to 
determine whether it had genotoxic potential and to estabhsh the nature of 
such damage. Following such studies an investigation of APNG genotoxicity 
was performed out in in vivo assays. Initially the in vivo studies were 
carried out using intraperitoneal dosing regimens to maximise possible 
effects. The studies employed a bone marrow metaphase analysis in rats.
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with a micronucleus assay in mice to measure somatic cell effects, and a 
dominant lethal assay in mice, to look for potential germ cell effects.
Once the genotoxic effects of APNG were estabhshed in vivo, 
investigations were made into some of the possible mechanisms involved 
and were extended to include the use of oral treatments. The oral route is 
a more physiological method of administration than the previously used 
intraperitoneal doses, the aim being to demonstrate that APNG was stable 
enough to pass through the gut, and remain active, and therefore any effects 
observed might be of greater biological significance. For this purpose a host- 
mediated (HMA) assay in mice was used; this type of assay also gives some 
information on the pharmacokinetic profile of the chemical in vivo. Both i.p. 
and oral regimes were compared using this system.
Following the HMA assays a variety of in vitro and in vivo 
unscheduled DNA synthesis (UDS) assays were employed to identify sites 
of potential genetic damage caused by A PN G . The hver was the main site 
for investigation, but the stomach and duodenum were also studied as 
potential target organs in vivo.
To further determine its mode of action, some attempts were made 
to examine DNA adduct formation using a ^^ P postlabelling technique. This 
was to be carried out in conjunction with Professor Chalhs who investigated 
adducts formed using hplc and/or Elisa immunological techniques.
Having estabhshed a genotoxicity profile for the nitrosopeptide (APNG) 
it was judged to be a potential carcinogen in rodents. It was decided that 
it was unnecessary to expose large numbers of animals to such an agent and 
that the potential carcinogenic hazard of APNG in vivo could be assayed in 
a restricted carcinogenicity study in mice, using both oral and i.p. regimens.
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Overall, the purpose of this work was to investigate a novel class of 
chemicals which may be formed in vivo and which could be involved in 
either tumour formation or heritable genetic damage in man.
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CHAPTER 2
THE in vitro MUTAGENICITY OF 
NITROSO- AND DIAZO- PEPTIDES
INTRODUCTION
The possibihty that nitrosated peptides maybe created under conditions 
similar to those found in the stomach (Chapter 1 ) and the fact that Chalhs 
et al. (1984) were able to synthesise and characterise two nitrosopeptides, 
N-acetyl prolyl-N-nitrosoglycine (APNG) and N-acetyl valyl-N-nitrosoglycine 
(AVNG), enabled the investigation of these agents for their potential 
mutagenicity. Chalhs also generously supphed a series of diazopeptides for 
examination to relate their possible mutagenicity to their stability. As with 
the investigation of any potential mutagenic compound, the initial screen 
employed was the Salmonella typhimuHum/m^sŒnmdXioiï microsome assay 
described by Ames et al (1975) and Maron and Ames (1983); this assay is 
usuahy referred to as the "Ames Test". The use of bacteria for screening 
chemicals for potential mutagenicity and carcinogenicity to humans is based 
on the premise that DNA is similar throughout hving organisms. Thus 
agents that affect DNA in one species are also hkely to damage the DNA 
of other species. As it is relatively simple to use and the induction of 
mutation in bacteria is an indicator of DNA damage in higher species, the 
use of the "Ames Test" has become widespread as a screen for the 
genotoxicity of chemicals and has been shown to correlate well with the 
activity of known genotoxic carcinogens (McCann et al. 1975; McCann and 
Ames, 1976; Sugimura et al. 1978; Ashby and Tennant, 1988; Ashby et al. , 
1989; Tennant and Ashby, 1991). In addition recent surveys, based on the 
US National Toxicity Programme, have promoted discussion to determine
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the vahdity of the Sahnonella/mammahan mutagenicityassay as a short­
term system for predicting chemical carcinogenicity (Tennant et al 1987; 
Zeiger, 1987).
In the assay histidine-dependent Salmonella typhimurium  strains revert 
to histidine independence, allowing the growth of colonies on histidine- 
deficient media. Trace amounts of histidine are present, sufficient to allow 
initial growth, which is presented as a fine lawn. The density of the lawn 
can be used to judge the toxicity of the chemical agents under study. 
Revertant colonies may arise firom dividing cells either spontaneously or by 
chemical induction following base-pair substitution or frame-shift mutation. 
The bacterial strains TA1530, TA1535, TAIOO and TA102 detect base-pair 
substitution mutation and strains TA1537, TA1538, TA97 and TA98 frame- 
shift mutation. The bacteria are particularly mutable since they lack a DNA 
repair mechanism {uvrB deficient) and possess a deep rough (r/a) mutation 
making the cell wall more permeable to potential mutagens. In addition 
strains TA97, TA98, TAIOO and TA102 carry a plasmid (pKMlOl) making 
them  more mutable by enhancing an error-prone DNA repair system which 
is normally present in these organisms. Strain TA102 carries, in addition, 
the multi-copy plasmid pAQI, each plasmid having an accessible region at 
which potential back mutations may occur.
Since most chemicals require metabolic transformation to produce active 
metabohtes, the assay is conducted with and without a mammalian 
microsomal mixture (S-9 mixture) derived from rat liver. It is also possible 
that the agent assayed could undergo detoxication to produce a less 
mutagenic product.
This chapter describes studies to determine the potential mutagenicity 
of the nitrosopeptides, APNG and AVNG, and also a series of diazopeptides. 
Only APNG was assessed with all the strains described above whereas all
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the other agents were assayed only in strain TAIOO. The amounts of the 
compounds synthesised were too small to allow for a more comprehensive 
programme and as strain TAIOO proved to be the best detector strain for 
APNG it was used for the mutagenicity assays with the other compounds.
EXPERIMENTAL
M aterials and m ethods
The compounds assayed were two nitrosopeptides and five 
diazopeptides. The nitrosopeptides APNG or AVNG were yellow 
crystalline solids and were synthesized and supphed by Professor B.C. 
ChaUis of the Open University, Milton Keynes, Bedfordshire 
previously of Imperial College, London. The diazopeptides were 
diazoacetylglycylglycine calcium salt (NGGG), diazoacetylglycine, ethyl 
ester (NGGE), diazo-2-hydroxypropio inylglycine ethyl ester (NSGE), 
diazoacetylglycine calcium  salt (NGG) and 2-diazo-4- 
methylpentanoylglycine ethyl ester (NLGE). As with the 
nitrosopeptides, these were also crystalline soUds and were 
synthesized and supphed by B.C. Chalhs. AU the compounds, in 
particular the diazopeptides, have short half hves and were stored in 
the dark, with desiccant, at between -15 to -20 “C. AU the 
compounds were used within 2  hours of dissolution (for NGG and 
NLGE within 30 minutes). AU of the compounds were purified by 
repeated ciystalhsation and the purity confirmed to be greater than 
95% using hplc analysis.
The negative controls were either sterile deionized water, 
ethanol or dimethylsulphoxide (DM80) depending on the vehicle used 
for the nitroso-compound, all of which do not alter or interfere with
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the assays at the concentrations used. The positive controls included 
sodium azide (NaAz), 9-aminoacridine (9AA), 2-nitrofluorene (2 NF), 
nitrosomethylurea (NMU), benzo(a)pyrene (BP) and 2- 
aminoanthracene (2 AA). The NMU was used as a positive control 
most likely to behave in a similar fashion to APNG and was thus 
assayed both in the presence and absence of S-9 despite the fact that 
it does not require metabohc activation. The positive controls were 
obtained from Sigma London Chemical Co. Ltd., Poole, Dorset.
The growth broth was supphed by Oxoid Ltd., Basingstoke, 
Hampshire, and the Vogel Bonner ’E’ plates from either Lab M Ltd., 
Salford, Lancs or SafePharm Labs Ltd., Derby, Derbyshire. AU other 
media were prepared In  house’ according to the methods of Maron 
and Ames (1983). Aroclor 1254 was a gift from the Monsanto 
Chemical Co., St. Louis, Missouri, USA. AU other chemicals were 
obtained from standard sources including the Sigma London Chemical 
Co. Ltd., Poole, Dorset and BDH Chemicals Ltd., Poole, Dorset. The 
disposable plastics were obtained from Sterihn, Hounslow, Middlesex.
Bacteria
The histidine-dependent strains of Salmonella typhimurium  
described as TA1530, TA1535, TA1537, TA1538, TA97, TA98, TAIOO 
and TA102 were originaUy supphed by Professor B.N. Ames, The 
University of California, Berkeley, California, U.S.A. The stock is 
maintained frozen in hquid nitrogen (in nutrient broth containing 
0.9% DMSG). Fresh cultures were always used. The thawed bacteria 
were grown overnight (16 hours) at 37 °C in nutrient broth with 
continuous shaking. The cultures were decanted into universal 
bottles and stored at 4°C until 30 minutes before use when the
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cultures were brought to room temperature. The following checks 
were carried out to ensure that the bacteria retain their expected 
characteristics:
i) rfa characteristic
All strains were tested for the presence of the 
deep rough (r/a) character by measuring their sensitivity 
to crystal violet. Nutrient agar plates were streaked 
with bacteria onto which a 6  mm filter disc, containing 
2 0  fjLg crystal violet in 2 0 /xl of water, was placed 
centrally. The growth was assessed after 16 hours; only 
those strains showing growth inhibition around the disc 
possessed the rfa character.
ii) Plasmids
Strains TA97, TA98, TAIOO and TA102 were 
checked for resistance to ampicillin as an indicator of 
the presence of thepKM lO l plasmid. Strain TA102 was 
also checked for resistance to tetracychne as an indicator 
of the presence of the multicopy pAQI plasmid. These 
tests are carried out by streaking the bacteria across a 
nutrient agar plate to which was added a 6  mm filter 
disc containing 10 pg  of ampiciUin for the pKM 101 
plasmid or 10 pg of tetracycline for the pAQI plasmid. 
The antibiotic discs used were preprepared and supplied 
by Difco, Illinois, USA. Growth inhibition around the 
disc indicated the absence of the relevant plasmid 
whereas growth up to the disc indicates the presence of 
the plasmid.
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iii) Sensitivity to diagnostic mutagens
For the APNG studies the reversion 
characteristics of each strain were checked using a spot 
test employing known mutagens. These mutagens were 
as follows: For strain TA1535, TAIOO and TA102: N- 
methyl-N’-nitro-n-nitrosoguanidine (MNN G) without 8-9 
activation. For strain TA1537 and TA97: 9-
aminoacridine (9AA) without 8-9 activation. For strain 
TA1538 and TA98: 2-nitrofluorene (2 NF) without 8-9 
activation.
The spot test was carried out as follows: To 2 ml 
of molten top agar, containing histidine (50 /LtM), and 
biotin (50 nM), was added 0 . 1  ml of an overnight culture 
of bacteria and if required the 8-9 mix. The resultant 
mixture was poured directly onto 20 ml Vogel Bonner E 
medium and allowed to set. A few crystals of the  
appropriate mutagen were subsequently added and the 
effects evaluated after two days.
M etabolic activation m ixture (8-9 m ix)
Male 8 prague-Dawley rats (180-250 g) were given a single 
intraperitoneal injection of Aroclor 1254 at 500 m g/kg in corn oil (200 
mg/ml). Three days following administration they were fasted for 16 
hours, killed and the hvers homogenised using a Potter type power- 
driven pestle and mortar ( 1  g hver: 3 ml Tris/KCl buffer pH 7.4). 
The homogenate was centrifuged for 20 minutes at 9,000 g and the  
supernatant frozen in ampoules in liquid nitrogen. The 8-9 activation 
system comprised of:-
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Thawed supernatant (25% w/v) - 1 0 % v/v  (final concentration) 
Nicotinamide adenine 
dinucleotide phosphate (NADP) - 4 mM
Glucose-6 -phosphate (G-6 -P) - 6  mM
Potassium chloride (KOI) - 33 mM
Magnesium chloride (MgClg) - 8  mM
Phosphate buffer - 0.1 M (pH 7.4)
When required, 0.5 ml of this mixture was added to the assay 
system and is referred to as the 10% 8-9 mixture.
Various batches were prepared, identified by the date of preparation 
and their ability to activate was confirmed using benzo(a)pyrene as 
the model mutagen with bacterial strain TA1538.
Salm onella/m am m alian m icrosom e m utagenicity assay 
procedures
For the spot test assays the procedure was as follows:
To tubes containing 2 ml of molten top agar, containing histidine (50 
/xM) and biotin (50 /xM), was added 0.1 ml of the bacterial strain and 
if  required the 8-9 mix. The resultant mixture was poured directly 
onto 20 ml Vogel Bonner E medium and allowed to set. An antibiotic 
filter disc was then placed in the centre of each plate to which was 
added the compound (50 /xl of 25 m g/m l solution i.e. 1.25 mg of 
APNG). The plates were incubated at 37 “C for two days and 
assessed visually for an increase in the number of revertants and for 
signs of toxicity.
For the plate incorporation studies the procedure was as 
follows:
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Two ml of molten top agar, containing histidine (50 /xM) and 
biotin (50 jtxM), was added to plastic disposable test tubes, followed by 
0 . 1  ml of the bacterial strain, the relevant quantity of the mutagen 
and when required the 8-9 mix. The resultant mixture was poured 
directly onto 20 ml Vogel Bonner E medium and incubated for three 
days at 37 "C. The resulting colonies were counted with an Artek 
automatic colony counter (Dynatech Labs Ltd., Billingshurst, 8 ussex) 
and the plates evaluated visually for the presence of background lawn 
of growth. The data are presented as the mean number of colonies 
per plate for tripUcates (standard deviations are not used as the 
measure of variance from three plates is not normally relevant in the 
analysis of Ames data). The correlation coefficient (C) for the strains 
did not usually exceed 15%, except for strain TA1537 where colony 
counts less than 15 produce a C value of up to 25%. In the absence 
of any toxicity to the bacteria, a mean colony count of double the 
experimental control (spontaneous reversion) was considered to 
represent a mutagenic response (Ames, McCann & Yamasaki, 1975). 
A concentration dependent response is also required but no analyses 
were carried out unless the result was equivocal. Toxicity to the 
bacteria was indicated by a sparse or absent background lawn. In 
addition, plates that appeared to have an increase in revertants were 
checked to establish that the colonies were histidine independent and 
thus true revertants. That is, false revertants could arise in the 
absence of a background lawn and any surviving His^ 
bacteria could utihse the trace amounts of histidine present in the top 
agar and grow to appear as revertant colonies. These "pseudo" 
revertants colonies would not however grow on Vogel Bonner ’E’ 
plates supplemented with biotin only.
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Experim ental design
The experiments were carried out in three distinct phases. 
Initially APNG was studied, followed by AVNG and finally the series 
of diazopeptides.
APNG, being the first of the compounds to be synthesised, was 
comprehensively studied. Initially it was investigated using the spot 
test, both in the presence and absence of a 10% 8-9 mixture. APNG 
(1.25 mg) was added to plates seeded with the bacterial strains 
TA1535, TA1537, TA1538, TA97, TA98, TAIOO and TA1 0 2 . This was 
followed by a toxicity assay in a plate incorporation study using strain 
TAIOO where APNG was assayed at 0 - 5000 /xg/plate both in the 
presence and absence of a 10% 8-9 mixture. Having estabhshed that 
5000 /Ltg/plate was the concentration causing minimal toxicity, two 
plate incorporation studies were carried out. In the first series of 
studies APNG was investigated in strains TA1530, TA1535, TA1537, 
TA1538, TA98, TAIOO and TA102 at concentrations of 0 - 5000 
/xg/plate, both in the presence and absence of a 10% 8-9 mixture. 
The mutagenicity of APNG was further studied in strains TA1535, 
TAIOO and TA102 at concentrations of 0 - 5000 /xg/plate with 
intermediate concentrations selected to give a better profile of the 
mutagenicity curve and in strains TA1537, TA1538 and TA98 at the 
concentrations used in the first plate incorporation study, both in the 
presence and absence of a 10% 8-9 mixture.
AVNG was subsequently investigated in two plate incorporation 
studies. In the first, the mutagenicity of AVNG was investigated 
using bacterial strain TAIOO at concentrations of 0 - 5000 /xg/plate 
both in the presence and absence of a 10% 8-9 mixture. The repeat 
study, in strain TAIOO, employed the same range of concentrations
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but with different intermediate concentrations, both in the presence 
and absence of a 10% S-9 mixture. The differing concentrations in 
the repeat study were chosen to present a better profile of the 
mutagenicity curve. The diazopeptides were studied at various times 
and with differing concentrations of 0 - 5000 /xg/plate. However they 
were all investigated using strain TAIOO in the presence and absence 
of a 10% S-9 mixture. Initially NGG, NGGG, NSGE and NLGE were 
assayed using doses of 0 - 5000 /xg/plate, with NGGE being studied at 
0 - 1000 jug/plate. The concentrations were selected at log intervals 
up to 1000 jLtg/plate with one higher concentration of 5000 /xg/plate 
(the normal highest concentration used in screening studies within 
our laboratoiy). NGGE was only assayed at doses up to 1000 /xg/plate 
due to the unavailability of the compound. In the repeat studies 
NSGE, NLGE and NGGE were investigated as previously described. 
However NGG was investigated using doses of 0, 10, 50, 200, 1000, 
2500 and 5000 /xg/plate and NGGG with 0,100, 500, 1 0 0 0 , 2500 and 
5000 /Ltg/plate. These concentrations were selected so as to provide 
a better representation of the mutagenicity curve.
RESULTS
APNG
The results of the spot test are shown in Table 2 .1 . APNG  
displayed no mutagenicity in strains TA1537, TA1538 and TA98. A 
weak positive mutagenic response was seen in strain TA1535, a 
positive mutagenic response in strain TA97 and a strong mutagenic 
response in strain TAIOO and TA102. The positive results were 
independent of the addition of an S-9 mix.
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The results of the preliminary toxicity assay are shown in 
Table 2 .2 . There was inadequate growth of the background lawn in 
strain TAIOO, without an S-9 mix, at 5000 /xg/plate APNG indicating 
toxicity. As the toxicity was confined to this concentration it was 
decided to use this as the highest dose for the subsequent plate 
incorporation studies. It was noted during the preliminary toxicity 
study that APNG gave a positive response both in the presence and 
absence of an S-9 mix, the response being slightly higher in the 
presence of the S-9 mix.
The plate incorporation assay results are shown in Tables 2.3 
and 2.4. Concentration-dependent increases in mutagenicity were 
observed in strains TA1530, TA1535, TAIOO and TA102 both in the 
presence and absence of S-9 mix. The responses were usually greater 
in the presence of S-9 mix, particularly at the highest level of APNG. 
It was noted that at the highest concentrations of APNG (3500-5000 
/xg/plate), in the absence of S-9, toxicity was seen to varying degrees; 
these effects were abohshed when the S-9 mixture was present.
Several mutagenicity values that were greater than double the 
were seen
spontaneous valuesj^in strains TA1537, TA1538 and TA98, but these 
effects were not reproducible and were thus considered artifacts.
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Table 2.1.
Effect o f APNG on reversion of Salmonella typhimurium 
strains in  the Ames Spot Test
Strain
TA
Result
Without S-9 Mix With 10% S-9 Mix
1535 + +
1537 - -
1538 - -
97 ++ ++
98 - -
100 +++ +++
102 +++ +++
Approximately 1.25 mg APNG was placed centrally on a plate containing 
0 . 1  ml of an overnight culture of the indicated strain.
Negative
+ Weak positive (low number of observed mutants 
< 2 0  in the ring)
+ + Positive (between 20 and 200 mutants in the 
ring)
+ + + Strong positive (>200 mutants in ring)
No zone of inhibition was observed indicating low toxicity 
APNG = N-acetyl prolyl-N-nitrosoglycine
Sodium azide was used as a positive control in a spot test to confirm that 
the strain used was mutable
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Table 2.2.
Preliminary toxicitv assay with APNG on Salmonella 
typhimurium  TAIOO in the Ames plate incorporation assay
Compound and 
concentration 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mix
APNG
0 (HgO) 113 107
1 125 142
10 124 149
100 175 249*
1000 857* 918*
5000 490# 1688*
BP
5 1628*
The results are presented as the mean number of revertant colonies 
from three plates.
APNG
BP
#
*
= N-acetyl prolyl-N-nitrosoglycine 
= benzo(a)pyrene 
= sparse lawn
= value greater than twice the control figure and 
may be considered a positive mutagenic response.
A spot test was carried out with all strains, using the relevant mutagen 
as a positive control, in the absence of S-9.
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Table 2.3.
The mutacfenicitv of APNG in the Ames Salmonella 
typhimurium strains 
First study
Mean number of revertants/plate
Compound and 
concentration 
(/xg/plate)
10%
S-9
mix
Strain TA
1535 1537 1538 98 100 102
APNG
0 - 14 7 18 25 105 206
10 - 13 5 16 23 115 200
50 - 16 8 18 22 116 199
200 - 18 16* 16 24 210* 229
1000 - 31* 11 18 24 664* 387
5000 - 94* ## 32# # 1152* 452*
NMU
100 — 347* 11 18 57* 1243* 850*
APNG
0 + 15 11 23 28 100 212
10 + 15 10 18 24 103 189
50 + 15 13 16 27 162 209
200 + 19 12 19 27 247* 200
1000 + 37* 10 24 35 599* 291
5000 + 66* 31* 36 57* 1468* 1022*
NMU
100 + 590* 11 20 28 1271* 736*
BP
5 + 911*
The results are presented as the mean number of revertant colonies 
from three plates.
* = v^ue greater than twice the control figure and
may be considered as a positive mutagenic effect.
#  = sparse lawn
# #  = absent lawn
APNG = N-acetyl prolyl-N-nitrosoglycine
NMU = nitrosomethylurea
BP = benzo(a)pyrene
A spot test was carried out with all strains, using the relevant mutagen as a 
positive control, in the absence of S-9.
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Table 2.4.
The mutagenicity of APNG in the Ames Salmonella 
typhimurium  strains 
Second study
Compound 
and Cone 
(/xg/plate)
Mean number of revertants/plate
10%
S-9
mix
Strain
1530 1535 1537 1538 98 100 102
APNG
0 - 9 13 13 20 37 110 211
10 - 16 22 53
50 - 12 22 41
200 - 15 18 22 43
500 - 31* 17 332* 229
1000 - 52* 23 14 25 53 774* 252
2000 - 118* 30* 1399* 337
3500 59# 742# 537*
5000 - 191* 11# 2# 3## 37 372# 447#
NMU
100 - 1213* 23 43 1332* 730*
APNG
0 + 9 18 20 33 26 123 216
10 + 10 29 34
50 + 9 24 32
200 + 8 8 30 33
500 4- 21* 23 334* 246
1000 4- 86* 35 9 25 42 515* 276
2000 4- 44 49* 701* 307
5000 4- 41* 10 19 50 1001* 682*
7500 88* 49* 1190* 1006*
NMU
100 4- 1258* 11 26 39 1508* 732*
BP
5 4- 917*
The results are presented as the mean number of revertant colonies 
from three plates.
* = value greater than twice the control figure and
may be considered as a positive mutagenic effect.
#  = sparse lawn
# #  = absent lawn
APNG = N-acetyl prolyl-N-nitrosoglycine
NMU = nitrosomethylurea
BP = benzo(a)pyrene
All the strains were checked for a positive response using standard mutagens in a 
spot test
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In both studies with APNG the positive control, NMU 
responded well and was mutagenic in strains TA1535, TAIOO and 
TAX02, both in the presence and absence of S-9 mix. Moreover, in 
the first study, NMU gave a shght increase in strain TA98 without 
S-9 mix but this result was not reproducible. The other positive 
control, benzo(a)pyrene, gave the expected mutagenic response in all 
studies.
AVNG
The results of the mutagenicity studies are shown in Tables 2.5 
and 2.6. In both studies concentration-related increases in 
mutagenicity were observed. The response was greater with S-9 as 
the toxicity seen at 5000 /itg/plate, in the absence of S-9, was 
abolished.
In both studies the positive control (benzo(a)pyrene) gave the 
expected result.
Diazopeptides
The results are shown in Tables 2.7. to 2 .1 1 . 
Concentration-related increases in mutation were seen with NGGE, 
NGGG, NSGE and NGG, independent of the S-9 mixture. The 
mutagenic responses of NGGG, NGG and NSGE were similar, but 
NGGE proved to be considerably more potent with mutagenic effects 
being seen at concentrations as low as 1 0  /xg/plate. NLGE displayed 
no mutagenicity at the doses studied. All the positive controls used 
gave the expected mutagenic response.
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Table 2.5.
The mutasfenicitv of AVNG in  Salmonella typhimurium 
strain TAIOO in  the Ames plate incorporation assay
First study
Compound and Mean number of revertants/plate
Concentration ------------------------------------------
(Mg/plate) Without S-9 Mix With 10% S-9 Mix
AVNG
0 110 121
10 123 143
50 159 160
200 226* 263*
1000 842* 843*
5000 961# 1769*
BP
5 541*
The results are presented as the mean number of revertant colonies 
from three plates.
#  = sparse lawn
* = value greater than twice the control figure and
may be considered a mutagenic result.
APNG = N-acetyl valyl-N-nitrosoglycine
BP = benzo(a)pyrene
Sodium azide was used as a positive control in a spot test to confirm that the 
strain used was mutable
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Table 2.6.
The mutagenicity of AVNG in Salmonella typhimurium
strain TAIOO in the Ames plate incorporation assay
Second study
Compound and 
Concentrâtion 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mix
AVNG
0 150 180
200 201 201
500 257 231
1000 586* 402*
2500 1342* 1333*
5000 110# 760*
BP
5 725*
The results are presented as the mean number of revertant colonies from three 
plates.
= sparse lawn
= value greater than twice the control figure and 
may be considered a mutagenic effect.
= N-acetyl valyl-N-nitrosoglycine 
= benzo(a)pyrene
#
*
AVNG
BP
Sodium azide was used as a positive control in a spot test to confirm 
that the strain used was mutable
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Table 2.7.
The m utagenicity o f NGGG in  Salmonella typhimurium 
strain TAIOO in  the Ames nlate incorporation assay
Compound and 
Concentration 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mix
Study 1 Study 2 Study 1 Study 2
NGGG
0 (Ethanol) 82 132 94 108
1 97 90
10 103 93
100 133 129 134 97
500 186 176
1000 246* 252 351* 283*
2500 387* 378*
5000 624* 589* 553* 605*
NaAz
5 801* 1163*
2AA
4 1849* 863*
The results are presented as the mean number of revertant colonies 
from three plates.
* = value greater than twice the control figure and
may be considered a mutagenic effect.
NGGG = diazoacetylglycylglycine calcium salt
NaAz = sodium azide
2AA = 2 aminoanthracene
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Table 2.8.
The mutagenicity of NGGE in Salmonella typhimurium
strain TAIOO in the Ames nlate incorporation assay
Compound and 
Concentration 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mix
Study 1 Study 2 Study 1 Study 2
NGGE
0 (Ethanol) 96 106 100 109
0.1 104 105 116 123
1 156 183 178 186
10 683* 826* 565* 790*
100 1373* 1426* 1284* 1378*
1000 1694* 1894* 1667* 1778*
NaAz
5 707* 1163*
2AA
4 1849* 963*
The results are presented as the mean number of revertant colonies 
from three plates.
* = value greater than twice the control figure and
may be considered a mutagenic effect.
NGGE = diazoacetylglycine ethyl ester
NaAz = sodium azide
2AA = 2 aminoanthracene
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Table 2.9.
The mutagenicity of NSGE in Salmonella typhimurium
strain TAIOO in the Ames plate incorporation assay
Compound and 
Concentration 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mi:
NSGE
0 (Ethanol) 84 102
10 88 82
100 113 105
1000 371* 333*
5000 1086* 1001*
NaAz
5 1686*
2AA
4 658*
The results are presented as the mean number of revertant colonies from three 
plates.
* = value greater than twice the control figure and
may be considered a mutagenic effect.
NSGE = diazo-2 -hydro3yproprionylglycine ethyl ester
NaAz = sodium azide
2AA = 2 aminoanthracene
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Table 2.10.
The mutasfenicitv of NGG in Salmonella typhimurium
strain TAIOO in the Ames plate incorporation assay
Compound and 
Concentration 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mix
Study 1 Study 2 Study 1 Study 2
NGG
0 (Ethanol) 47 46 50 58
1 47 44
10 52 36 52 49
50 56 67
100 102* 97
200 123* 123*
1000 406* 179* 379* 176*
5000 861* 430* 722* 515*
NaAz
5 1592* 686*
2AA
4 208* 645*
The results are presented as the mean number of revertant colonies 
from three plates.
* = value greater than twice the control figure and
may be considered a mutagenic effect.
NGG = diazoacetylglycine calcium salt
NaAz = sodium azide
2AA = 2 aminoanthracene
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Table 2.11.
The mutagenicity of NLGE in Salmonella typhimurium
strain TAIOO in the Ames plate incorporation assay
Compound and 
Concentration 
(/xg/plate)
Mean number of revertants/plate
Without S-9 Mix With 10% S-9 Mix
Study 1 Study 2 Study 1 Study 2
NLGE
0 (Ethanol) 89 86 87 105
1 89 105
10 97 107 93 105
100 93 111 101 118
1000 91 111 121 97
5000 89 132 100 93
NaAz
5 801* 1263*
2AA
4 1849* 986*
The results are presented as the mean number of revertant colonies 
from three plates.
* = value greater than twice the control figure and
may be considered a mutagenic effect.
NLGE = 2-diazo-4-methylpentanoylglycine ethyl ester
NaAz = sodium azide
2AA = 2 aminoanthracene
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Other possible reasons for the protection against toxicity at the top doses 
include the possibility that in the presence of S-9 detoxifying enzymes are 
present that only are effective at high concentration. Alternatively it is 
possible that the pH or osmolarity of the solutions could interfere with 
the bacteria.
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DISCUSSION
The results of the studies with Salmonella typhimurium  described in 
this chapter demonstrate that both nitroso- and diazo-peptides are 
mutagenic.
For APNG, the first compound investigated, it is evident that it is a 
base-pair mutagen giving responses in strains TA1630, TA1535, TAIOO and 
TA102. Moreover it was noted that the mutagenic response was 
independent of the presence of an S-9 mixture, it was only at the highest 
doses, 5mg/plate and above, where a greater effect was seen with S-9. This 
effect demonstrates that APNG is a direct-acting mutagen that is neither 
activated nor inactivated by the presence of a mammahan microsomal 
enzyme mixture (S-9) but that the presence of S-9 can protect against 
toxicity at high doses. The higher mutation observed, at the highest 
concentrations, in the presence of the metabohc mixture is probably due to 
the S-9, where the increased protein levels protect against toxicity. The 
most sensitive bacterial strain was TAIOO and it is this strain that was 
subsequently used to assess the potential mutagenicity of AVNG and the  
various diazopeptides.
AVNG also proved to be a mutagen in strain TAIOO. The levels at 
which effects were seen, the magnitude of the responses and the increased 
effects with S-9 are similar to those seen with APNG.
Anderson et al (1986) investigated APNG and AVNG for genotoxicity 
in mammahan ceUs using the established hne of Chinese hamster ovary cells 
(CH0-K1-BH4). Three indices of damage were assessed namely chromosome 
aberrations (CA), sister chromatid exchange (SCE) and induction of 
thioguanine-resistant variants (HGPRT). Treatment of cells with either 
APNG or AVNG resulted in dose-dependent increases in all three indices
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and as the studies were carried out in the absence of S-9 it was concluded 
that both compounds were direct-acting mutagens.
The diazopeptides were mutagenic in strain TAIOO to varying degrees, 
with the exception of NLGE which was not mutagenic. NGGE proved to be 
mutagenic at much lower concentrations than NGGG, NSGE and NGG 
which all had similar mutagenic profiles. The order of mutagenic potency 
relates, to some degree, to their stabihties (Table 2.12).
Table 2.12.
The relative stabilities as rate coefficients 
k^rPiazopeptidel for the decom position of 
the diazopeptides at 25 ° C
Diazopepitide lO^kgsec^^ Mutagenicity
NGGE 0.99 ++++
NGGG 1.63 ++
NSGE 3.25 +++
NGG 4.2 ++
NLGE 42.7
+ + to + + + + degree of mutagenicity, 
non-mutagenic.
Reprinted with the permission of B.C. Chalhs (Personal conmiunication)
The most stable and most mutagenic diazopeptide was NGGE with 
NLGE being the least stable and least mutagenic. The relationship between  
the other three is less clear but they do fall between the extremes.
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Unlike the nitrosopeptides, (APNG and AVNG) which are novel 
compounds, diazopeptides have been previously synthesised and 
investigated. The biological properties of these N-(2-diazoacetyl) compounds 
have attracted interest and have been shown to induce pulmonary tumours 
and leukaemias (Brambilla et al. 1970, 1972), have anti-tumour activity 
(Baldini and Brambilla, 1966; Sava et al. 1979; Giraldi and Nisi, 1976) and 
antimetastatic activity (Giraldi et al. 1979). It has also been shown that 
diazopeptides form readily under simulated gastric conditions (Chalhs et al. 
1987a) and also from gaseous nitrogen oxides in serum and blood (Challis et 
al. 1987b). The formation under gastric conditions occurs in a similar 
fashion to that of APNG and AVNG (Challis, personal communication).
As the diazopeptides are both unstable and difficult to synthesize, the 
nitrosopeptides may prove to be good model compounds for 
mutagens /carcinogens of this class, both probably acting foUowing 
breakdown to generate carbonium ion intermediates. The increased 
stabihty and comparative ease of manufacture of the nitrosopeptides wül 
aUow for greater scope of use in both in vitro and in vivo biological systems.
Summarising, it was shown that the nitrosopeptides are direct-acting 
genotoxins in the base-pair detecting Ames Salmonella typhimurium  strains 
and as previously estabhshed in the in vitro CHO systems (Anderson et 
al.,1986). It was also demonstrated that diazopeptides may also be 
mutagenic, their potency being related, to some extent, to their stabihty. 
Finahy it is beheved that the nitrosopeptides are the more promising 
compounds to use for further studies and may act via an active carbonium 
ion, as do the diazopeptides.
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CHAPTERS
THE in vivo GENOTOXICITY OF APNG
INTRODUCTION
Following the completion of the in vitro assays,where APNG was found 
to be a direct acting mutagen, a series of studies were designed to determine 
if APNG possessed genotoxic potential in vivo.
A variety of assays has been developed to investigate the in vivo 
genotoxicity of potential mutagens. Among those commonly used are the 
bone marrow metaphase analysis and the micronucleus assay in rodents, 
both being somatic cell genotoxicity assays, and the dominant lethal assay 
in rodents which detects germ cell damage. These assays have been 
recommended in the guidelines of various regulatory authorities (DOH, 
1989) and the methods described by learned societies e.g. the United 
Kingdom Environmental Mutagen Society (UKEMS), as useful for the 
identification of in vivo genotoxic agents. Such assays give some 
understanding of the type of genetic damage caused. This chapter describes 
the investigation of the potential of APNG to cause genetic damage using 
the in vivo bone marrow metaphase assay in rats and the dominant lethal 
and micronucleus assays in mice.
Acute toxicity studies were performed, prior to carrying out the above 
assays, to determine suitable dose levels. Initially an intraperitoneal dosing 
regimen was selected to maximise the potential effects of APNG in the 
absence of any in vivo data on this type of agen t.
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The bone marrow m etaphase analysis in  rats
The bone marrow metaphase analysis assay can detect direct 
damage to chromosomes and although the damage detected is often 
lethal its presence indicates more subtle chromosome damage, in 
other cells, which may then lead to heritable cytogenetic 
abnormahties (Richold et al., 1990),. The rat, mouse and Chinese 
hamster have all been used in this assay (Goetz et al., 1975). 
Although the Chinese hamster has a more easily identifiable 
karyotype, with fewer chromosomes (2 2 ) than the other species, the 
rat was selected since more background data are available, and this 
is generally the species of choice. Both sexes were used as it has 
been reported by Bateman (1984) that the bone marrow metaphase 
analysis assay can detect sex differences. Furthermore, both single 
and multiple (5 day) intraperitoneal dosing regimens were employed 
as the bone marrow cell population is asynchronous and it is possible 
that an agent may exert genotoxic effects at various stages of the cell 
cycle.
The dominant lethal assay in  m ice
The dominant lethal assay is rarely used for the routine 
screening of potential genotoxins as no compound has been shown to 
cause genetic damage in specific germ cell systems without showing 
effects in somatic cell assays (Richold et al., 1990). However, the use 
of a dominant lethal assay can be important in identifying the type of 
genetic damage caused by a genotoxic agent. The dominant lethal 
assay provides data related to heritable damage which may have 
consequences in subsequent generations in addition to giving
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information on the potential of an agent to cause genotoxic damage 
which may lead to cell death or neoplasia. The somatic cell assays 
only provide information on the later type of damage.
The dominant lethal assay is used to detect agents which 
produce chromosomal aberrations in sperm and thus affect the 
viabihty of the progeny (Bateman, 1966; Green et al., 1987). This 
effect on the progeny in mammals will reduce htter size. The deaths 
before implantation are presented as a discrepancy between the 
numbers of eggs shed and counted as corpora lutea (in rat), and the 
number of implants. In mice the counting of corpora lutea is difficult 
and the pre-implantation loss is usually inferred from the reduction 
in the average number of implants per uterus when compared with 
those in control matings (Bateman, 1984). Those eggs which implant, 
after development, may be classified either as hve embryos (normal 
or abnormal), late deaths (where there is evidence of the growth of 
foetal and placental material) or early deaths (‘moles’ or early 
resorptions where there is no evidence of foetal or embryonic 
material). Protocols vary extensively but two are commonly used, 
being reconunended by the UKEMS (Anderson et al., 1983). One 
involves the treatment of male animals with either a single dose or 
five consecutive daily doses of the chemical in question. These male 
animals are then mated to females, weekly for 8  weeks (mice) or for 
10 weeks (rats). This protocol allows for individual phases of 
spermatogenesis to be investigated. Failure of development of 
foetuses within a particular week will indicate which spermatogenic 
phase has been affected. This method uses a large number of 
animals.
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The other protocol (Anderson et aZ., 1983), uses a smaller 
number of animals where the males are treated throughout the 
period of spermatogenesis (either once weekly or daily) and mated to 
one or two groups of females after the treatment has finished. This 
protocol does not allow for effects on specific phases of 
spermatogenesis to be identified but gives an overall assessment of 
damage.
The mouse was used for the dominant lethal studies reported 
in this thesis. Both protocols have been used to study the potential 
effects of APNG after intraperitoneal administrations and in one 
study the use of an oral dose was included.
The bone marrow m icronucleus analysis in  m ice
The micronucleus assay, like the metaphase analysis assay, 
evaluates chromosomal damage in somatic cells. However, it is 
considered to be as equally sensitive as the metaphase studies and it 
was considered to be a suitable assay to study further the effect of 
APNG on somatic cell tissues.
The method for the detection of micronuclei in bone marrow 
was developed by Schmid and coworkers (1971; 1976) who showed 
that the majority of micronuclei occur in very young erythrocytes and 
that an increase in numbers may be seen after treatment with 
mutagens. These micronuclei arise from chromosomal fragments or 
from whole chromosomes that are not incorporated into the daughter 
nuclei at the time of cell division. Whole chromosomes or fragments 
can be differentiated by kinetophore staining techniques (Miller & 
Adler, 1989)
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Micronuclei are easy to detect in red blood cells, since unlike 
other cell types red blood cells have no nuclei. A few hours after 
completion of the last mitosis, erythroblasts expel their nuclei, but 
any micronuclei present remain in the cytoplasm of the young 
erythrocytes and are easily recognised. These immature erythrocytes 
stain differently from older forms; for approximately 24 hours the 
newly formed erythrocytes stain blue (with May Grunwald and 
Giemsa stains) and are known as polychromatic erythrocytes (PCE), 
whereas the mature forms stain red and are known as 
normochromatic erythrocytes (NCE). If the scoring is restricted to 
micronuclei seen in PCEs it is inferred that these anomalies had 
arisen during the course of the previous mitosis and that changes in 
the number seen within treatment groups is due to the agent studied. 
The NCE to PCE ratio is normally 1:1 and this is also assessed. 
Changes in this ratio indicate marrow toxicity, where a decrease in 
PCEs is often accompanied by an influx of NCEs.
The mouse is the usual species of choice and according to the 
Collaborative study group (1986) male mice alone are considered 
sufficient for general screening due to their higher susceptibihty. 
Treating the mice twice, 24 hours apart, is recommended with the 
marrow being sampled 24, 48 and 72 hours after the second 
treatment. Three samphng times span the intervals over which 
maximum frequencies of micronuclei are known to occur. This 
regimen was used with APNG and is reported in this chapter.
59
s  Jî.Blowers - PhD Thesis The in vivo genotoxicity of APNG
EXPERIMENTAL
M aterials and methods
The compound studied was APNG. The negative control for the 
assay was the solvent used with APNG, physiological saline (0.9%). 
APNG was dosed either as a solution, or in the case of the high doses, 
as a fine suspension. The positive control agents were 
cyclophosphamide (CTX) for the micronucleus and dominant lethal 
assay and mitomycin C (MMC) for the bone marrow assay. All media 
and chemicals were obtained from standard sources including the 
Sigma London Chemical Co. Ltd., Poole, Dorset and BDH Chemicals 
Ltd., Poole, Dorset. The microscopes used in these assays were 
supphed by either Leitz, Ernst Leitz Wetzko GMBH, West Germany 
or Zeiss, Carl Zeiss GMBH, West Germany.
Animals
In the rat bone marrow assay and the acute toxicity study male 
Sprague-Dawley rats, 8-10 weeks old were used these were obtained 
firom Charles River, Margate. For the acute toxicity studies in mice 
8 - 1 0  week old mice were used; for the dominant lethal assay sexually 
mature male and female mice 8 - 1 0  weeks old were used and for the 
micronucleus assay 10-12 week old male mice were used. These mice 
were obtained firom Harlan Olac, Kent. All the animals were fed Rat 
and Mouse N o.l diet (Special Diet Services, Witham). The diet was 
given ad libitum  with unhmited access to mains tap water. The 
animals were housed in groups in plastic and stainless steel, solid 
floor cages and were kept in ventilated rooms under the following 
conditions:-
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Temperature: 20-25 “ C
Humidity: 45-75%
Lighting: 12 h hght: 12 h dark
(06.00-18.00 h; 18.00-06.00 h GMT
Acute toxicity studies
Prior to the in vivo genotoxicity studies the LD^ o of APNG was 
determined for both rats and mice (male and female). Groups of 5 
animals (male and female) were used and treated with various doses 
of APNG up to 2 g/kg bodyweight. Three studies were carried out; 
two using single dose regimens, in mice and rats and one using five 
daily doses in rats. The animals were observed for two weeks and, 
the mortahties recorded and the LD50 calculated using the method of 
Litchfield and Wilcoxon (1949). In addition the surviving animals 
were examined after a gross post-mortem examination for signs of 
tissue damage; any organs that were abnormal were preserved in 
formalin, sectioned and examined under the microscope. Based on 
the values obtained, it was decided to study APNG at a single dose of 
200 m g/kg bodyweight and a multiple dose of 50 m g/kg bodyweight 
per day in the rat bone marrow metaphase assay (both approximately 
half the LD50 value); at 180 m g/kg bodyweight for the highest dose in 
the mouse dominant lethal assay and with two doses of 1 0 0  m g/kg  
bodyweight (i,e. 2 0 0  m g/kg bodyweight in total) in the mouse 
micronucleus assay.
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The bone marrow m etaphase analysis in  rats
Five groups of ten, 8-10 week old, male rats were used. A 
single dose study was carried out on three groups given ip doses of 
the vehicle control, 200 m g/kg bodyweight APNG or MMC at 3.5 
m g/kg bodyweight. The bone marrow was sampled 24 hours after 
the administration. The remaining two groups were given 
intraperitoneal doses of the vehicle control or 50 m g/kg bodyweight 
APNG for five consecutive days. The bone marrow was sampled 6 
hours after the final dose. Two hours before samphng the mitotic 
inhibitor colchicine was injected intraperitoneaUy at 2 m g/kg  
bodyweight.
The animals were killed by cervical dislocation, both femurs 
removed, cleaned with a piece of lint, and the bone marrow aspirated 
into 10 ml of Hank’s balanced salt solution (HBSS) in a centrifuge 
tube using a syringe and needle. The tubes were centrifuged for 
approximately 5 minutes at 115 g and the supernatant discarded. 
The peUet was resuspended in the remaining small volume of hquid 
and 5 ml of 0.075 M potassium chloride (at 37 “ C) was added dropwise 
with mixing, and incubated for 20 minutes at 37 “ C. Fixative (0.5 ml 
of 3:1 methanol: acetic acid) was added dropwise with shaking. The 
resultant mixture was allowed to stand for 20 minutes at room 
temperature. This was centrifuged at 115 g for 5 minutes, the  
supernatant discarded and the ceUs were suspended in the remaining 
small volume. Two ml of fixative (as above) was then added dropwise 
with mixing and centrifuged at 115 g for a further 5 minutes and this 
step was repeated twice. The remaining pellet was made up to 0.5 ml 
with hresh fixative.
62
S.D.Blowers - PhD Thesis The in vivo genotoxicity of APNG
Metaphase spreads were prepared by allowing one or two drops 
of the suspension to fall onto clean wet slides. These were dried on 
a hot plate (at 60 ° C) with two shdes prepared per animal. These 
were stained with Giemsa (1 ml Giemsa in 40 ml water for 3 
minutes) dried and mounted using DPX mounting medium.
The shdes were coded by aUocation of random numbers and 
examined at xl20 magnification until suitable metaphase spreads 
were found. These spreads were then examined at xl200  
magnification, under oil immersion, for chromatid or chromosome 
aberrations (gaps, breaks and other damage). The method used was 
that described by Preston et al., 1987. The code was broken only 
when ah the slides were scored.
The dom inant lethal assay in  m ice
All the studies were based on the recommendations of 
Anderson et al. (1984) but with adaptations designed to ehcit the 
maximum response. These adaptations allowed for the animals to be 
examined near term for both dominant lethal and teratological effects 
(Jenkinson et al. 1987).
Study 1: Groups of 20 sexuahy-mature male mice were given 
a single intraperitoneal dose of APNG at 18, 60 and 180 m g/kg  
bodyweight body weight, or the control vehicle, saline. Every 
week for eight consecutive weeks each male was housed with 
two virgin females. Mating was confirmed by the presence of 
vaginal plugs. The females were killed on day 18 after mating 
(those unplugged were killed on the 18th day after the initial 
pairing) and the uteri examined for the numbers of five
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implants, early and late deaths and abnormalities. These were 
then evaluated for dominant lethahty or teratogenic effects, by 
evaluating the numbers of dead and abnormal foetuses.
Study II: Groups of 40 sexually-mature male mice were given 
a single intraperitoneal dose of APNG at 60 m g/kg bodyweight. 
During week 3, each male was housed with one virgin female 
and during week 4, with 3 virgin females. Mating and 
examinations were carried out as described for Study I
Study III Groups of 10 sexually-mature male mice were dosed 
with APNG once a week for eight weeks, either orally at 100 
m g/kg bodyweight or by intraperitoneal injection at 20 or 60 
m g/kg bodyweight. Two groups of 5 mice were similarly dosed 
with the solvent control.
After 8 weeks, each male was housed, for two 
consecutive weeks, with four females. The females were 
examined 18 days after first introducing the males and 
examined as for study I.
The bone marrow m icronucleus analysis in  m ice
Three groups of 24,10-12 week-old male CD-I mice were given 
two intraperitoneal injections, 24 hours apart, of the vehicle control 
(distilled water), APNG at 100 m g/kg bodyweight per day or CTX, 
the positive control, at 50 m g/kg bodyweight per day. Groups of 8 
mice from each group were randomly selected and killed by cervical 
dislocation 24, 48 or 72 hours after the second injection. The femurs
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were removed, cleaned with lint and the ends removed. The marrow 
was aspirated using a syringe and needle into foetal calf serum in a 
centrifuge tube. The cells, in serum, were further aspirated, several 
times, through the needle, until the bone marrow was present as a 
fine suspension. The tubes were centrifuged at 180 g for 5 minutes 
and the supernatant removed. The remaining hquid was mixed by 
gently fiicking the tubes and a smaU drop was drawn between two 
cleaned slides. The shdes were air dried and fixed in methanol for 20 
minutes. They were then stained with May-Grumwald (1:1 with 
Gurrs buffer pH 6 .8 ) for 5 minutes followed by Giemsa (1:9 with 
Gurrs buffer, pH 6 .8 ) for 10 minutes. The shdes were then rinsed in 
buffer for 2 to 5 minutes, air-dried and covershpped with DPX.
The shdes were examined using a 100 x objective under oil 
immersion and 1000 polychromatic erythrocytes (PCE) were 
examined for each animal and the numbers of micronuclei recorded. 
In addition, the PCE:NCE ratios were determined, by assessing a 
further 200 cells and counting both PCE and NCE numbers.
RESULTS
Acute toxicity studies
The individual results from the LD50 studies are shown in 
Table 3.1. The LD50 of APNG was 475 and 575 m g/kg bodyweight for 
male and female rats respectively, in a single dose study; 100 and 90 
m g/kg bodyweight for male and female rats respectively, in a multiple 
dose study and 330 and 275 mg/kg bodyweight for male and female 
mice respectively, in a single dose study. At the highest doses the 
animals died immediately, however most of the animals that died in
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Table 3.1.
The effect o f APNG on m ortality in  acute toxicitv studies 
i/ Single dose ip - Rat
Dose
(mg/kg)
% mortality
males females
0 0 0
100 0 0
200 20 0
400 60 20
600 40 60
800 100 100
1000 100 100
ii. Multiple dose (5 daily ip treatments) - Rat
Dose
(mg/kg)
% mortality
males females
0 0 0
10 0 0
50 40 20
100 40 60
150 80 100
200 100 100
iii. Single dose ip - Mouse
Dose
(mg/kg)
% mortality
males females
0 0 0
100 0 20
200 20 40
400 80 80
600 80 100
800 100 100
1000 100 100
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the intermediate dose groups, i.e. at doses around the LD50 levels, did 
so after a period of several days and on post mortem examination it 
appeared that the kidneys were severely damaged. On subsequent 
examination, histologically, this observation was confirmed with many 
animals having severe nephrotic damage.
The bone marrow m etaphase analysis in  rats
The results are shown in Table 3.2. No significant differences 
were seen between the incidence of chromosomal aberrations in the 
control and APNG treated groups. However, an increase in the  
number of chromosome gaps was seen in the 50 m g/kg bodyweight 
per day APNG group. The positive control group (MMC) responded 
well producing a significant increase in the number of both breaks 
and gaps.
Table 3.2. Incidence of abberant metaphases (and damage tvpe> in the bone marrow 
of male rats given ip doses of APNG or MMC
Mean no. of: No. of:
Treatment
Dose 
and route
No. of cells 
scored Gaps
Chromatid
breaks
Chromosome cells with more 
breaks than ten aberrations
Cells with 
breaks
Cells with 
aberrations
24-hr sampling time
Control - 200 0 0 0 0 0 0
APNG 200 mg/kg ip 200 1 0 0 0 0 1
MMC
(positive 
control)
3.5 mg/kg ip 250 34* 35* 2 3 22* 37*
6-hr sashling time
Control - 250 4 0 0 0 0 4
APNG 50 mg/kg ip 
for 5 days
200 15* 0 0 0 0 14
APNG - N-acetyl prolyl-N-nitrosoglycine 
The values are means for groups of 10 rats
The statistical comparisons were made using a c h i - square test where * P < 0 . 0 1 .
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Table 3.3.
The effect o f APNG on the preefnancv of CD l m ice in  a single 
Intraperitoneal dose dom inant lethal study 
Study 1
No . of 
weeks 
after 
dose Parameters 0(control)
APNG CTX
18 mg/kg 60 mg/kg 180/mg kg 200 mg/kg
1 TI 11.6 11.5 11.1 11.8 9.8**
LI 11.1 10.8 10.2 11.3 5.9***
ED 0.50 0.63 0.72 0.58 3.62***
LD 0 0 0.17 0 0.31
% Preg 70 95 90 60 65
2 TI 11.4 11.8 11.7 11.6 8.8**
LI 10.9 11.5 11.5 11.1 5.0***
ED 0.47 0.30 0.53 0.56 3.85***
LD 0 0 0.21 0 0
% Preg 85 80 95 80 65
3 TI 12.1 10.3 12.3 11.0 11.6
LI 11.6 9.6 11.5 10.3 ( -H i Ex) 8.3*
ED 0.47 0.44 0.42 0.53 3.06***
LD 0.06 0.19 0.32* 0.18 0.19
% Preg 85 80 95 85 80
4 TI 12.2 11.9 11.8 12.3 11.8
LI 11.5 11.2 10.7 11.5 10.7
ED 0.60 0.61 0.50 0.53 0.87
LD 0.10 0.11 0.67** 0.33 0.20*
% Preg 100 90 90 75 75
5 TI 11.5 12.1 13.1 11.3
LI 11.0 11.8 12.3 11.0 (4 - 2Ex)
ED 0.42 0.17 0.41 0.13
LD 0.05 0.11 0.35* 0.13 (4 - lEx)
% Preg 95 90 94 75
6 TI 12.6 13.3 12.0 11.8
LI 11.8 12.3 ( 4 - 1 Ex) 11.3 11.1
ED 0.70 0.84 0.60 0.65
LD 0.10 0.21 0.10 0.12
% Preg 100 95 100 85
7 TI 12.5 12.7 12.5 10.9
LI 11.9 11.9 ( 4 - 1 Ex) 11.7 10.5 ( 4 - 1 Ex)
ED 0.55 0.53 0.58 0.24
LD 0 0.26* 0.21 0.12
% Preg 100 95 95 85
8 TI 11.8 12.2 11.8 12.7
LI 11.5 (+1 Ex) 11.0 11.0 12.2
ED 0.33 0.89 0.60 0.50
LD 0 0.28* 0.15 ' 0.06
% Preg 90 90 100 90
APNG = N-acetyl prolyl-N-nitrosoglycine
CTX = Cyclophosphamide
TI = Total implants - mean/litter
LI = Live implants - mean/litter
ED = Early deaths - mean/litter
LD = Late deaths - mean/litter
The values are mean number per litter for groups of 40 females 
%Preg = Pregnancy rate 
Ex = Exencephalic foetuses
The statistical comparisons were made using the Chi-square test where;- *p < 0.05; 
**P < 0.01; ***p< 0.001
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Table 3.4.
The effect o f APNG on the pregnancy of CD l m ice in  
a single intraperitoneal dose dominant lethal study
Study 2
Wk following
dose Abnormality
Incidence (mean no./litter) 
o f abnormalities in mice given APNG (mg/kg)
0 (control) 60
3 TI 12.4 11.5
LI 11.8 10.6
ED 0.41 0.53
LD 0.12 0.41*
% Pregnant 89 85
4 TI 12.0 11.9
LI 11.3 11.0 ■
ED 0.52 0.55
LD 0.17 0.26
% Pregnant 81 78
APNG
TI
LI
ED
LD
% Pregnant =
N-acetyl proIyl-N-nitrosoglycine
total implants 
hye implants 
early deaths 
late deaths
the percentage of the dams pregnant within the group
The yalues are the mean number per htter for groups of 40 mice, at 3 weeks 
or 120 m ice, at 4 weeks.
The statistical comparisons were made using a Chi-square test where 
* P < 0.05
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Table 3.5.
The effect o f APNG on the pregnancy of CDl m ice in  
a m ultiple intraperitoneal dose dom inant lethal study
Mating period 
(days) post 
8-wk treatment
Incidence (mean no./litter) of 
abnormality in mice given APNG (mg/kg)
Abnormality 0 (control) 20 60
1 - 5 TI
First mating
12.5 12.6 12.8
LI 12.0 12.1 11.1
ED 0.38 0.35 1.11*
LD 0.14 0.10 0.56*
% Pregnant 55 40 ■ 45
6-10 TI
Second mating
10.8 10.2 11.9
LI 10.5 9.9 11.6
ED 0.22 0.34 0.15
LD 0.03 0 0.15*
% Pregnant 93 91 65
1-10 TI
Combined data
11.4 11.8 12.2
LI 11.1 11.4 11.4
ED 0.28 0.37 0.55
LD 0.07 0.04 0.32*
% Pregnant 73 66 55
APNG
TI
LI
ED
LD
% Pregnant =
N-acetyl prolyl-N-nitrosoglycine
total implants 
hye implants 
early deaths 
late deaths
the percentage of the dams pregnant within the group
The yalues are the mean number per htter for groups of 40 mice
The statistical comparisons were made using a Chi-square test where
P < 0.05
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Table 3.6.
The effect o f APNG on m icronuclei production in  m ouse marrow
Sampling time 
following second 
dose
%PCE (P:N) for mice given
Vehicle
control
APNG 
100 mg/kg
CTX 
50 mg/kg
24 hours 0.29 0.90*** 6.08***
(55:45) (40:60) (29:71)
48 hours 0.29 0.56** 4.14***
(50:50) (41:59) (27:73)
72 hours 0.34 0.90** 1.46***
(46:54) (40:60) (35:65)
APNG = N-acetyl prolyl-N-nitrosoglycine 
CTX = Cyclophosphamide
%PCE = The percentage of polychromatic erythrocytes 
containing micronuclei, representing the genotoxic effects
P:N = The proportion of polychromatic to
normochromatic erythrocytes seen in the marrow, 
representing the degree of marrow toxicity
The statistical analysis compared the proportion of cells with micronuclei between 
groups using the least significant difference based on the pooled residual mean 
squares firom a factorial analysis of variance (Snedecor and Cochran, 1967) where:- 
** = P > 0.01;
*** = P > 0.001
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The results from the in vivo studies show that APNG is a genotoxic 
agent in mice in the micronucleus and dominant lethal assays. In the rat 
there was httle evidence of a response in the bone marrow metaphase assay, 
except for an increase in the number of gaps. Although gaps are considered 
the most subjective and probably the least biologically significant category 
of aberrations (Anderson and Richardson, 1981), the increase in the numbers 
of micronuclei seen in the mouse assay indicates genetic damage and lends 
weight to the argument that the effect seen in rats represents a true effect. 
This difference in results between rats and mice, may be due to species 
sensitivity differences. The positive results seen in the in vivo assays 
support the findings of the previous in vitro experiments i.e. the Salmonella 
Zyphimurium/mammalian microsome assay (Chapter 2) and Chinese 
hamster ovary cell mutation assays (Anderson et al., 1986).
The observations in the dominant lethal assay are unusual.
Conventionally, statistically significant increases in the number of early 
deaths are required for a positive result (Anderson et al., 1983; Bateman, 
1966 and 1977). However, such a result was only seen in one of the studies 
reported here, the multiple dosing study and was not seen in the single dose 
studies. The increase in the number of late deaths, in the absence of a 
corresponding increase in the number of early deaths is surprising and since 
all females mated were apparently in good health, and the htter sizes were 
normal, the effects observed were probably not due to maternal influences. 
Even though the increases in the number of late deaths were not dose- 
related, the statistically significant increases in all three studies would 
suggest that the occurrence of late deaths is a consistent event being caused 
by heritable damage to the sperm. In addition to the late deaths there was 
some evidence that morphologically-abnormal foetuses were produced (some 
exencephalic foetuses were seen). Bateman and Epstein (1971) and Gropp
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et al. (1976) have suggested that late deaths may result from trisomie 
genotypes. An abnormal karyotype such as this might also be responsible 
for exencephahes, a high incidence of which was seen in the first study and 
these arose at doses at which dominant lethals were not observed. A similar 
observation was made for CTX where gross abnormahties were observed in 
the offspring at doses which produced only small increases in early deaths 
(Jenkinson et al., 1987). These results indicate that there appears to be a 
dehcate balance between early deaths, late deaths and abnormal foetuses. 
If the numbers of early deaths are too great, insufficient offspring may 
survive to allow malformations to be detected. The effect of producing late 
deaths in the absence of early deaths is very unusual and no evidence of 
such an effect having been produced with other chemicals has been reported 
in the Hterature. Further investigations of the genetic effects of APNG in 
dominant lethal assays would be of great interest. Some analysis of foetal 
chromosomes could elucidate possible effects. However, it was decided that 
due to the scarcity of the compound such studies were impractical and that 
investigations into other in vivo genetic effects of APNG were required. 
Furthermore, it was decided to investigate the potential of APNG to cause 
effects after oral administration. It is hoped that future work may be able 
to follow up the apparent "male teratogenic" effects (i.e. male mediated F^  
abnormalities) seen with APNG.
Summarising, it is evident that APNG produces genotoxic effects in 
vivo as shown by the micronucleus assay in mice, with a degree of 
confirmation from metaphase analysis in rat bone marrow. It has been 
observed that APNG has an effect on the male germ cells causing an 
unusual increase in late deaths and male-mediated Fj abnormalities in the 
dominant lethal assay. These results infer that APNG, although a short-
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lived agent, does survive in vivo (maybe as a metabolite) sufficiently long to 
damage the bone marrow and to cross the 'blood/testis barrier" to injure the 
developing sperm.
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CHAPTER 4
HOST-MEDIATED ASSAYS IN MICE
INTRODUCTION
The studies described in Chapter 3 demonstrated the in vivo genotoxic 
activity of APNG in mice. However, in these studies only intraperitoneal 
dosing regimes were used in order to maximise the potential mutagenic 
effects and to conserve the availability of APNG. The studies reported in 
this chapter have been carried out to evaluate the mutagenic potential of 
APNG, both after ip and oral treatments, in the host-mediated assay (HMA) 
as described by Arni et al. (1977) and modified by Howes (1987). The host- 
mediated assay determines the genotoxicity of mutagens in the fiver of mice 
by measuring the induction of revertants of Salmonella typhimurium  strains 
which have previously been administered to the animal by tail vein 
injection. This method allows metabolism by the animal in vivo in 
conjunction with a bacterial point mutation assay. The aim of these studies 
was to establish whether APNG was absorbed after oral administration in 
a form that retains its mutagenicity and also to provide some comparative 
information on the pharmacokinetics of the compound after both 
intraperitoneal and oral administration.
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EXPERIMENTAL
M aterials and methods
The compound was APNG as described previously. The assay 
control for these studies was the compound solvent, phosphate 
buffered saline (PBS), pH 7.4. The bacterial positive control 
compound was sodium azide (Sigma London Chemical Co Ltd, Poole).
The centrifuge was supphed by FSA, Loughborough, Leics, and 
the Ultraturrax homogenizer by IKA-labortechnik, Switzerland. The 
media, chemicals and disposable plastics were obtained from standard 
sources as described in Chapter 2.
Animals
Female CD-I mice, 6 to 8 weeks old (weight 20-25g Charles 
River, Margate, Kent) and fed on Rat and Mouse No.l. diet (Special 
Diet Services, Witham). The diet was given ad libitum  with 
unlimited access to mains tap water. The animals were housed in 
groups of three to five in plastic and stainless steel, sohd floored 
cages. The cages were kept in ventilated rooms under the following 
conditions:-
Temperature: 20-25 ” C
Humidity: 45-75%
Lighting: 12 h light: 12 h dark
(06.00-18.00 h; 18.00-06.00 h GMT)
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Host-m ediated assay
For the dose-response studies an inoculum of strain TAIOO in 
nutrient broth was incubated for 16 hours, in a shaking water bath 
at 37 “ C. The cells were collected by centrifugation at 1500g for 15 
minutes and the pellet resuspended in one twentieth of the original 
volume of phosphate buffered saline at pH 7.4. An ahquot of the cell 
suspension (0.1 ml) was injected into a tail vein of each mouse (not 
fasted) immediately prior to dosing with the control PBS or APNG 
given orally at 100, 200, 300, 400 or 500 m g/kg bodyweight (at 10 
m l/kg bodyweight body weight) or given intraperitoneaUy at 200 or 
400 m g/kg bodyweight (at 10 m l/kg bodyweight). Each treatment 
group contained between 4 and 6 mice. One hour after administration 
the mice were killed by cervical dislocation and the bacteria recovered 
from the Uvers using the following method:
The Uver of each mouse was removed and homogenised in 10 
ml ice-cold 50 mM Tris/KCl, pH 7.4, using an Ultraturrax 
homogeniser. The cell debris was sedimented by centrifugation for 
10 minutes at approximately lOOg and the supernatant removed; this 
was further centrifuged at approximately 170gfor 30 minutes and the 
sedimented bacterial cells resuspended in 1 ml of 50 mM Tris/KCl 
(pH 7.4).
The number of His  ^ revertants was determined by mixing 
0.1ml of the bacterial suspension (recovered from the liver) with 2ml 
top agar (containing 0.05 mM histidine, 0.05 mM biotin and ampicillin 
at 25 Mg/ml) and pouring on to Vogel Bonner agar plates. Three 
replicate plates were prepared for each liver sample. Total numbers 
of bacteria present in each liver were assessed by plating a dilution
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(lO"®) of each suspension on nutrient agar plates containing ampicillin 
at 25 jug/ml. The revertants on the Vogel Bonner plates were 
counted after 3 days incubation at 37 “C and the total counts on 
nutrient agar after 1 day. For the time course studies, groups of four 
mice (not fasted) were given APNG using either an intraperitoneal 
dose of 200 m g/kg/ bodyweight at 0 to 2 Vi hours before the 
administration of bacteria, or an oral dose of 500 m g/kg bodyweight 
at 0 - 60 minutes before administration of bacteria. One hour after 
the administration of the bacteria the mice were killed by cervical 
dislocation and bacteria recovered from the hvers as described 
previously.
The data were evaluated using a two level nested analysis of 
variance (Sokal and Rohlf, 1969) on transformed data. If an effect 
was significant it was further investigated using the Least Significant 
Difference method (Snedecor and Cochran, 1967), Bartlett’s test of 
homoscedasticity was used to check the equality of the group 
variances.
RESULTS
The results are shown in Tables 4.1.-4.3. and Figures 4.2.and 4.3. It 
can be seen that APNG, orally or intraperitoneaUy administered, induced 
revertants in strain TAIOO isolated firom the livers of CD-I mice.
In the dose-response study (Table 4.1.) significant increases in 
revertants were seen after intraperitoneal treatment with 200 and 400 
m g/kg bodyweight APNG (6 and 8 V2 fold increases respectively). After oral 
administration only the group treated with 500 m g/kg bodyweight had a 
greater than twice background increase in histidine revertants. However,
80
S.D.Blowers - PhD Thesis Host-mediated assays in mice
significant increases in histidine revertants were seen at doses over 200 
m g/kg bodyweight and above and the effect was clearly dose-related. In this 
study the variance components show that 86.6% of the variation was due to 
between group differences, 10.8% due to between animal differences and 
2.6% to between plate differences in the oral dose study. In the 
intraperitoneal study the values were 78.0%, 5.3% and 16.8% respectively.
Tables 4.2. and 4.3. with Figures 4.1. and 4.2. show the effect of 
administration of APNG before injecting the bacteria, illustrating the time 
that the APNG, or metabohtes, remain active in vivo. In the case of an 
intraperitoneal dose of APNG (Table 4.2. and Figure 4.1.) there was no 
evidence of an increase in revertants when APNG was administered more 
than 30 minutes before the bacteria.
After the oral administration of APNG (Table 4.3. and Figure 4.2.) the 
response was lower than with the intraperitoneal treatment and no evidence 
of an increase in histidine revertants was seen after 40 minutes. In these  
studies the variance components showed that 74% of the variation was due 
to between group differences, 3.5% to between animal differences and 21.5% 
to between plate differences.
The numbers of cells recovered from the animals, as measured by the 
viable count, allowed for between 5 x 10’ and 10® bacteria per plate. Where 
the recovery was less than 5 x 10® per ml (the equivalent of 5 x 10’ per 
plate) the mutation value was not included in the analysis.
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Table 4.1.
The m utagenicity of APNG to Salmonella typhimurium 
TAIOO in  the m ouse host-m ediated assay
Compound
and
dose
(mg/kg)
Mean histidine revertants/plate
Plate
control
After
oral
treatment
After
ip
treatment
Control 114 100 100
APNG
100 95
200 112 689***
300 122**
400 155*** 958***
500 254***
Sodium azide
(5 /Lig/plate) 1530#
The animals were dosed intravenously (iv) at time 0 with 0.1 ml of strain TAIOO, 
at 20 times the overnight concentration, in phosphate buffered saline.
The bacteria are recovered 1 hour after they are given to the mice and plated as 
for a normal Ames assay but with ampicillin in the media. They were incubated 
at 37 “ C for three days.
APNG = N-acetyl prolyl-N-nitrosoglycine
#  = value greater than twice background, considered to be mutagenic
The statistical analysis used was an analysis of variance using the least significant 
difference test to identify significant results where:
** = P < 0.01
*** = P < 0.001
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Table 4.2.
Effect o f tim e on an ip dose of APNG (200 mef/kef) on  
Salm onella typhimurium  TAIOO in  the m ouse host-m ediated assay
Compound
and
concentration
Time
i.v.
(minutes) before 
dose of bacteria
Mean revertants/ 
plate
APNG
(500 mg/kg) 150 90
120 89
90 76
75 84
60 78
45 116
30 100
15 200***
10 231***
5 338***
0 747***
Solvent
(saline) 0 103
Plate control NA 106
Sodium azide
(5 jLtg/plate) NA 1176#
APNG = N-acetyl prolyl-N-nitrosoglycine 
NA = Not applicable
The animals were dosed intravenously (iv) at time 0 with 0.1 ml of strain TAIOO, 
at 20 tim es the overnight concentration, in phosphate buffered saline.
The bacteria are recovered 1 hour after they are given to the mice and plated as 
for a normal Ames assay but with ampicillin in the media. They were incubated 
at 37 ° C for three days.
#  = value greater than twice background, considered to be mutagenic
The statistical analysis used was an analysis of variance using the least significant 
difference test to identify significant results where:
P < 0.01 *** = p  < 0.001
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Legend Figure 4.1.
The figure shows the effect of time on the administration of an 
intraperitoneal (ip) dose of APNG (200mg/kg) in the mouse host-mediated 
assay using strain TAIOO.
The anim als are dosed intravenously (iv) time 0 with 0.1ml of strain TAIOO 
at 20 times the overnight culture concentration in PBS.
The compound is dosed orally at the indicated times before the iv dose of 
bacteria.
The bacteria are recovered, from the hver, 1 hour after the dose of bacteria 
and plated as for a normal Ames assay but with ampicillin in the media. 
They are incubated at 37 “ C for 3 days.
S.D.Blowers - PhD Thesis Host-mediated assays in mice
Figure 4.1.
Effect o f tim e on an intraperitoneal dose of APNG (200 m g/kg) 
in  the host-m ediated assay
M ean R e v e r t a n t s / P I a t e
8 0 0
6 0 0  -
4 0 0  -
200  -
0 0 5 10 15 3 0  4 5  GO 75 9 0  120 150
Time (min) before iv d o s e  of TA100
APNG 2 0 0  m g/kg ip S o lv en t  co n t ro l
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Table 4.3.
Effect o f tim e on an oral dose o f APNG (500 m g/kg) on 
Salmonella tvphimurium TAIOO in  the m ouse host-m ediated assay
Compound
and Time (minutes) before Mean revertants/
Dose i.v. dose of bacteria plates
APNG
(500 mg/kg) 60 88
50 92
40 112
30 127**
20 152***
15 158***
10 218***
5 190***
0 195***
Solvent (saline) 0 95
Plate control NA 106
Sodium azide
(5 /xg/plate) NA 1176#
APNG = N-acetyl prolyl-N-nitrosoglycine 
NA = Not applicable
The animals were dosed intravenously (iv) at time 0 with 0.1 ml of strain TAIOO, 
at 20 times the overnight concentration, in phosphate buffered sahne.
The bacteria are recovered 1 hour after they are given to the mice and plated as 
for a normal Ames assay but with ampicühn in the media. They were incubated 
at 37 “ C for three days.
#  = value greater than twice background, considered
to be mutagenic
The statistical analysis used was an analysis of variance using the least significant 
difference test to identify significant results where:
= P < 0.01 *** = P < 0.001
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Legend Figure 4.2.
The figure shows the effect of time on the administration of an oral dose of 
APNG (500mg/kg) in the mouse host-mediated assay using strain TAIOO.
The animals are dosed intravenously (iv) at time 0 with 0.1ml of strain 
TAIOO at 20 times the overnight culture concentration in PBS.
The compound is dosed orally at the indicated times before the iv dose of 
bacteria.
The bacteria are recovered, from the hver, 1 hour after the dose of bacteria 
and plated as for a normal Ames assay but with ampicillin in the media. 
They are incubated at 37 “ C for 3 days.
S /-
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Figure 4.2.
E ffect o f tim e on an oral dose o f APNG (500 m g/kg) 
the host-m ediated assay
M ean  R e v e r t a n t s /P I a t e
2 5 0
200
1 5 0  -
100  -
I
5 0  -
0 0  5 10 15 20  3 0  4 0  5 0  6 0
Time (min) before iv d o s e  of TAIOO
APNG 5 0 0  mg/kg po S o lv e n t  c o n t ro l
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DISCUSSION
Previous in vivo studies reported in Chapter 3 employed only 
intraperitoneal dosing and so no evidence of oral activity of APNG was 
estabUshed. As the standard in vivo assays (dominant lethal, micronucleus 
and bone marrow assays in rodents) are time consuming, expensive and 
require relatively large amounts of the chemical, a more efficacious assay 
was required to investigate the potential oral activity of the compound. The 
mouse host-mediated assay was selected using the Salmonella typhimurium  
strain TAIOO as the indicator bacteria as this was the most sensitive strain 
in the Ames assays. Some indication of the pharmacokinetic profile of the 
compound is obtainable using this method and since an intact animal is used 
the results give valuable information as to the stability of the 
nitrosopeptides in a dynamic in vivo system.
The results from these studies clearly show that APNG, or its 
products, are mutagenic in the mouse host-mediated assay. A direct dose- 
relationship is apparent after dosing by both routes, but the magnitude is 
greater following intraperitoneal dosing. This may imply that when 
administered orally, much of the compound is inactivated prior to absorption 
or that much of it fails to cross the gastrointestinal mucosa. Furthermore 
the animals used in these assays were not fasted and some of the APNG  
may have been bound in the food rather than being absorbed.
It was also shown that APNG, administered orally, is absorbed more 
slowly than after intraperitoneal administration. The differences in the 
active life of APNG, as indicated in the time studies, between the different 
routes of administration is almost certainly due to different absorption 
times. It is evident, however, that the mutagenic activity of APNG is lost 
rapidly in vivo, irrespective of the route of administration, as APNG given
8 8
S.D.Blowers - PhD Thesis Host-mediated assays in mice
minutes before the bacteria was seen to lose rapidly its potential to cause 
mutation.
The fact that APNG displays activity in vivo, such as kidney toxicity 
and genotoxicity to both somatic and germ cells (Chapter 3) and the rapidity 
of the loss of its mutagenic potential, as indicated in the host-mediated 
assays, shows that it initiates toxic effects rapidly and it is possible that the 
effects may be due to more than one metabohte.
Although all of these studies have used high doses that are far in 
excess of the possible physiological exposure levels of such compounds, the 
effects and the speed of action may indicate that very low levels of such 
compounds may be significant in the initiation of genotoxic events in vivo. 
The possibihty that the in vivo toxicity, seen previously in the kidney 
(Chapter 3) is mediated by products other than the parent compound cannot 
be excluded.
In summary, the use of the host-mediated assay has shown that 
APNG can be absorbed orally and that it is short-lived in the hver in vivo 
indicating that the previously reported genotoxic effects must be initiated 
rapidly, unless they are mediated by degradation products of the nitroso 
compound.
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CHAPTERS
CELL REPLICATION AND DNA REPAIR
INTRODUCTION
The measurement of chemically induced DNA repair as unscheduled 
DNA synthesis (UDS) is currently accepted as an indicator of genotoxicity 
and hence potential carcinogenicity of chemicals in selected target organs 
(Mirsahs, 1988). Some of the most commonly used DNA repair assays 
involve the in vivo and in vitro treatment of rat hepatocytes by potential 
DNA damaging agents (Williams, 1977 a, b; Mirsalis and Butterworth, 1980). 
Unscheduled DNA synthesis (UDS) assays also have been developed for 
other organs and other cell types including the gut and testis (Furihata and 
Matsushima, 1982; Furihata et al., 1984), lymphocytes (Shinner et al., 1980), 
pancreas (Steinmets and Mirsalis, 1984), spermatocytes (Working and 
Butterworth, 1984; Bentley and Woking 1988) and kidney (Tyson and 
Mirsahs, 1985).
In these assays a measurement of the excision-repair process is made 
by assessing the incorporation of tritiated thymidine into the DNA. This 
occurs after DNA damage resulting from the chemical, or a metabohte, 
binding covalently to the DNA. The damaged DNA is enzymically excised 
and replaced with complementary undamaged nucleotides. If the thymidine 
supphed is tritiated and available to the cells in the medium or to the 
tissues in vivo studies the repaired DNA will become radioactive and the 
degree of DNA damage can be measured by either scintillation spectrometry 
or by autoradiographic methods (Butterworth, 1987 a,b).
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Both methods have their advantages and disadvantages. The 
scintillation methods, have the advantage that a large number of samples 
may be processed quickly, the disadvantage is that they are unable to 
distinguish between those cells that have been damaged and repaired, and 
those cells undergoing scheduled DNA synthesis. In the scintillation 
methods hydroxyurea is usually added to the media to suppress any residual 
scheduled DNA synthesis. It is important that this scheduled synthesis is 
inhibited, as a single cell during cell division will incorporate large amounts 
of radioactivity which may swamp the less pronounced effects of repairing 
cells. However, this is not always entirely successful as about ten percent 
of cells remain in scheduled synthesis (Pearson and Styles, 1984) and can 
lead to large variations in the recorded counts within groups, even in cells 
such as primary hepatocytes which are essentially non-dividing and have few  
rephcating cells.
By using an autoradiographic method of analysis the problem of dividing 
cells is overcome as those cells undergoing division are easily identified (by 
the presence of their very dense black nuclei) and can be excluded from the 
analysis of DNA repair. However, the measurement of the number of cells 
dividing can give useful information as to effect of the compound on 
scheduled synthesis. Mitogenic agents may be identified in this way and also 
agents which influence cell prohferation rates by non-genotoxic mechanisms. 
The problems associated with the autoradiographic methods are related to 
the increased time of preparation and the difficulty in assessing large 
numbers of cells, although the advent of automated machines has partly 
overcome this problem.
The present chapter describes the investigation of the effects of 
APNG on cell division and DNA repair in the liver, kidney and gut mucosae
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of rats after both in vivo and in vitro treatments. The purpose of this work 
was to identify some possible target organs in which the nitrosopeptides 
may act, and to study the type of damage produced. Previous work in this 
thesis has indicated that the kidney is damaged (Chapter 3, acute toxicity 
studies) but the effects on the hver or gut (the probable site of formation of 
nitrosopeptides) have not been directly investigated. Although it is known 
that APNG is sufficiently stable to cross the gut waU, it is still not clear if  
these compounds would be active long enough to damage the stomach or 
duodenum; furthermore there is no direct evidence of a damaging effect on 
the hver, although the host-mediated studies (Chapter 4) have demonstrated 
that APNG does reach the hver after oral administration.
EXPERIMENTAL
M aterials and m ethods
The compound was APNG. The assay negative control was the  
solvent, phosphate buffered sahne (PBS) at pH 7.4. The positive 
control agents were either 2-acetylaminofluorene (2-AAF) or N- 
methyl-N-nitro-l-nitrosoguanidine (MNNG).
The culture media (RPMI 1640 or LI 5) and the Hank's 
balanced salt solution, calcium- and magnesium-free (HBSS), were 
supphed by Gibco (Europe) Paisley, Scotland. Foetal bovine serum  
was obtained from Sera Laboratories, Crawley, Sussex; the  
gentamycin from Flow Laboratories, Irvine, Scotland; collagenase 
from BCL, Lewes, Sussex; the Sagatal from May and Baker, 
Dagenham, Essex and the ^H-thymidine (specific activity 
approximately 30 mCi/mmol) from Amersham International, 
Amersham, Bucks. Ilford K-5 photographic emulsion, Ilford phenisol
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and the Kodafix were obtained from Eastman Kodak, Moberly, 
Cheshire. All other chemicals were obtained from the Sigma London 
Chemical Co. Ltd., Poole, Dorset.
Equipm ent
The microscopes used in these studies were supplied by either 
Leitz, Ernst Leitz Wetzko GMBH, West Germany or Zeiss, Carl Zeiss 
GMBH, West Germany (with 12x eyepieces and lOOx oil immersion 
objectives). The fluorescence spectrophotometer used was a Perkin- 
Elmer MPF-3L, Perkin-Elmer, USA. The hquid scintillation 
spectrophotometer used was a Packard 2200CA, Camberra Packard, 
Pangbourne, Berks. The image analysis system was a purpose 
designed unit supphed by Seescan Imaging, Cambridge, 
Cambridgeshire with programmes specifically designed for each of the 
procedures used. The centrifuge was a Centaur 2, MSE, England, the 
sonicator, a Soniprep, MSE, England. The COg incubator was a flow 
61-510-00, Flow Laboratories, England.
The perfusion apparatus used for the in vitro studies was an 'in 
house' design and is shown in Fig. 5.1. The perfusion apparatus used 
for the in vivo studies was an eight channel design, one channel of 
which is illustrated diagrammatically in Fig. 5.2 and was also designed 
in house.
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Figure 5.1.
Perfusion apparatus for in vitro hepatocvte isolation
CV
GE
GI
GO
L
OF
P
R
T
WB
H,0
w
ws
Collection vessel
Gas exchange aparatus
Gas inlet
Gas outlet
Liver
Overflow
Pump
Resevoir
Three way taps
Waterbath
Water inlet for water jacket
Running order
1) Prior to Perfusion 
R - P - GE - P - R
2) During Perfusion
CV - P - GE - P - L - CV
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Fimire 5.2.
Perfusion apparatus for in vivo hepatocvte isolation
CV = Collection vessel Running order
L = Liver 1) Prior to Perfusion
P Pump circuit R - P - R
R Resevoir
T Three way taps 2) During Perfusion
WB = Waterbath circuit CV - P - L - CV
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Animals
Male Sprague-Dawley rats 6-8 weeks old (weight 170-250 g) 
were obtained from Olac (Bicester, Oxon.) and were fed on Rat and 
Mouse No. 1 diet (Special Diet Services, Witham). The diet was given 
ad libitum  with unlimited access to mains tap water. The animals 
were housed in plastic and stainless steel, solid-floored cages which 
were kept in ventilated rooms under the following conditions:-
Temperature: 20-25 “ C
Humidity: 45-75%
Lighting: 12 h light: 12 h dark
(06.00-18.00 h; 18.00-06.00 h GMT)
In vitro and in vivo rat hepatocyte DNA repair assays
The hepatocytes for both assays were isolated using a two step 
collagenase perfusion technique (Gray et al. 1983, Howes, 1987). The 
rats were anaesthetised by intraperitoneal injection of Sagatal (80 
m g/kg bodyweight). The abdomen was then swabbed with 70% 
ethanol and wiped down to prevent loose fur from contaminating the  
peritoneal cavity. A mid-line incision in the skin was made and 
pinned back. A U-shaped incision in the abdominal wall was made 
and inverted over the thorax. The stomach and small intestine were 
everted and moved to the left, exposing the portal vein leading to the 
liver. A 20 gauge cannula (filled with heparinized HBSS) was 
inserted into the portal vein and tied in with a suture. The aorta and 
inferior vena cava were cut, the cannula connected to the pump 
system and the liver was perfused with Hank’s balanced salt solution
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(calcium and magnesium free) at 37 ° C. This clears the blood from 
the liver and allows for its excision from the surrounding tissue.
The excised liver was then placed onto a plastic platform above 
a reservoir of perfusate containing 0.05% collagenase which was 
aerated with 95% oxygen and 5% carbon dioxide. This perfusate was 
circulated, at 50 ml/minute, through the liver using a peristaltic 
pump until the liver tissue was observed to be breaking up or until 
30 minutes had elapsed. When perfused, the liver was removed and 
placed in a 50 ml cylinder. The hepatocytes were removed by gentle 
agitation with a glass rod into 50 ml of Hank’s balanced salt solution 
(HBSS) containing 2.5% bovine serum albumin. The cell suspension 
was filtered through a 120 fim pore nylon gauze, placed in a glass 
universal, and centrifuged for 3 minutes at approximately 50 g. The 
cells were washed and recentrifuged twice in culture medium (RPMI 
1640 containing lO^M hydrocotisone sodium succinate, lO^M insulin, 
5% foetal bovine serum and 50 /xg gentamycin/ml).
The viability of the hepatocytes was determined by trypan blue 
exclusion and measured using a haemocytometer, only viable cells 
being capable of excluding the dye.
The unscheduled DNA synthesis hepatocyte assays were 
carried out using three distinct procedures and are described as:-
(i) in vitro unscheduled DNA synthesis assays in hepatocytes 
using scintillation spectrometry.
(ii) in vitro unscheduled DNA synthesis assays in hepatocytes 
using autoradiography.
(iii) in vivo unscheduled DNA synthesis assays in hepatocytes 
using autoradiography.
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The in vitro unscheduled DNA synthesis assay in  hepatocytes 
determ ined by scintillation spectrom etry
Hepatocytes were isolated as described above and seeded onto 
90 mm tissue culture dishes at 6.7 x  10® viable cells/dish, in 9 ml of 
RPMI 1640 culture medium.
The cultures were incubated in a humidified atmosphere of 
95% air 5% carbon dioxide at 37 “ C. After 4 hours, the medium  
was replaced with 10 /xl fresh medium containing 10 /xM hydroxyurea. 
After a further hour, 10^1 (10/xCi) ®H thymidine and 40 /xl of an 
APNG solution or the positive control (MNNG) was added to each 
plate in serum free medium; duplicate cultures were set up.
Following a 16 hour incubation the medium was removed from 
the dishes and the cells washed with ice-cold phosphate-buffered 
saline containing 2 mM thymidine. This was repeated and the 
remaining cells were detached using a rubber pohceman, pipetted into 
a tube and centrifuged at approximately 50 g and kept at 4 “C prior 
to the isolation of the DNA.
The nuclei were isolated and the ®H-thymidine activity was 
measured according to the procedure described by Althaus et al. 
(1982) as modified by Howes (1987). The cells were suspended in 0.9 
ml of a hypotonic buffer (10 /xM Tris HCl, 5 mM MgClg at pH 8.0) and 
sonicated for 2-3 seconds. They were then incubated in 1% Triton 
X-100 for 10 minutes and sonicated again. The resulting solution was 
centrifuged at 550 g for 10 minutes and suspended in 1 ml 0.25 M 
buffered sucrose (containing 50 /xM Tris, 25 mM KCl, 15 mM MgClg 
at pH 8.0). This mixture was slowly layered over 1 ml of 0.88 M 
buffered sucrose and centrifuged at 1500 g for 15 minutes to
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precipitate the nuclei. Any RNA present was hydrolysed by 
resuspending the nuclei in 1.0 ml of 10 mM Tris HCl buffer (pH 8.0) 
to which was added 1.5 ml of 0.55 M KOH. This mixture was 
incubated at 37 ° C for 1 hour after which it was neutralized with 0.4 
ml of 1 M HCl. The DNA and protein present were precipitated by 
the addition of 10% trichloroacetic acid containing 5% bovine serum 
albumin and centrifuged at 1500 g for 5 minutes. The pellet was 
washed with 5% TCA and recentrifuged. The washed pellet was 
resuspended in 3.5 ml of 5% TCA and incubated at 90 “C for 20 
minutes to hydrolyse the DNA. Any remaining protein was removed 
by centrifuging at 1500 g for 10 minutes. Aliquots of the supernatant 
(0.5ml), containing the DNA, were added to 10 ml of scintillation fluid 
(Optiphase Safe) and the radioactivity measured on a Packard liquid 
scintillation spectrophotometer. The remaining supernatant was 
stored at -20 “ C for the DNA assay.
The DNA was assayed using a modification of the fluorometric 
method of Kissane and Robbins (1988) where 0.25 ml of the 
supernatant containing the DNA was mixed with 0.2 ml 30% (w/v) 
3,5-diaminobenzoic acid dihydrochloride. This mixture was incubated 
at 60 ° C for 30 minutes and perchloric acid (0.6 M) was added giving 
a final volume of 2 ml. Standard samples of calf thymus DNA were 
used as the control to generate a standard curve. The fluorescence 
of the samples was measured using a Perkin-Elmer fluorescence 
spectrophotometer and the DNA content calculated from the standard 
curve. The tritiated thymidine incorporation, measured in 
disintegrations per minute (dpm), was then expressed per /xg DNA.
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The in vitro unscheduled DNA synthesis assay in  hepatocytes 
determ ined by autoradiography
Three experiments were carried out using the same general 
method with the following differences:- Experiment 1 had MNNG as 
the positive control, the slides exposed to the photographic gel for 14 
days and assessed manually; Experiment 2 had MNNG as its positive 
control the slides exposed for 7 days and assessed manually; 
Experiment 3 had 2AAF as its positive control, was developed for 7 
days and was assessed using a newly acquired Seescan image analysis 
system. Initially the positive control was MNNG as this was the most 
appropriate mutagen for comparison with APNG, however, AAF is the 
standard mutagen used in UDS assays and was used as the control in 
the third experiment.
The general method is described below:- 
The hepatocytes were isolated as described above and seeded onto 35 
mm tissue culture dishes, containing a 10 nun diameter clean glass 
coverslip, at 5 x 10® cells/dish in 1 ml of RPMI culture medium. 
(Note:- in the in vivo assays the total cell count is used and not the 
viable count as described for the in vitro assays). The cultures were 
incubated for two hours in a humidified 95% air:5% carbon dioxide 
atmosphere at 37 “ C, the cells were washed with 1 ml of serum free 
RPMI medium followed by 1 ml of serum free RPMI medium  
containing ^H-thymidine, at 5 /LtCi/ml, with APNG or the positive 
control (experiment 1 and 2, MNNG at 6.7x10 ® and 6.7x1 O^ M and in 
experiment 3 2AAF at lO^M). These dishes were incubated for a 
further 18 hours (as above). The medium was then replaced with 
serum free RPMI medium containing 2 mM unlabelled thymidine and
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incubated, as above, for 1 hour. The cells were washed three times 
with serum free medium, twice with distilled water and finally fixed 
with ethanol and acetic acid (3:1 v /v  for 3 x 10 minute-periods). The 
coverslides were lifted from the dishes, allowed to dry in a dust free 
atmosphere and mounted, using DPX, cells uppermost on 
gelatine/chrome alum subbed slides and left to dry for 2 days in a 
dry, dust-free, atmosphere.
The slides were coated, in the dark, with Ilford K-5 
photographic emulsion mixed 1:1 with 2% glycerol at 43 “C and 
allowed to dry on a cold plate, at 4 “ C, before being placed in a light­
tight box. These were then exposed at 4 'C  (for 14 days in 
experiment 1 and for 7 days in experiments 2 and 3). The slides were 
developed using Ilford phenisol, at room temperature, for 3 minutes, 
washed in distilled water and fixed 2 minutes in Kodafix. They were 
subsequently washed in running tap water followed by distilled water 
and stained in Ehrlich’s haematoxylin for 20 seconds, rinsed in 
distilled water, blued in tap water for 3 minutes, followed by 5 
seconds in 0.5% aqueous eosin. The cells were washed in distilled 
water, followed by ethanol and finally xylene. When dry coverslides 
were added using DPX mounting medium and left to set for two 
days. The resultant silver grains were counted in experiment 1 and 
2 by using a hand tally at xl200 magnification. In experiment 3 an 
image analysis system (Seescan) was used to automatically count such 
grains. In experiments 1 and 2,25 cells were counted from four slides 
and in experiment 3, 50 cells from two slides. The grains were 
assessed over the nucleus and also from three equal-sized areas in the
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cytoplasm. The mean cytoplasmic count was subtracted from the 
nuclear count to give the net grain increase or decrease per nucleus 
(conventionally described as NG) for each cell. In addition the slides 
were examined for the percentage of cells in repair (defined as those 
cells having greater than a +5 net grain increase) or scheduled 
synthesis.
The in vivo unscheduled DNA synthesis assay in  hepatocytes 
determ ined by autoradiography
Once the effect of APNG on hepatocytes had been established 
in vitro an experiment to investigate the effects in vivo was carried 
out. This study used a single oral dose of APNG at 500 m g/kg  
bodyweight, the dose employed in the Host-mediated assays (Chapter 
4). 2AAF was used as the positive control at a dose of 100 m g/kg  
bodyweight. Six animals were treated (two control, two APNG and 
two 2AAF) and the livers were perfused within a 30 minute period, 
16 hours after treatment. The hepatocytes were isolated as described 
above and seeded onto 35 mm dishes and treated as described in the  
previous section with the following alterations. Firstly, the cultures 
were not treated, and secondly they were incubated for only 4 hours 
in the media containing tritiated thymidine. This was followed by 
incubating in serum firee RPMI medium containing 2 mM unlabelled 
thymidine for 16 hours before the washing and fixing stages. The 
number of grains was assessed using the Seescan Image analysis 
system. As previously, both the percentage of cells undergoing repair 
and in scheduled synthesis were determined.
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The in vivo/in vitro DNA synthesis assay in  rat stom ach and 
duodenal mucosae
In this experiment the gut mucosal cells were examined using 
the procedure of Furihata et al. (1984). Groups comprising two fasted 
rats were treated, either with 200 m g/kg bodyweight APNG orally at 
2 and 16 hours prior to killing or with the rat glandular stomach 
carcinogen MNNG at 200 m g/kg bodyweight 16 hours before killing. 
The control anim als were given the vehicle, phosphate buffered 
saline. Immediately following treatment the animals were allowed 
food. The rats were killed by cervical dislocation and the stomach 
and duodenum (approximately the first 1cm of the small intestine) 
removed together. The stomach and duodenum were opened, 
following the line of the greater curvature down through the 
intestinal portion, washed with saline and by L-15 medium, at 37 “ C. 
The mucosa was removed from the stomach glandular area and from 
the duodenum using the edge of a glass microscope slide, scraped 
gently across the tissue. Approximately 20 mg portions were removed 
and duplicate cultures were made. Each sample was placed in 3 ml 
of L-15 medium containing 10 /LtCi ®H-thymidine/ml, 100 /xg 
streptomycin/ml and lOOU penicillin G /m l. The cultures for UDS 
measurement contained 10 /xM hydro^gmrea (HU). The cultures were 
incubated, in air, at 37 ” C with gentle shaking for two hours and then  
centrifuged at 50 g for 3 minutes. The supernatant was removed and 
the remaining tissue washed twice with L-15 medium. The tissue 
was resuspended in the culture medium, as described above, but 
containing 1 mM unlabelled thymidine, and incubated, at 37 * C, for a 
further 30 minutes. This was recentrifuged and the supernatant
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discarded. The remaining tissue was homogenized in PBS, 
centrifuged at 50g, and the tissue pellet was maintained at 4 “ C prior 
to the isolation of DNA. The nuclei were isolated and the 
thymidine activity measured as described previously.
The in vivo DNA synthesis assay in  rat stom ach 
and duodenal m ucosae
This experiment was designed as an alternative to that 
described in the previous section and used autoradiographic 
examination of the tissues instead of scintillation counting. Three 
groups each of two fasted rats were treated as described in the 
previous section. However, 2 hours prior to killing the animals were 
given a single subcutaneous (SC) injection of tritiated thymidine at 1 
mCi/kg bodyweight. The stomach and duodenum were removed and 
opened along the greater curvature, as described above, and pinned 
flat on a corkboard before being fixed in phosphate buffered formo- 
saline. After two weeks the tissue was removed and sectioned as
shown below:
Section A gives a longitudinal section through the duodenum  
and section B a section through both the glandular and non glandular
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portion of the stomach. The tissues were mounted in paraffin wax 
blocks and 2-4 /xm sections were cut and mounted on gelatine/chrome 
alum, subbed shdes. The sections were then deparaffinised by 
washing in chloroform and allowed to dry. The shdes were coated in 
K-5 photographic emulsion and exposed in a dark, desiccated box at 
4°C for two weeks before being developed as described previously. 
The slides were examined at 1200x magnification on a hght 
microscope and an estimation of the degree of scheduled synthesis 
was made using a Seescan image analysis system to count the grains. 
This assessment was made for the duodenum, the non-glandular 
stomach and both the fondai and antral areas in the glandular region 
of the stomach.
RESULTS
For the hepatocyte culture assays, the viabihties of the cultures were 
greater than 80% for the in vitro assays, and greater than 65% for the in 
vivo assays. The differences in viabihty were due to the equipment used in 
the isolation, where the multi-channel system, used in the in vivo 
experiments, has a less efficient gassing system and so the yield of 
competent cells is lower. This difference in no way compromises the 
experiment as the surviving cells are fully able to function normally.
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The in vitro unscheduled DNA synthesis assay in  hepatocytes 
determ ined by scintillation spectrom etry
The results are shown in Table 5.1. The data are presented as 
a percentage of the control values. In experiment 1 a concentration- 
related increase in effect was seen with APNG up to 4 x lO^M. The 
positive control, MNNG also showed a concentration-related response. 
In experiment 2, a concentration-related increase in effect was seen  
with APNG and the positive control MNNG showed a good response 
at 7 X 10'® M but not at 7 x 10'® M where there was some evidence of 
toxicity.
The in vitro unscheduled DNA synthesis assay 
in  hepatocytes determ ined by autoradiography
The results are shovm in Table. 5.2. The data are presented 
as the net grain increase or decrease, comparing the nucleus to an 
equivalent area in the cytoplasm (taken from the mean of three 
cytoplasmic areas). Also presented are the percentage of cells 
undergoing repair, these were defined as those cells having greater 
than a 5 net grain increase, or scheduled synthesis, defined as those 
cells having dense black nuclei.
It is clear that in all three experiments a concentration-related 
increase in unscheduled DNA synthesis is seen up to 4 x lO^M and 
the positive control responded well in all three experiments. In 
experiment 1 the higher grain counts observed were due to a longer 
exposure (14 days) than in experiments 2 and 3 where the exposure 
time was reduced to 7 days. 2AAF was used in experiment 3 as it is
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Table 5.1
The effect of APNG on in vitro unscheduled DNA 
synthesis (UDS) in  cultured rat hepatocytes 
determ ined using scintillation spectrom etry
Group and 
concentration
Increase in counts as dpm//ig DNA 
(%control)
Experiment No.
Control 8 9 3 ( 1 0 0 ) 5 2 1 ( 1 0 0 )
APNG
4  X 1 0 " 9 M 1 1 8 8 ( 1 3 3 )
4  X 1 0 “ ® M 1 0 2 4 ( 1 1 5 )
4  X 1 0 “ 7 M 1 2 9 5 ( 1 4 5 ) 3 5 0 ( 6 7 )
4  X 1 0 ” ® M 1 2 8 7 ( 1 4 4 ) 7 5 0 ( 1 4 4 )
4  X 1 0 “ ® M 1 7 4 1 ( 1 9 5 ) 8 0 2 ( 1 5 4 )
MNNG
7  X 1 0 “ ® M 1 4 5 4 ( 1 6 3 ) 1 1 3 6 ( 2 1 8 )
7  X 1 0 “ ® M 4 1 8 8 ( 4 6 9 ) 6 9 3 ( 1 3 3 * )
The table shows the increase in d.p.m. per iig DNA 
presented as a percentage of the control value.
APNG = N-acetyl prolyl-N-nitrosoglycine
MNNG = N-methyl-N-nitro nitrosoguanidine
a = toxicity was observed to the cells in the form of condensed rounded
cells.
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a better positive control in this system although MNNG is a more 
similar to APNG. No significant differences in the percentage of cells 
in scheduled synthesis was seen at any dose.
The in vivo unscheduled DNA synthesis assay in  
hepatocytes determ ined by autoradiography
The results are shown in Table 5.3. It can be seen that an oral 
dose (500 m g/kg bodyweight) of APNG caused an increase in UDS 
after 16 hours. The positive control (2AAF at 100 m g/kg bodyweight)
responded well. No significant increase in the percentage of cells in
scheduled synthesis was seen.
The in vivojin vitro DNA synthesis assay in  
rat stom ach and duodenal m ucosae
The results are shown in Table 5.4. In the stomach APNG 
inhibits both scheduled and unscheduled DNA synthesis especially at 
the two hour pretreatment level. In the duodenum APNG did not 
affect either scheduled or unscheduled DNA synthesis. The positive 
control (MNNG) increased both scheduled and unscheduled DNA 
synthesis in the duodenum.
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Table 5.2.
The effect of APNG on in vitro unscheduled DNA 
synthesis (UDS) in  cultured rat henatocvtes using  
autoradiography
Group
and
Concentration
Change in grain count comparing the 
nucleus to the cytoplasm and % of 
cells undergoing repair or synthesis
Experiment No.
1 2 3
NG %R
(%S)
NG %R
(%S)
NG %R
(%S)
Control - 1 1 . 5 - 1 0 . 5 - 3 0 . 5
( 0 ) ( 0 . 5 ) ( 0 )
APNG
4 X  1 0 ” 'm + 3 1 0 + 5 1 5
( 0 ) ( 0 ) ( 0 )
4  X  1 0 ” ^M + 7 6 7 3 + 4 4 5 + 2 2 6 8
( 0 . 5 ) ( 1 . 5 ) ( 0 )
4  X 1 0 ” % + 1 5 0 8 0 + 2 0 7 7 + 3 8 8 0
( 0 ) ( 0 ) ( 1 . 0 )
MNNG
2  X  1 0 ” % + 7 3 6
( 0 ) ( 1 . 0 )
2  X 1 0 ” % + 5 8 6 8 + 1 1 7 0
( 0 ) ( 0 ) ( 0 )
2AAF
1 0 ” % + 5 0 9 0
( 2 . 0 )
Experiment 1 investigated at the effect after 14 days autoradiography where the 
silver grains were hand counted
Experiment 2 investigated at the effect after 7 days autoradiography where the 
silver grains were hand counted.
Experiment 3 investigated at the effect after 7 days autoradiography where the 
silver grains were assessed using a Seescan Image Analysis System.
APNG
2AAF
NG
%8
%R
= N-acetyl prolyl-N-nitrosoglycine 
= 2 acetylaminofluorene
= net grain increase or decrease comparing the nuclear 
grain count to an average of three cyto^asmic 
counts (equal to the nuclear area).
= the percentage of cells in scheduled synthesis 
= the percentage repair (% of cells > 5 NG)
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Table 5.3.
The effect o f an oral dose of APNG on in vivo 
unscheduled DNA synthesis (UDS) in  cultured rat 
henatocvtes determ ined bv autoradiography
Group and 
Dose NG %R %S
Control -3 0.5 0
APNG
500 mg/kg po +12 34 0
2AAF
100 mg/kg po +20 40 0.5
Six animals per group were treated
APNG = N-acetyl prolyl-N-nitrosoglycine
2AAF = 2 Acetylaminofluorene
NG = net grain increase or decrease where the average of three
cytoplasmic counts (equal to the nuclear area) was subtracted from 
the nuclear grain count.
%S = the percentage of cells in scheduled synthesis
%R = the percentage repair (% of cells > 5 NG)
po = per os
1 1 0
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The in vivo DNA synthesis assay in  rat stom ach 
and duodenal m ucosae
The results are shown in Table 5.5. In all of the areas of the 
gut examined there was no evidence of any increase in unscheduled 
DNA synthesis with APNG. With the positive control (MNNG). 
there was a significant increase in net grains seen in the antrum
In the scheduled synthesis assessment there was some 
evidence that APNG had reduced scheduled synthesis, a slightly 
larger effect being seen with the 2 hour pretreatment group, in the 
glandular stomach. No evidence of a reduction in scheduled synthesis 
was seen in either the non-glandular stomach or the duodenum. 
These results confirm the results seen in the in vivo/in vitro DNA 
synthesis assay.
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Table 5.4.
The effect o f the oral adm inistration o f APNG on 
scheduled and unscheduled DNA synthesis in  rat gut 
m ucosae using scintillation spectrom etry
DNA synthesis measured as dpm//ng DNA
Group
and
Concentration
Stomach Duodenum
UDS Sch UDS Sch
Control 290
APNG
200 mg/kg po 60
2 h pretreated 
200 mg/kg po 140
16 h pretreated 
MNNG
200 mg/kg po 240
16 h pretreated
880
30
340
100
90
100
1330
1410
1060
730 150 2900
po = per os
APNG = N-acetyl prolyl-N-nitrosoglycine 
MNNG = N-methyl-N-nitronitrosoguanidine 
dpm = disintegrations per minute
UDS = unscheduled synthesis (the scheduled synthesis is 
blocked with hydroxyurea)
Sch = scheduled synthesis 
(%C) = percent of control value
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Table 5.5.
The effect o f the oral adm inistration of APNG on scheduled  
and unscheduled DNA synthesis in  rat gut m ucosae using
autoradiography
DNA synthesis measured as net silver grains, 
nucleus - cytoplasm
Stomach Duodenum
Fundus Antrum
Non
glandular
Group
and
Cone.
UDS Sch UDS Sch UDS Sch UDS Sch
Control
APNG
-1 +45 -1 +50 0 +30 0 +28
200 mg/kg po 
2 hours 
pretreated
-3 +30 -1 +40 0 +28 0 +28
200 mg/kg po 
16 hours 
pretreated
0 +33 -1 +41 0 +35 0 29
MNNG
200 mg/kg po 
16 hours 
pretreated
+2 +43 +4 +50 -1 +45 +1 +37
po = per os
APNG = N-acetyl prolyl-N-nitrosoglycine 
MNNG = methyl nitro nitrosoguanidine 
UDS = net grain increase (nucleus compared to cytoplasm) 
in the non-dividing mucosal cells of the gut.
Sch = net grain increase (nucleus compared to cytoplasm) 
in the dividing, crypt mucosal cells of the gut.
(%C) = percent of control value
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DISCUSSION
The results of the studies presented in this chapter have illustrated 
various points. Firstly, it was shown that the nitrosopeptide APNG is an 
agent that causes DNA damage which is repaired in the in vitro unscheduled 
DNA synthesis assay in primary hepatocytes. The degree of response would 
suggest that APNG is a severe DNA damaging agent, although there is httle 
evidence of acute toxicity to the cells. This result is unusual in so far as 
most mutagens seem to exert their effects at approaching toxic levels. This 
result confirms the results seen in the other assays reported in this thesis 
where effects are seen in both in vitro and in vivo tests. Following these in 
vitro assays, an in vivo assay, after oral administration, has shown that 
APNG is able to damage hepatocytes in situ  but once again there was little 
evidence of cellular toxicity at a dose inducing DNA repair. These results 
confirm that APNG, or its metabolites, are sufficiently stable to be absorbed 
and cause DNA damage as seen in the host-mediated assays (Chapter 4). 
However, in the in vivo system the complex patterns of uptake, distribution, 
metabolism, detoxication and excretion are all taken into account 
(Butterworth, 1987) making this an appropriate system for assessing the 
capability of agents to cross the gut wall and act on the liver or in other 
tissues.
Following this work, the affect of APNG on the gut was assessed 
using an assay initially developed by Furihata et al., 1984 for the 
investigation of the effects of agents on both scheduled and unscheduled 
DNA synthesis in the gut. Furihata et al. have previously shown that gut 
carcinogens such as MNNG increase the unscheduled DNA synthesis in gut
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ornithine decarboxylase (ODC) activity as a marker of cell proliferative 
activity some of the problems associated with HU might be circumvented 
and it might be useful to investigate APNG using such a system.
To summarise, the results of this chapter have shown that:
1. APNG is capable of causing repairable DNA damage to the 
hepatocytes.
2. APNG products are sufficiently stable to cross the gut wall to 
affect both the liver and kidneys of rats.
3. APNG has a cell proliferation effect on the kidneys which may be 
related to its toxicity, stimulating some cellular repair.
4. APNG inhibits the proliferation rate of the gut mucosal stem cells.
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CHAPTER 6
POSTLABELLING STUDIES WITH APNG
INTRODUCTION
The somatic mutation theory of cancer proposes that cancer is caused 
by genetic damage induced by chemicals or viruses. These mutations may 
be the result of a covalent interaction of the chemicals with DNA and may 
be an important, initial stage in chemical carcinogenesis. There is 
considerable evidence showing that many carcinogens, or their metabohtes, 
undergo such interactions in vivo with the formation of DNA adducts 
(Watson, 1987). This adduct formation need not be caused by direct DNA 
damage, indirect mechanisms, such as interference with the DNA synthesis 
pathways, may also give rise to adducts (Barrows and Shank , 1981). Other 
alterations to DNA may also be imphcated in mutation, including strand 
breakage, gene-rearrangement or gene-amplification (Watson, 1987). It does 
appear, however, that the covalent binding of chemicals to DNA would be 
a significant initiating event leading to genomic alterations, unless the  
adduct is repaired.
Prior to the early 80’s most studies to investigate DNA adducts 
involved the radio-labelling of carcinogens which were administered to 
animals and the presence of the reaction products with DNA, were 
determined after the isolation of DNA firom various organs, usually hver, and 
subsequent hydrolysis of DNA. The identity of the adducts were usually 
determined by co-chromatography of the hydrolysate on hplc with the  
appropriate reference compounds. In this way a variety of agents causing 
carcinogenicity were identified including some alkylating agents and 
polycychc aromatic hydrocarbons (Watson, 1987). These methods have
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limitations, since they are only suitable for agents which may be extensively 
radiolabelled to permit detection, and they obviously do not lend themselves 
for the analysis of human samples.
As a result, alternative methods for studying the interaction of 
carcinogens with DNA have been developed. One of these methods utihses 
the incorporation of high-specific radioactivity in the form of radioactive 
phosphorus C^P) into DNA adducts and is described as the ^^P-post-labelling 
technique.
In the early 80 s^ Randerath and co-workers reported a new method 
using ^^P-post-labelling for the analysis of carcinogens (Randerath et al., 
1981, 1984a, 1985a and Gupta et al., 1984). The procedure involves the 
incorporation of ^ P^ into non-radioactive nucleic acid constituents using an 
enzyme-catalysed derivatisation followed by a chromatographic separation 
of the radioactive products. The chromatographic separation may be 
achieved either by multi-dimensional thin layer chromatography (tic) 
although the use of hplc has been reported (Haseltine et al., 1983).
The use of ^^P-labelling methods has several advantages over other 
methods. It is very sensitive and only micrograms of DNA are required; it 
is suitable for the assessment of complex mixtures; it can be used as a short­
term assay in animals for detecting the in vivo genotoxic activity of 
chemicals and it also offers the possibility of monitoring human exposure as 
adducts from a small amount of biopsy tissue, acquired for other purposes, 
may be measured.
Many modifications to the method have been proposed with the aim 
of increasing the sensitivity and accuracy the methods (Reddy et aZ.,1984; 
Gupta, 1985, and Reddy and Randerath, 1986). However, the basic method 
(Randerath et al., 1981,1984a, 1985a and Gupta et al., 1984) was used in the 
studies reported in this thesis . The potential of APNG to form stable
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adducts was evaluated using a post-labelling technique. The presence of 
such adducts in in  vivo experiments can be examined after the treatment of 
animals with suitable diets, containing both the precursors, potential 
substrate and nitrite as well as after treatment with APNG.
These studies were carried out simultaneously with hplc 
measurements of adducts and Ehsa immunological methods for the 
identification of potential adducts carried out by Prof B.C. Challis 
(unpublished data).
EXPERIMENTAL
M aterials and m ethods
The compound was APNG. Also DNA treated, in vitro, with 
APNG was supphed by Professor Chalhs for the direct assessment in 
the ^^ P post-labelling studies. The [^ P^] ATP (50 mCi/ml) was 
obtained from Amersham International pic, Amersham, Bucks.; the 
four dinucleotide biphosphates, dpAp, dpGp, dpCp and dpTp, firom 
Pharmacia, Uppsala, Sweden; and the bicine, polynucleotide kinase (3 
U/m l), potatoe apyrase (40 /xU/ml) and sodium succinate from the 
Aldrich Chemical Co. Ltd., Poole, Dorset. All the other chemicals 
were obtained from the Sigma Chemical Co., Poole, Dorset.
Equipment
The low speed centrifuges and the microfuges were made by 
MSE Ltd and supphed by FSA, Leics. The PEI plates were from 
Macherey-Nageland supplied by Camlab, Cambridge, Cambridgeshire, 
and were exposed in glass tic tanks supplied by FSA, Leics. The 
procedures were carried out in a class 2 fume cupboard behind 
Perspex radioactive protection screens, made in house, with constant
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radioactive monitoring using a Geiger counter. The autoradiographic 
film was by Kodak which was developed with Kodak developer and 
Kodafix supphed by the Sigma Chemical Co. Ltd., Poole, Dorset. The 
water baths and the incubator were supphed by FSA, Leics. The 
homogeniser was an Ultraturrex supphed by FSA, Leics.
Animals
The rats used in the post-labelling studies were those described 
in the DNA synthesis assays , Chapter 5, which were given a single 
oral dose of APNG at 500 m g/kg either 2 or 16 hours before the  
removal of the tissues.
®^ P post-labelling studies
Two sets of studies were carried out. Firstly the in vitro 
treated DNA was studied fohowed by the investigation of tissues from 
rats treated with APNG.
In vitro studies
For the in vitro studies the DNA samples were treated in the 
fohowing way:
An ahquot of the control (calf thymus DNA) or APNG-modified 
DNA, containing 1 /ig of DNA, was pipetted into a 1.5 ml Eppendorf 
tube to which was added water to give a final volume of 0.2 ml. To 
this mixture was added 20 lA of 3M sodium acetate, pH 5.2, and 400 
111 of absolute ethanol at -20 " C. The precipitated DNA was pelleted  
by centrifugation in a microfuge for 10 minutes and the supernatant 
discarded. The remaining liquid was removed under a stream of 
nitrogen and the pellet incubated with 2 iig each of micrococcal
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endonuclease and spleen exonuclease in 20 mM sodium succinate 
containing 10 mM CaClg, pH 6.0, at 37 “ C for 2 hours. This digest was 
labelled by taking 1.7/il of the mixture and adding to 83 /Ltl of a 
solution prepared by mixing 1 fil of O.IM Bicine NaOH, 0.1 M MgClg, 
0.1 M dithiothreitol (DTT), 10 mM spermidine at pH 9 with 4 /xl 
[y.32p] ATP (150-200 /LtCi), 1.2 /Ltl of 0.5 mM non-radioactive ATP, 1.1 
/Lil of water and 1 /xl of polynucleotide kinase (3.0 U//xl). The 
resultant solution was mixed in the microfuge and incubated at 30 “ C 
for 30 minutes. To this was added a freshly prepared 1:1 mixture of 
the four dinucleotide biphosphates dpAp, dpGp, dpCp and dpTp (4 
/xg/ml each), and potato apyrase (40 /xU//xl). This reaction mixture 
was incubated at 38 “C for 30 minutes and 11 /xl of the digest was 
added to the centre of one edge of a PEI-cellulose tic sheet to which 
a 20 cm strip of Whatman N o.l filter paper had been stapled. The tic 
sheet was then developed in IM sodium phosphate buffer as shown 
below.
The wick and top of plate were removed thus disposing of the 
®^P-labelled unmodified nucleotides and retaining the P^P] adducts at 
the origin. The cut portion of the plate was washed twice in
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deionized water and dried before being resolved in the reverse 
direction using 1.8 M hthium formate, 4.26 M urea at pH 3.5, as 
shown below.
The plates were washed twice as before and dried. They were 
rotated 90 ° and resolved in 0.26 M LiCl, 0.15 M Tris HCl, 2.6 M urea 
at pH 8.0 followed by washing and drying as before. Finally the  
plates were resolved in the same direction with 1.7 M sodium 
phosphate, pH 6.0, and were subsequently washed and dried (see 
below).
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The plates were overlaid with X-ray film and exposed for three 
days at -80 “ C before being developed and examined for the presence 
of labelled adducts.
In vivo studies
In the in vivo studies, where the hver and kidney tissues were 
retained from the 2 and 16 hour treatment groups of the DNA 
synthesis assays described in Chapter 5, the DNA from each tissue 
was first extracted. Portions of the tissues were macerated, using 
scissors, in 5 ml of ice cold lysis buffer. The mixture was 
homogenised and 5 ml of the lysis buffer with 0.1 ml 20% SDS and
0.1 ml of protinase K (10 mg/ml) were added. This was mixed gently 
and incubated for 2 hours in a waterbath at 37 ° C. 1 ml of IM Tris 
buffer, pH 9, was added followed by approximately 20 ml of saturated 
phenol which was mixed by gently inverting the tubes several times. 
The resultant mixture was centrifuged at 2000g in a bench centrifuge 
for 15 minutes and the upper layer removed to a fresh tube with a 
plastic pasteur pipette. An equal volume of saturated 
phenokchloroform (1:1) was added, mixed as above, and centrifuged 
again at 2000 g for 15 minutes. The top layer was removed and an 
equal volume of chloroform was added, mixed, centrifuged and 
separated as described above. This last step was then repeated and 
to the resultant upper phase was added 2 ml of 3M sodium acetate at 
pH 5.2 followed by 40 ml of absolute ethanol at -20 “C. This 
precipitates the RNA and DNA which are removed from the mixture 
by spooling onto a pasteur pipette, with a hook on the end. When the 
nucleic acids were collected, on the pasteur pipette, the resultant 
"lump" was washed with 70% ethanol to remove the "salts" and
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resuspended in 5 ml water with gentle stirring. The suspension was 
then treated with an RNAase (0.1 mM) overnight to remove the RNA 
and the procedure repeated from the phenol addition stage. After 
precipitation the "cleansed" solution was assayed for its DNA content 
by dilution and measuring the absorbance at 260 nm and compared 
to a known standard. The DNA solution was stored at 4 “C before 
being treated as for the in vitro samples
RESULTS
The results from both untreated and APNG-treated DNA are shown 
in plate 6.1. It is clear that no adducts are seen in the untreated DNA and 
that a single spot representing the presence of an adduct, or adducts, was 
seen with the DNA treated with APNG in vitro. The results from the rats 
given APNG m vivo are shown in plate 6.2. and 6.3. where no adducts were 
seen in the control tissues (liver and kidney). However a single spot 
representing adducts is seen in the hver and kidney from rats given an oral 
dose of APNG after both a 2 or 16 hour treatment period. These results 
were confirmed in a repeat studies on the same DNA The spot seen in 
both the in vitro and in vivo experiments was present in approximately the 
same place and it was also in the same place in the liver and kidney.
DISCUSSION
It was proposed by Professor ChaUis that nitrosated peptides would 
generate an Os-carboxymethylguanosine adduct which he synthesised as a 
control for both hplc analysis and antibody generation for use with the Elisa 
techniques. However, these two methods proved to be too insensitive to 
detect adducts from in vivo treated animals although it was possible to
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Plate 6.1. 
from  ju vjtm  treated DNA
Control DNA
A P N G -treated  DNA
mm
mm
m a m
m
# 0 #
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Plate 6.2.
Adducts from in vivo treated DNA
DNA from  the liver of control anim als
DNA from  the liver of APNG-treated rats
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Plate 6.3.
Adducts from in vivo treated DNA
DNA from the kidney of control anim als
m
DNA from  the kidney of APNG-treated rats
mm
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detect the presence of two adducts in in vitro treated DNA (Challis, personal 
communication). Challis hypothesised that these adducts corresponded to 
Nr^and Og adducts. In addition it was proposed that it would be possible to 
detect adducts using the post-labelling technique described by various 
workers (Randerath et al,, 1981,1984a, 1984b; Gupta and Dighe, 1984). This 
chapter describes results from such studies where DNA adducts were looked 
for in in vitro treated DNA and in DNA from the hver and kidneys of rats 
given oral treatments of APNG.
It was seen that a spot corresponding to adducts was detected after 
both the incubation of DNA in vitro and in vivo after treatment of rats, in 
both the hver and kidneys and that it was in the same position. It is 
proposed that APNG does cause the formation of a stable adduct, or adducts, 
in DNA These results confirm that APNG is a DNA damaging agent as 
seen in the studies reported in the earher chapters. These results also show 
that APNG does form an apparently stable adduct which may have 
carcinogenic consequences unlike the previous studies which only detected 
transient damage. In addition the fact that ^^ P post-labehing can detect the 
damage caused by nitrosopeptides may mean that such damage can be 
detected in vivo after treatment of animals with suitable substrates, 
including nitrite and high aminoacid containing foods. It may also be 
possible to detect adducts, corresponding to the APNG induced ones, in 
human tissue thus establishing a link between nitrosopeptides and damage 
in man.
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The fact that ChaUis was unable to use hplc or Ehsa techniques to 
identify damage is probably due to the nature of the adducts. The type of 
adduct proposed is smaU and difficult to detect in the hplc assays due to 
interference with other agents and in the Ehsa techniques the fahure to 
successfully raise a pure monoclonal antibody to the Og- 
carbojymethylguanosine, synthesised by Professor Chalhs, meant that 
detection of the adduct was impossible. The detection of the adduct in the 
®^P post-labehing assay was also difficult and the presence of only a single 
spot does not mean that only one adduct is present. It is quite hkely that more thar 
one adduct is present and they run together in the system used. It could be 
useful to use different running buffers to estabhsh whether there is more 
than one adduct present. However within the terms of the investigation the  
presence of adducts had been shown and it was felt unnecessary to pursue 
this further.
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CHAPTER 7
THE LONG TERM TOXICITY OF APNG 
IN MICE
INTRODUCTION
Further to the investigations previously described, it was possible to 
study APNG in a limited, long-term toxicity study in mice where it was 
considered that some information regarding its potential carcinogenicity 
could be acquired.
The current methods for investigating carcinogenicity have evolved 
from the long-term studies first carried out in the 1950’s and reviewed by 
Shubik and Sice (1956) where guideUnes for such studies were proposed. 
These authors emphasized the importance of uniformity and high purity of 
the substance to be assayed, the minimum numbers of animals to be used, 
the choice of species, strain, sex, route of exposure, and vehicle, and 
importantly the need for sufficiently high doses and length of treatment so 
as to detect weak carcinogenic effects leading to tumours late in life. These 
guidelines apply today. It is still required that for a chemical to be 
characterised as a carcinogen an animal assay is necessary, even though 
there are many short-term assays for the determination of genotoxicity 
giving some guidance as to the potential carcinogenicity of such agents. 
These short-term assays have not as yet replaced the animal studies, as the  
correlation between genotoxicity and carcinogenicity is not as convincing as 
was originally hoped when these assays were developed. The short-term  
assays cannot mimic all of the factors that modify a chemical in vivo (Harper 
and Morris, 1984) and may not be used as indicators of the potential 
carcinogenicity of agents with total confidence.
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Carcinogenesis is believed to be a multistage procedure involving the 
genome through two stages often described as initiation (or conversion) and 
promotion. Initiation is the process by which a normal cell is transformed 
to a neoplastic cell and the development is the process of growth of the 
neoplastic cell into tumours with the associated abnormal chacteristics 
(WiUiams, 1984). Carcinogenicity (long-term) studies are generally designed 
to measure the end-point of tumours in treated animals and do not 
distinguish between the stages involved. So positive results from long-term 
studies only demonstrate that a chemical is carcinogenic to animals under 
the conditions of the study and do not necessarily indicate how the agent 
causes such damage. The imphcation of a positive result in a carcinogenicity 
study is also that the agent has the potential to be hazardous and a risk to 
man, but this need not always be the case. The fact that in carcinogenicity 
studies high doses are usually employed means that it is not necessarily true 
that the agent is a carcinogen at lower doses and may thus be of less 
significance to man.
Many routes of administration are used in carcinogenicity studies but 
two methods are commonly employed. The first stratagem involves the use 
of parenteral administration of the agent. This method allows for the  
compound to be given in precise amounts to reach the general circulation 
without modification by the gut or hver. This method of administration has 
the advantage that a high dose can be administered easily but it has been 
shown that many substances produce sarcomas or physical damage at the  
site of repeated injection (Grasso et al., 1971). This method of treatment is 
therefore only valid if the tumours are produced at sites remote firom the 
injection area. It is thus considered that intraperitoneal and intravenous 
injections are not well suited for the repeat administration of agents in
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carcinogenicity studies but are useful in research with either a single or 
limited number of doses (Robens et al., 1989). The second stratagem, the 
one usually employed in carcinogenicity studies, is to administer the agent 
by the route that most closely mimics the main route of potential human 
exposure. Routes that may be employed include oral treatment 
(administered either by gavage or in the food), dermal treatment (using skin 
painting), or by inhalation.
Two of the most important factors in the design of carcinogenicity 
studies include the use of an adequate number of animals and the life span 
of the animals, which must be sufficiently short enough to allow for a 
reasonable assessment of an effect within 2-3 year. Although various animal 
species may be selected for use in carcinogenicity studies, rats or mice are 
those most commonly employed. These species are favoured for mainly 
logistical reasons related to the cost of carrying out such studies. In 
addition the amount of chemical available may dictate the species to be used
i.e. if  the agent is rare or difficult to synthesize the use of the smaller 
species may be beneficial. It is also required that animals of both sexes are 
used to detect tumour types more characteristic of a particular sex.
The firequency of treatment in carcinogenicity studies may vaiy, being 
given daily or weekly by injection or continuously by administration in the 
diet. It is usual to place the animals on treatment at weaning (or shortly 
after) so they can be exposed for the greater part of their life (18-24 months 
for mice and 24-30 months for rats) although treatments for shorter periods 
are often used. The treatment and control groups are allowed to live for a 
pre-determined time and the incidence of tumours is assessed throughout 
the life of the animals. However, animals are often killed early in their
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lifespan (15 months) to evaluate chronic toxicity at an age where they are 
not compromised by lesions appearing in old age (Robens et aZ.,1989).
The number of animals required in a carcinogenicity study is normally 
50 animals per group, with additional animals for interim kills. However, 
as the principal endpoint in the chronic assay for carcinogenicity is whether 
the animals develop tumours, the actual numbers required for a sufficiently 
powerful test will vary according to the proportion of animals with tumours 
in the various groups. So if the agent under study is suspected to be a 
potential carcinogen, from short-term studies, a smaller group of animals 
may be sufficient to estabhsh whether the agent is a carcinogen (Ashby and 
Morrod, 1991).
The investigation of the animals for tumours takes place in two 
stages. Firstly, at a post-mortem examination the tissues are examined for 
gross lesions. Secondly, the tissues are fixed and examined histologically. 
The more tissues examined, the better the discrimination and identification 
of tumours will be. Some limit must be made as to the number of tissues 
examined, due to the cost of examination.
Due to the expense of carrying out a full carcinogenicity study 
(approximately £500,000) it was not possible to investigate APNG in any 
detail. However, as the genotoxicity studies indicated that APNG caused 
severe genetic damage it was decided that a very limited long-term study in 
mice, using oral and intraperitoneal routes of administration, could yield 
useful information as to its long-term toxicity and might identify it as a 
carcinogen. The use of an intraperitoneal route was selected to maximise 
the chance of observing an effect although the oral route, which was also 
used, was the preferred route. Mice were used in this study as the greatest
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responses were seen in this species in the in vivo mutation studies reported 
earher.
EXPERIMENTAL
M aterials and methods
The compound was APNG. The negative control was, the 
solvent, physiological saline (0.9%) All the media and chemicals were 
obtained from standard sources.
The histological samples for the long-term study were prepared 
using microtones supphed by FSA, Leics and the tissues were stained 
in an automatic staining unit from the same supplier.
Animals
The mice used in the long-term studies were sexually mature 
male and female mice (8 weeks old) and were obtained from Harlan 
Olac, Margate, Kent. The animals were fed on Rat and Mouse N o.l 
diet (Special Diet Services, Witham). The diet was given ad libitum  
with unlimited access to mains tap water. The animals were housed 
in groups in plastic and stainless steel, sohd floored cages. The cages 
were kept in ventilated rooms under the following conditions:-
Temperature : 20-25 ”0  
Humidity : 45-75%
Lighting : 12 h light: 12 h dark
(06.00-18.00 h; 18.00-06.00 h GMT)
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Procedures
The long-term study in mice involved the weekly treatment of 
three groups, of 6, 8 week old, male and female mice; the first group 
was orally dosed with the solvent control, saline; the second group 
with a single oral dose of APNG at 500 mg/kg bodyweight and the  
third group with a single intraperitoneal dose of APNG at 200 m g/kg 
bodyweight. The animals were treated with a single injection once 
weekly for 13 weeks (Table 7.1.), weighed weekly and their health 
status observed. If the bodyweight started to faU, due to treatment, 
the weekly doses were withheld to allow for recovery. The mice were 
killed when they showed signs of distress or lumps and the animals 
examined at post-mortem.
The males were allowed to hve until the maximum time of 12 
months and the females were allowed to hve until 15 months in the  
absence of any observable toxicity.
On necropsy the foUowing organs were removed, fixed in 
formal-saline and examined:-
Brain Mammary gland
Caecum Muscle
Colon Ovaries
Duodenum Pancreas
Oesophagus Prostate
Eyes Rectum
Femur Seminal vesicles
Heart Skin
Ihum Spleen
Jejunum Stomach
Kidneys Testes
Liver Thymus
Lungs Urinary bladder
Lymph node Uterus
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In addition any tissue that was observably abnormal was 
removed and fixed for histological examination.
The tissues were kept in buffered formal saline for at least two 
weeks and were then processed for histology. Free-hand sections of 
the tissues were mounted in paraffin wax and 12 /Ltm sections were 
cut. These were stained with the standard haematoxylin and eosin 
histological staining.
The processed sUdes were then examined by an experienced 
pathologist (Dr. J.H.Evans) and any pathological changes in the 
tissues were noted.
RESULTS
The data from the long term study are presented in the following 
tables and figures:
Figure 7.1. shows the dose treatment times and figure 7.2. the 
bodyweights of the mice from week 8, start of treatment, to week 25, four 
weeks after the end of treatment. The animals were treated for thirteen  
consecutive weeks in the case of the control and oral APNG dose groups and 
for eleven of the thirteen weeks for the ip APNG treated group. The 
animals firom the ip group were not treated on weeks fifteen or twenty due 
to a noticeable detrimental effect on their health and a decrease in 
bodyweight caused by dosing. It was observed that within one week of the  
cessation of treatments, the animals were recovering and, by week 
twentyfive, all of the animals, with the exception of the male ip treated 
group, had attained their expected adult weights. It was a further five 
weeks before the male ip treated APNG group animals achieved their 
optimum weights.
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Figure 7.1. Plan of treatment times
Dose (ng/kg once weekly)
No treatRDt, aninls losing weight
i i
400 -
300 -
200 -
100 -
0 I I I ... I .  I .0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 10 1920 21 22 23 2425
Age of mice in weeks
po control ■  APNG po WÊÊ APNG ip
Single dose, twice weekly, at nrked t ie s
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Figure 7.2. Bodyweights of mice in long-term study
Bodyweight tgl
Last treatment
I Start of treatment
I
I
8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Age of mice (weeks)
oral ip
Control 0 - i -  500mg/kg o 200mg/kg o
Control 0 - x -  500mg/kg o - e -  200mg/kg o
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Table 7.1. shows the mortality or post-mortem times for the animals 
after treatment with APNG, table 7.2. a summary of the gross post-mortem 
findings along with the major pathological changes detected, table 7.3. and
7.4. the incidence of tumours in female and male mice respectively and table
7.5. a summary of the tumour incidences.
All of the control animals survived to the terminal post mortem date 
with httle or no observable effect on their health, although on histological 
examination a variety of age-related pathology was seen. The most severe 
effects included a small basophihc fiver nodule seen in one of the males, and 
the presence of a pulmonary adenoma in one of the females. No malignant 
tumours were seen in the controls.
In the ip treated groups, most of the animals were observed to have 
severe peritoneal adhesions and histologically there was a large amount of 
associated damage. In the males, one animal had kidney damage, two had 
adenomas and two carcinomas. In the females, two animals had kidney 
damage, one had a cystic uterus and one had an adenoma with multiple 
lymphomas. It was not possible to examine two of the females histologically 
as the tissue had autolysed before fixing.
In the oral treated groups, most of the animals survived to the end 
of the study, one male died during the dosing period, probably due to 
damage caused by the catheter. In the male group three animals were 
healthy, one had a kidney tumour, two had adenomas and one with multiple 
lymphomas. In the female group two animals were healthy and the other 
four had a variety of malignant tumours including one with a squamous 
carcinoma of the stomach, two with carcinoma of the lung, one with a 
fibrosarcoma of the vagina and one with multiple lymphosarcomas. In 
addition these same animals were observed to have a variety of adenomas.
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Table 7.1.
Long-term toxicity study - M ortality or post m ortem  tim es
Animal Group Sex Week Mortality or reason for kill
No. No.
1 Control d 68 Terminal PM
2 po 68 Terminal PM
3 68 Terminal PM
4 68 Terminal PM
5 68 Terminal PM
6 68 Terminal PM
7 APNG d 43 Apparent Bilateral hernia
200 mg/kg animal in distress
8 ip 35 Moribund with distended
abdomen
9 23 Moribund, blood in faeces
10 45 Moribund
11 52 Early kill
12 52 Early kill
13 APNG d 65 Died NAD
14 500 mg/kg 68 Terminal PM
15 po 62 Died NAD
16 8 Died after injection
17 68 Terminal PM
18 49 Large lump on left leg
1 Control 9 68 Terminal PM
2 po 68 Terminal PM
3 68 Terminal PM
4 68 Terminal PM
5 68 Terminal PM
6 68 Terminal PM
7 APNG 9 52 Moribund with distended
200 mg/kg abdomen
8 ip 37 Moribund
9 51 Moribund with blood from
vagina
10 45 Moribund
11 20 Died NAD
12 24 Died NAD
13 APNG 9 68 Terminal PM
14 500 mg/kg 68 Terminal PM
15 po 68 Terminal PM
16 68 Terminal PM
17 68 Terminal PM
18 68 Terminal PM
NAD = No abnormality detected
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Table 7.2.
Long-term toxicitv study - Post m ortem  findings
Animal
No.
Group Sex Week
No.
Gross findings Histological
findings
Control
po
68
68
68
68
68
68
NAD
NAD
NAD
NAD
NAD
NAD
Amyloid tissue in 
spleen 
NAD 
NAD 
NAD
Basophilic nodule 
in liver 
NAD
8
9
10 
11
12
APNG d 
200 mg/kg 
ip
43
35
23
45
52
52
Pale kidneys,
V. large spleen, 
R. kidney cystic 
large thymus and 
adhesions. 
Adhesions 
Adhesions 
Adhesions 
Kidneys pale and 
cystic with 
adhesions 
Kidneys pale and 
cystic with 
adhesions
Pulmonary adenoma 
Adhesion damage
Adhesion damage 
Adhesion damage 
Adhesion damage 
Lung adenoma 
Kidney adenocarcinoma 
Adhesion damage 
Severe glomerular 
nephrosis with a 
kidney adenocarcinoma
13
14
15
16
17
18
APNG cf 
500 mg/kg 
po
65 NAD
68 NAD
62 NAD
8 NAD
68 NAD
49 Lump on R leg
Amyloid tissue in 
GI tract
Pulmonary adenoma 
Kidney adenoma 
with glomerular 
cysts
NAD
NAD
NAD
Lymphoma
NAD = No abnormality detected
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Table 7.2. continued  
Long-term toxicitv study - Post m ortem  findings
Animal Group Sex Week 
No. No.
Gross findings Histological
findings
Control
po
68
68
68
68
68
68
NAD
NAD
NAD
NAD
NAD
NAD
NAD
Uterine polyps 
with amyloid material 
in the spleen and 
GI tract 
NAD
Pulmonary adenoma 
NAD
Cystic ovaries
10
11
12
APNG 9 
200 mg/kg 
ip
52
37
51
45
20
24
Cystic kidneys Severe glomerular
and ovaries nephrosis
Adhesions Adhesion damage
Pale, large spleen Glomerular nephrosis 
with pale cystic Adhesion damage
kidneys 
Adhesions 
Cystic kidneys 
Inflamed uterus 
Adhesions 
Pale kidneys, 
large spleen 
with gangrenous 
loop in gut 
Adhesions 
Adhesions
Adhesions
Cystic uterus 
Adhesion damage
Pulmonary adenoma 
Lymphomas in the 
liver, kidneys, GI 
tract and lymph glands 
Adhesion damage 
No examination, 
tissue autolysed 
No examination, 
tissue autolysed
13
14
15
16
17
18
APNG 9 
500 mg/kg 
po
68
68
68
68
68
68
Lump in non- 
glandular stomach
Cystic kidneys 
Several lumps 
in the lung
Large fibrous 
lump in the 
vagina
Lump in left lung 
NAD 
NAD
NAD
Squamous cell 
carcinoma in stomach 
Pulmonary adenoma 
Tubular papillary 
adenoma of the kidney 
Pulmonary carcinoma 
Cystic kidneys 
Carcinoma of the lung 
Fibrosarcoma of the 
vagina
Cystic ovaries 
NAD
Multiple lymphosarcomas 
Pulmonary adenomas 
NAD
NAD = No abnormality detected
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DISCUSSION
It was apparent from the inception of the long-term study that a 
negative result, that is no evidence of an increase in malignant tumours, 
would make any data obtained of limited value. However, it was felt that 
in the hght of the evidence obtained in the genotoxicity assays, APNG was 
almost certainly a prime candidate for being a carcinogen and a small animal 
study would probably demonstrate its potential to cause tumours, even if 
the groups would be too small for a successful statistical analysis.
In the study carried out, the ip dosing scheme proved to be less 
successful than the oral treatments since those given an ip dose of APNG 
suffered severe internal adhesions and none of the mice survived to 68 
weeks, the time at which it was intended the animals be examined at post 
mortem. In the ip treated group three of the ten animals examined 
histologically had mahgnant tumours.
In the oral/ireated groups, most of the mice survived to at least 60 
weeks and five of the eleven animals examined histologically had mahgnant 
tumours of varied types.
It is clear from this study that there is an increase in both benign and 
malignant tumours in male and female mice after both ip and oral 
treatments. However, these increases are not statistically significant except 
for the increase in the number of females with malignant tumours after oral 
treatment with APNG. If the data from males and females are combined, 
both the number of animals with tumours and the number of animals with 
malignant tumours are statistically significant.
It is also apparent that after treatment with APNG the malignant 
tumours found were of different types and at multiple sites: in the females 
they were found in the lungs, the stomach, the vagina and the lymphatic
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system with one animal having a generalised lymphoma; in the males they 
were found in the lungs and the kidney with one animal having a 
generahsed lymphoma. After ip treatment two from six treated males had 
mahgnant tumours and in the females one from six. In the oral/treated 
groups one from six males and four from six females had mahgnant 
tumours. The group that had the greatest incidence of tumours was the 
oraUy treated females, however, due to the small group sizes it is not 
possible to make any predictions on the sensitivity of the sexes to APNG.
Ashby and Morrod (1991) suggested that if a chemical ^a^ shown to  ^
be a genotoxin in a predictive test a limited bioassay could be carried out 
instead of a frih carcinogenicity study. They proposed that such a bioassay 
should be in male rats and female mice. This present study has used both 
sexes in mice, as it was not feasible to use rats because of the larger amount 
of compound that would be required for the dosing. Nevertheless, this study 
has produced a multiple site rodent carcinogen and this would suggest that 
APNG is a carcinogen that acts by a genotoxic mechanism.
In conclusion APNG is a carcinogen at the doses given in the study 
described in this chapter. It is also evident that although APNG is reactive 
and short-hved in vivo it is able to cause the formation of tumours at sites 
^  distant p6 the site of administration and it is also feasible that the 
endogenous formation of nitrosopeptides could be implicated in cancer.
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CHAPTERS
DISCUSSION
In assessing the role that N-nitroso compounds play in the induction 
of cancer in man, it is necessary to determine the circumstances in which 
humans are exposed to such compounds. It is relatively simple to determine 
the circumstances under which man might be exposed to N-nitroso 
compounds, but in many cases, such as in the endogenously synthesized N- 
nitroso compounds, it is difficult to assess the exposure levels or to measure 
the degree of any toxic effects. The use of epidemiological studies to relate 
cancer to either exogenous or endogenously-formed N-nitroso compounds is 
difficult, if  not impossible, and the use of in vitro or in vivo genotoxicty 
assays may help in the understanding of the mechanisms involved in both 
mutagenicity and carcinogenicity and in identifying agents which present a 
hazard to man.
The work presented in this thesis is aimed towards understanding the 
role in mutagenesis and carcinogenesis of a novel class of nitroso compounds, 
which may be formed in vivo. The formation of N-nitroso compounds in 
vivo may be by acid-catalysed reactions, most hkely in the stomach, or by 
bacterially-catalysed reactions, mainly in the gut. The conditions for the 
acid-catalysed formation of N-nitroso compounds requires a pH of about 2-3 
and these conditions are normally only found in the stomach. However, 
some catalysed reactions may take place at higher pH’s, i.e. at about pH 5, 
and this pH can be encountered, for example, in the vagina, in a bacterially- 
infected urinary bladder or in the large bowel of people eating large volumes 
of ill-absorbed sugars. Nitrite is a requirement for the nitrosation reactions
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involving acid-catalysis; however the presence of nitrate in the diet can also 
lead to nitrosation after bacterial reduction. The presence of some bacteria 
may also lead directly to the formation of N-nitroso compounds and this may 
take place almost anywhere in the gastrointestinal tract.
Many authors have claimed that N-nitroso compounds are formed 
endogenously at various sites, for example in the normal acid stomach 
(Milton-Thompson et al., 1982 and Pignatelh et al., 1987), in the achlorhydric 
stomach (Reed et al., 1981 and Pignatelh et al., 1987), in the infected urinary 
bladder (Brooks et al.,1972 and Hicks et al., 1977) and in the infected vagina 
(Harrington et al., 1973). In ah of these cases, except for the normal 
stomach, bacterial colonistion, nitrosatable amine and nitrate are required. 
However, these conditions for the formation of N-nitroso compounds are by 
no means unusual,and are present in a large proportion of the population. 
Correlations between the risk of cancer and bacterial infections in the 
stomach, urinary bladder and vagina have been established and that high 
nitrate intake is associated with cancer of the oesophagus and stomach (HiU, 
1988). Gastric cancer is one of the commonest cancers , and hence of 
great importance and it has been proposed that a possible mechanism for 
the formation of tumours involves gastric atrophy followed by a raised pH 
leading to the estabUshment of a resident bacterial flora (Hill, 1988). This 
in turn would reduce gastric nitrate to nitrite and hence catalyse the 
formation of N-nitroso compounds, these being the possible cause of the  
progression to gastric cancer (Hill, 1988). Such evidence does not prove that 
N-nitroso compounds cause cancer but the link is undeniable. So the 
presence of nitrites in diet that may give rise to the formation of 
nitrosamines, nitrosamides and nitrosoureas in vivo could be important as 
these agents may be genotoxic and could be implicated in cancer formation.
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As one of the requirements for the formation of N-nitroso compounds 
is the presence of nitrosatable amines or amides it would seem reasonable 
to suppose that protein could be one of the prime sources for such agents 
where the breakdown products are amino-acids and peptides. It is possible 
to nitrosate peptides in a similar way to amides, where secondary amino 
groups give rise to nitrosamides and primary amino groups give products 
resulting from diazotization (Wilhams, 1988). Although peptides may be 
nitrosated at the terminal amino groups, it is also possible that those 
peptides with ring structures at the basic end of the molecule will react at 
the peptide bonds, forming N-terminal nitrosated peptides (ChaUis, 1989). 
The possibihty that such compounds exist gives rise to the question, "Are 
these compounds genotoxic and can they be implicated in cancer?"
The work presented in this thesis was carried out to specifically 
investigate the class of chemicals referred to as nitrosopeptides. Some 
diazopeptides were also examined, these compounds being less stable than 
the nitrosopeptides, but as these are the possible products of the breakdown 
of nitrosopeptides they could be the active genotoxic components.
in vitro mutation assays
The initial investigation for the potential genotoxicity of a compound 
involves the use of short-term in vitro mutation assays. The second Chapter 
shows the results of assaying both nitroso- and diazo-peptides in the 
Salmonella typhimurium/meimmdXmxi mutagen assay (Ames et al., 1975; 
Maron and Ames, 1985) The results obtained in Chinese hamster ovary 
genotoxicity assays (Anderson, et al., 1986) were also discussed. It was 
estabhshed that two nitrosopeptides (APNG and AVNG) were direct-acting 
mutagens in both systems and that some diazopeptides were also direct
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acting mutagens in the base-pair detecting strain TAIOO (Chapter 2, 
Blowers et al., 1989). Once this had been established the investigation of 
one particular nitrosopeptide for its genotoxicity and mechanisms of action 
were undertaken. Only one compound was synthesized by Professor B.C. 
ChaUis , partly due to the cost of synthesis and this was used to represent 
the nitrosopeptides.
In vivo mutation assays
Once it had been estabhshed that the nitrosated peptides were direct- 
acting mutagens it was important to ascertain if these potential DNA 
damaging agents would affect in vivo systems. Prior to the investigation of 
APNG for its in vivo genetic toxicological effects, it was necessary to 
estabhsh the doses required and three acute toxicity studies were carried 
out. These studies were single and multiple intraperitoneal dose studies in 
rats and a single intrapertoneal dose study in mice. It appeared that APNG 
caused death by damaging the kidneys of the animals; no observable damage 
was seen in any of the other organs examined and the length of time taken 
for the animals to die was consistent with the effects seen with chronic 
kidney faUure.
Various assays exist for the investigation of the in vivo genetic 
toxicological effects of compounds. APNG was studied using the bone 
marrow metaphase analysis in rat, the bone marrow micronucleus assay in 
mouse (both somatic ceU genotoxicity assays) and the dominant lethal assay 
in mouse (a germ ceU assay). The results of these studies were presented 
in Chapter 3.
The rat bone marrow assay produced an increase in gaps with no 
major chromosomal damage. As gaps are considered the most subjective and
150
S.D^Blowers - PhD Thesis Discussion
maybe the least significant category of aberration (Anderson and Richardson, 
1981) it was felt that the result was equivocal and that another somatic cell 
assay, the mouse micronucleus assay was required to clarify the picture.
In the micronucleus study it was clearly seen that APNG produced a 
significant increase in micronuclei with minimal toxicity to the marrow. 
Although there was an apparent species difference in sensitivity, the 
increase in micronuclei, in the polychromatic erythrocytes of the mice, does 
make the result in rats more meaningful and it was concluded the APNG 
caused genotoxic effects in somatic cells in rodents following intraperitoneal 
treatment.
In the dominant lethal assay the usual endpoint for an effect is the 
loss of embryos at an early stage of development and it is assumed that the 
prime cause of such dominant lethahty is chromosome breakage 
(Bateman,1984). The broken chromosomes will then be lost, leading to 
monosomy and thus to the death of the developing embryo. Multiple hits 
and loss of a larger number of chromosomes would probably result in deaths 
at an early stage and would be apparent in the assay as preimplantation 
losses. However, in the dominant lethal assay intraperitoneal 
administration of APNG did not cause a dramatic dominant lethal effect (a 
shght increase in dominant lethality was seen in the third study) but did 
show a significant increase in the number of late deaths. In addition there 
was some evidence of an increase in the number of abnormally developed 
foetuses (exencephahc animals). These results imply that APNG caused 
some heritable genetic damage but not to the degree normally expected with 
most dominant lethal producing agents. It is proposed that APNG causes 
chromosomal damage, possibly resulting in the loss of only a small part of 
some chromosomes. This damage was probably less severe than usually
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seen with most DNA-damaging agents, allowing the foetus to develop 
further into pregnancy before the genetic changes caused lethality. An 
alternative possibihty is that some of the foetuses were trisomie causing 
either abnormal foetuses or late deaths as the developmental deficiencies 
become more manifest later in the pregnancy. There is evidence that 
exencephaly may be caused by such abnormahties (Bateman and Epstein, 
1971; and Gropp et al., 1976) seen in the present studies. It was concluded 
that APNG causes heritable genetic damage in the dominant lethal assay. 
The damage seen with APNG could have veiy great implications to man; the 
detection of an agent causing abnormal offspring could imply that a similar 
type of effect may be induced by dietary components and hence be 
significant in the production of human foetal loss. It would be interesting 
to follow up this work since these effects in the dominant lethal assay were 
very unusual and a literature search failed to reveal any other compound 
that caused late deaths in the absence of early deaths. However, other 
studies have demostrated FI, male-mediated, abnormalities which may be 
caused by a similar mechanism (Anderson et al., 1990). It would be possible 
to examine the developing foetuses for chromosomal abnormalities by 
looking at foetal liver (Jenkinson et al., 1987) and also to study the 
development of surviving animals post-partum for developmental 
abnormahties. Unfortunately, these studies would be expensive and were 
not provided for under the terms of the funding.
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Host-mediated assays
By this stage of the project, APNG had been shown to be a genotoxic 
agent but only after intraperitoneal administration and httle was known 
about its stabihty in biological systems. It was decided that studies in mice 
using the host-mediated assay could give information concerning the 
stabihty and the absorption rates of APNG in vivo. Chapter 4 presents the 
results of such studies where it was seen that APNG, after ip treatment, 
was short-hved in the blood. After oral treatment effects were still evident, 
the nitrosopeptide was once again short-hved but the pharmacokinetic 
profile was different, the levels of the mutagenic product in the blood were 
lower and remained active longer than after the ip treatment. These results 
indicate a slower rate of absorbtion through the gut than was seen from the 
peritoneum. It was concluded that although APNG was short-hved in vivo, 
either the compound itself, or its product, was sufficiently stable to pass 
through the gut wall and mutate the Salmonella in the liver.
DNA synthesis assays
From the studies so far carried out, it was appreciated that APNG 
was able to affect the testis and bone marrow after intraperitoneal 
treatment and reach the liver after oral administration. The next stage was 
to examine the effects of APNG on other tissues. As it was proposed that 
the nitrosopeptides may be formed in the stomach, the interest centred on 
the stomach, the potential site of formation, the duodenum, the liver and 
the kidney (it was shown that APNG was a kidney toxin and those animals 
that died in the LDgo assay had severely damaged kidneys). To study the 
potential effects of APNG on those tissues the Unscheduled DNA Synthesis 
(UDS) assay was employed in conjunction with some assessment of
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scheduled synthesis in both in vitro and in vivo systems. The results of 
these studies are presented in Chapter 5. It was evident that APNG was 
able to cause repairable damage to the hver DNA. It was interesting that 
this damage was not linked to toxicity resulting in cell death, but could lead 
to viable mutated cells in vivo which would be still capable of normal 
division and thus lead to tumour formation. This degree of damage in the 
hver is also compatible with those results seen in the dominant lethal 
studies and the bone marrow studies where the nature of the genetic 
damage, although present, appears to be of a non-lethal, nature not usuahy 
associated with many genotoxins. The results in the gut were interesting: 
APNG did not cause any increase in UDS but did have an inhibitory effect 
on the dividing ceUs. This increase in dividing cells in the kidney is 
probably related to the toxic effects of APNG which certainly damages the 
kidney and which is probably responsible for the death of animals given high 
doses of APNG. From the DNA synthesis assays it was concluded that 
APNG caused UDS in hepatocytes but that the techniques used may have 
been insufficiently sensitive to detect effects in the gut. APNG also 
inhibited DNA synthesis in the stomach.
Adduct formation
At this stage it was clearly seen that nitrosopeptides (in the form of 
APNG) were definitely genotoxic. However, it was not known if nitrosated 
peptides could be detected in vivo, without treatment with high levels of a 
specific agent. Professor B.C. Challis proposed that to detect these agents 
in vivo it was necessary to identify specifically formed DNA adducts which 
could be formed with this class of chemicals (personal communication). It 
was was considered unlikely that specific nitrosated peptides could be
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detected by chemical analysis, i.e. by glc or hplc methods. This is because 
the quantity of any particular adduct would be too small to detect. 
However, the combined affects of many different nitrosated peptides could 
be significant. He proposed that both nitroso and diazo peptides would 
produce Og carbo^ymethylguanosine adducts and that it should be possible 
to use hplc or immunological techniques to identify these products. He used 
DNA treated in vitro with APNG to produce such adducts and assayed 
hydrolysed DNA using hplc techniques. Using these techniques he was able 
to detect both Ng and Og adducts but the level of detection was such that this 
method would be too insensitive to detect normal levels of the adducts in 
vivo. However, he was able to identify both types of adduct in the DNA- 
derived from the animals, dosed with APNG in the UDS assays. He also 
attempted to raise an antibody to the Og adduct and to employ an 
immunological method (Ehsa analysis) to identify such adducts. Once again 
the method was too insensitive to detect the adduct except from in vitro 
treated DNA or from animals treated with APNG at very high levels.
As an alternative it was decided to employ the ^^ P post-labelling 
technique of PhiUips to look for adducts firom in vivo treated animals with 
the ultimate aim of analysing tissue from substrate exposed animals or 
humans. Chapter 6 shows the results firom such studies with APNG treated 
animals. It was possible to detect a single adduct in both hver and kidney 
from animals treated with APNG but the system proved to be too 
insensitive to detect such adducts in animals other than those treated with 
high levels of the nitrosopeptide itself. The problems associated with the 
detection method were almost certainly due to the nature of the adduct. It 
was probably too small for easy isolation and the ^^ P post-labelling methods 
are best suited to the detection of bulky adducts.
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Long-term studies
Finally the question, are APNG and thus nitrosated peptides 
carcinogenic? All the previous evidence had indicated that APNG would 
probably be a carcinogen and it would seem hkely that it would cause 
tumours in rodents. To carry out a fuU carcinogenicity assay in either rats 
or mice would have been both costly and, in view of the genotoxicity profile, 
unethical. Because of this it was decided to assay APNG in a limited sized 
study.
Groups of six male and female mice were used looking at the effects 
of APNG after both an oral and ip treatment regimen. The results are 
given in Chapter 6. It was clearly seen that APNG gave rise to mahgnant 
tumours in animals treated with APNG both after oral or intraperitoneal 
regimes and these tumours were found at multiple sites in both sexes. 
Ashby and Morrod (1991) suggested that if a chemical was shown to be 
genotoxic in short-term assays, a hmited rodent carcinogenicity bioassay 
could be carried out instead of a fuh-sized study. Furthermore, the 
induction of tumours, particularly at varied sites, could estabhsh that the 
agent being studied was a carcinogen, without the need for a more extensive 
and costly, assay. From the small study reported in this thesis, combined 
with the results firom the short-term studies, it is clear that APNG has been 
shown to be a potential genotoxic carcinogen.
Further work and conclusions
It has now been shown that nitrosopeptides (in particular APNG) can 
cause mutation and genotoxicity in many systems; that APNG is able to be 
absorbed orally and appears to cause such effects in the absence of any
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great toxicity. It is also evident that APNG is carcinogenic. However, due 
to the nature of the work presented in this thesis, where the aim was to 
estabhsh that nitrosopeptides were mutagenic and ultimately to show that 
they were carcinogenic, many of the interesting results seen with the 
various assays were not pursued. Accordingly there are areas which stih 
need to be investigated in greater detail. Some specific suggestions for 
future work are given below.
Heritable effects
The results from the dominant lethal studies were of particular 
interest and the increase in late deaths and abnormahties seen require 
follow up studies. The importance of showing that mutagens may also cause 
heritable congenital malformations can not be over stated. This aspect is 
often overlooked in toxicology as there are, at present, no assays that 
measure directly the induction of heritable congenital malformations which 
are used in the regulatory context (Douglas 1990). The use of a modified 
dominant lethal assay, as presented in this thesis and suggested by Knudsen 
et al (1977), certainly gave information on congenital defects and major 
abnormahties as well as foetal deaths. This assay is, however, not sensitive 
to lesser genetic damage which may cause chromosomal alterations that give 
rise to functional disorders, inherited tumours, or minor abnormahties that 
may only be detected after birth (Jenkinson and Anderson, 1990; Francis 
et al., 1990). It is proposed that this work is followed up with a ‘male 
teratogenicity' study in which male mice will be given a low dose of APNG 
for at least eight weeks before being mated with virgin females since it has 
been shown that chronic low doses can produce more damage than a single
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THE IN VIVO GENOTOXIC PROPERTIES OF 
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Abstract— The V-nitrosopeptide //-(V-acetyl-L-prolyl)-A-nitrosoglycine (APNG) was investigated for 
in vivo genotoxicity using the dominant lethal assay and the micronucleus test in mice, and the bone 
marrow test in rats. APNG was shown to cause definite genetic effects in the mouse but a much lesser 
effect in the rat, indicating that APNG is a genotoxic agent in vivo.
INTRODUCTION
A-Nitroso compounds have been shown to be power­
ful carcinogens in a wide range of animal species. 
Some, such as dimethylnitrosamine, are carcinogenic 
in at least 33 species of animal whereas others such 
as nitrosoproline have, so far, been proved to be 
non-carcinogenic in any test animal (Ministry of 
Agriculture, Fisheries and Food, 1987).
It is known that nitroso compounds can be formed 
endogenously in vitro. Ohshima et al. (1982) devel­
oped a simple aiid sensitive method for quantitatively 
estimating endogenous A-nitrosation by monitoring 
the A-nitrosamino acids excreted in the urine and 
faeces after feeding rats on amino acid precursors and 
nitrate.
As A-nitroso compounds may be formed by the 
reaction of nitrosating agents, nitrites or nitrogen 
oxides with amino containing compounds, it would 
be reasonable to suppose that nitrosated peptides 
may be formed in vivo. For amides and peptides to 
form TV-nitroso compounds, a low pH (less than 4) 
is required (Mirvish, 1975) so the possible site of 
formation could be the stomach (Outram & Pollack, 
1984). Milton-Thompson et al. (1982) and Reed et al. 
(1981) have shown that gastric aspirates contain 
small amounts of A-nitroso compounds. Their struc­
ture is unknown but some may be expected to be 
derived from common dietary nitrogenous com­
pounds such as proteins and peptides.
In 1984 Challis et al. reported the synthe­
sis, isolation and characterization of A-nitroso- 
peptides including A-(V-acetyl-L-prolyl)-A-nitroso- 
glycine (APNG) and A-(V-acetyl-L-valyl)-A-nitroso- 
glycine (AVNG). APNG proved to be relatively 
stable in aqueous buffer with a half-life of about 10 hr 
at pHs between 1 and 8 at 25°C. The results of 
Challis’ work suggest that A-nitrosopeptides are 
sufficiently stable, for their absorption through the 
stomach and düjdenum. On decomposition they
Abbreviations: APNG =  A-(A-acetyl-L-propyl)-A-nitroso- 
glycine; AVNG =  V-(À-acetyI-L-valyl)-V-nitrosogly- 
cine; CTX =  cyclophosphamide; MMC =  mitomycin C; 
NCE =  normochromatic erythrocytes; PCE =  poly­
chromatic erythrocytes.
generate an alkylating agent (Fig. 1) which is charac­
teristic of many carcinogens (Lawley, 1976).
APNG and AVNG have been shown to be direct- 
acting mutagens in the Ames Salmonella/microsome 
mutagenicity test (Challis et al. 1985). The positive 
responses were not abolished by a metabolic activa­
tion mix (S-9) and were also seen in the Salmonella 
typhimurium strains that detect base-pair substitution 
mutations (TA1535, TA 100 and TA 102).
These two nitrosopeptides were also investigated 
by Anderson et al. (1986) for genetic toxicity towards 
mammalian cells using an established line of Chinese 
hamster ovary cells (CH0-K1-BH4). Observations 
were made on three indices o f genetic damage, 
namely chromosome aberrations, sister chromatid 
exchange and induction of thioguanine-resistant 
variants. Treatment of cells with either compound 
resulted in dose-dependent increases in all indices, 
indicating that both compounds are direct-acting 
mutagens.
The studies reported here investigated the geno­
toxic activity of APNG in three in vivo genotoxicity 
assays; dominant lethal tests in mice, a micronucleus 
test in mice and a bone marrow metaphase analysis 
in rats. In order to maximize the potential effects the 
compound was administered ip in all the studies.
MATERIALS AND METHODS
Chemicals. The synthesis and physical properties of 
APNG have been described by Challis et al. (1984). 
Cyclophosphamide (CTX) and mitomycin C (MMC) 
were obtained from Sigma Chemical Co. Ltd, Poole, 
Dorset. All other chemicals were obtained from 
standard sources.
Acute toxicity studies
Prior to the in vivo genotoxicity assays the acute 
toxicity of APNG was determined in LDjo studies for 
both rats and mice using the method of Litchfield & 
Wilcoxon (1984). The results are shown in Table 1.
Dominant lethal studies
The initial study was based on the recommen­
dations of Anderson et a/. (1983). The subsequent
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Fig. I. Decom position o f  V-(A-acetyl-L-propyl)-A-nitrosoglycine.
studies were adaptations designed to elicit the maxi­
mum response based on the original study.
In the first study groups of 20 sexually mature male 
CD mice (Charles River, Margate) were given a single 
ip dose of a control vehicle with or without APNG 
at a concentration of 18, 60 or 180 mg/kg body 
weight. After dosing, each male mouse was housed 
with two virgin females per wk for a total of 8 wk. 
The females were killed on days 11-18 of gestation, 
according to mating date, and the uteri were exam­
ined for the numbers of live implants and for early 
and late foetal deaths.
In the second study groups of 40 sexually mature 
male CD mice were given a single ip dose of a control 
vehicle with or without 60 mg APNG/kg body 
weight. During the third week after dosing each male 
was housed with one virgin female, and during the 
fourth week with three virgin females. Following 
mating, confirmed by vaginal plugs, the females were 
killed on day 18 of gestation and examined for 
dominant lethal affects as above and for gross foetal 
abnormalities.
In the third study groups of ten sexually mature 
male CD mice were given eight weekly ip doses of a 
control vehicle with or without APNG at a concen­
tration of 20 or 60 mg/kg. After the 8-wk treatment 
each male was housed with four females for 5 days 
followed immediately by a period with a further 
group of four females for another 5 days. Following 
mating, confirmed by vaginal plugs, the females were 
killed and examined on day 18 of gestation for 
dominant lethality and gross foetal abnormalities.
Micronucleus assay in the mouse
The method followed was that of Heddle et al. 
(1984) using the staining method of Schmid (1975). 
Groups of 10-12-wk old male CD mice were given 
two doses, 24 hr apart, o f a control vehicle, with or 
without 100 mg APNG/kg/day or 50 mg CT^kg/day  
(positive control). The mice were killed 24,48 or 72 hr 
after the second injection, and the bone marrow 
sampled. From each animal 2000 polychromatic 
erythrocytes (PCE) were examined and the number 
of micronuclei recorded. The numbers of normo­
chromatic erythrocytes (NCE) were also counted and 
the PCE:NCE ratio was determined.
Rat bone marrow metaphase assay
Groups of ten CD rats (Charles River, Margate) 
were used (five male and five female). Two groups 
were treated for five consecutive days: one was given 
a control vehicle and the other 50 mg APNG/kg/day. 
The bone marrow was sampled 6 hr after the final 
dose. The other three groups were given a control 
vehicle, 200 mg APNG/kg or 3.5 mg MMC/kg (posi­
tive control) and the marrow was sampled 22 hr after 
the dose administration.
The chromosome preparation was as described by 
Killian et al. (1977). Once prepared the slides were 
assessed for quality and examined, and 50 cells/slide 
were scored.
RESULTS 
Dominant lethal studies
In the first study (Table 2) the pregnancy fre­
quencies remained high throughout the study and 
there was no evidence of an increase in early foetal 
deaths. There were significant increases in late deaths 
at wk 3, 4 and 5 in the intermediate-dose group, at 
wk 4 in the high-dose group and at wk 7 and 8 in the 
low-dose group. Also a large number of exencephalic 
foetuses were seen: one in the control group, two in 
the 18-mg APNG/kg group and five in the 180-mg 
APNG/kg group.
In the second study (Table 3) there was no evidence 
of an increase in early deaths, but there was a 
statistically significant increase in the number of late 
deaths at wk 3 in the 60-mg APNG/kg group com­
pared with that of the control group. At wk 4 there 
was also an increase in the number of late deaths in 
the 60-mg APNG/kg group, but this increase was not 
significant.
In the third study (Table 4) there was a statistically 
significant increase in the number of late deaths in the 
group treated with 60 mg APNG/kg. There was also 
an increase in the number of early deaths in the first 
mating group. When values were combined for both 
matings the increase in the number of late deaths was 
statistically significant whereas the early-death in­
crease was not. No effects were seen in the low, 20-mg 
APNG/kg group.
Table 1. LDc„ values of APNG
Study Species
LDjo (mg/kg body weight) 
Male Female
Single dose Rat 475 575
Multiple dose R at 100 90
(five daily injections)
Single dose Mouse 330 275
APNG = Af-(Af-acetyl-L-propyI)-A-nitrosoglycine
In vivo genotoxicity of APNG 787
Table 2. Summary o f the effects o f ANPG on dom inant lethality in CD  mice (first study) given a  single dose o f APNG or CTX
No. of 
wk after 
dose Abnormality
Incidence (mean no./litter) o f abnormality in mice given
0 (control)
APNG (mg/kg) CTX (mg/kg)
18 60 180 200
1 TI 11.6 11.5 11.1 11.8 9.8**
LI 11.1 10.8 10.2 11.3 5.9***
ED 0.50 0.63 0.72 0.58 3.62***
LD 0 0 0.17 0 0.31
% PregnantJ 70 95 90 60 65
2 TI 11.4 11.8 11.7 11.6 8.8**
LI 10.9 11.5 11.5 11.1 5.0***
ED 0.47 0.30 0.53 0.56 3.85***
LD 0 0 0.21 0 0
% Pregnant 85 80 95 80 65
3 TI 12.1 10.3 12.3 11.0 11.6
LI 11.6 9.6 11.5 10.3(-h i Ex) 8.3*
ED 0.47 0.44 0.42 0.53 3.06***
LD 0.06 0.19 0.32* 0.18 0.19
% Pregnant 85 80 95 85 80
4 TI 12.2 11.9 11.8 12.3 11.8
LI 11.5 11.2 10.7 11.5 10.7
ED 0.60 0.61 0.50 0.53 0.87
LD 0.10 0.11 0.67** 0.33 0.20*
% Pregnant 100 90 90 75 75
5 TI 11.5 12.1 13.1 11.3
LI 11.0 11.8 12.3 11.0 (-h2 Ex)
ED 0.42 0.17 0.41 0.13
LD 0.05 0.11 0.35* 0.13(-h i Ex)
% Pregnant 95 90 94 75
6 TI 12.6 13.3 12.0 11.8
LI 11.8 12.3(-h i Ex) 11.3 11.1
ED 0.70 0.84 0.60 0.65
LD 0.10 0.21 0.10 0.12
% Pregnant 100 95 100 85
7 TI 12.5 12.7 12.5 10.9
LI 11.9 11.9(-h i Ex) 11.7 10.5(-h i Ex)
ED 0.55 0.53 0.58 0.24
LD 0 0.26* 0.21 0.12
% Pregnant 100 95 95 85
8 TI 11.8 12.2 11.8 12.7
LI 11.5(-h i Ex) 11.0 11.0 12.2
ED 0.33 0.89 0.60 0.50
LD 0 0.28* 0.15 0.06
% Pregnant 90 90 100 90
APNG =  A-(A-acetyl-L-propyl)-A-nitrosoglycine CTX =  cyclophosphamide TI =  total implants 
LI =  live implants ED =  early deaths LD =  late deaths Ex =  exencephalic foetuses 
JThe pregnancy rate for the group.
The values are the mean no./litter for groups o f 40 mice, those marked with asterisks differ significantly (chi-square test) from  those o f the 
controls: 0.05; =^0.01; »**P <0.001.
Micronucleus assays in the mouse
The results of the micronucleus assays are shown 
in Table 5. The percentage of micronuclei in PCEs 
were significantly increased at all three sampling 
times after treatment with both the positive control 
(CTX) and with APNG. The PCE:NCE ratios in the 
treated groups were reduced when compared with 
those of the control groups at all three timepoints 
indicating marrow toxicity.
Rat bone marrow metaphase analysis
Table 6 shows the incidence of aberrant meta­
phases and different types of damage in rat bone 
marrow when sampled at 24 hr after a single dose of 
200 mg APNG/kg or at 6 hr after the last of five daily 
doses of 50 mg APNG/kg. No significant differences
were seen between the incidences o f chromosomal 
aberrations in the control and treated groups. An 
increase in the number of chromosome gaps was 
seen in the 50-mg APNG/kg/day group; however, as 
14 of the 15 gaps seen were present in a single cell, 
where the staining quality was poor, this result is 
probably of little relevance and may be ignored. The 
positive control (MMC) responded well with a large 
increase in the number of both breaks and gaps.
DISCUSSION
APNG has been found to be an in vivo genotoxic 
agent in mice as seen by the results o f the micro­
nucleus and dominant lethal assays. There was no 
evidence o f a response in the bone marrow metaphase
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Table 3. Summary o f the effects o f A PN G  on dominant lethality in CD mice 
(second study) mated 3 and 4 wk following a single ip dose o f APNG
Wk following 
dose
Incidence (mean no./litter) 
o f abnormalities in mice given A PN G  (mg/kg)
Abnormality 0 (control) 60
3 TI 12.4 11.5
LI 11.8 10.6
ED 0.41 0.53
LD 0.12 0.41*
% Pregnantf 89 85
4 TI 12.0 11.9
LI 11.3 11.0
ED 0.52 0.55
LD 0.17 0.26
% Pregnant 81 78
A PNG =  A-(A-acetyl-L-propyl)-fV-nitrosoglycine TI =  total implants 
LI =  live implants ED =  early deaths LD =  late deaths 
fT he pregnancy rate for the group.
The values are the mean no./litter for groups for 40 mice (for wk 3) or 120 mice 
(for wk 4). Those marked with an asterisk differ significantly (chi-square test) 
from those o f the control: *P <  0.05.
Table 4. Summary o f the effects o f A PN G  on dom inant lethality in CD mice (third study) mated 
over a 10-day period following eight ip doses o f APNG
M ating period 
(days) post 
8-wk treatment
Incidence (mean no./litter) of 
abnormality in mice given APNG (mg/kg)
Abnormality 0 (control) 20 60
17-5 TI
First mating
12.5 12.6 12.8
LI 12.0 12.1 11.1
ED 0.38 0.35 1.11*
LD 0.14 0.10 0.56*
% Pregnantf 55 40 45
6-10 TI
Second mating
10.8 10.2 11.9
LI io .5 9.9 11.6
ED 0.22 0.34 0.15
LD 0.03 0 0.15*
% Pregnant 93 91 65
1-10 TI
Combined data
11.4 11.8 12.2
LI 11.1 11.4 11.4
ED 0.28 0.37 0.55
LD 0.07 0.04 0.32*
% Pregnant 73 66 55
APN G  =  A-(A-acetyl-L-propyl)-A-nitrosoglycine TI =  total implants 
LI =  live implants ED =  early deaths LD =  late deaths 
tT he pregnancy rate for the group.
The values are the mean no./litter for groups o f 40 mice, those marked with an asterisk differ 
significantly (chi-square test) from those o f the controls: *P <  0.05.
Table 5. Effect o f two ip doses o f APNG on micronuclei production 
in mouse bone marrow
Sampling 
time (hr)f
Values o f % PCE (P :N ) for mice given
Vehicle
control
APNG 
(100 mg/kg)
CTX 
(50 mg/kg)
24 0.29 0.90*** 6.08***
(55:45) (40:60) (29:71)
48 0.29 0.56** 4.14***
(50:50) (41:59) (27:73)
72 0.34 0.90** 1.46***
(46:54) (40:60) (35:65)
APNG =  7V-(A-acetyl-L-propyl)-N-nitrosoglycine 
CTX =  cyclophosphamide P : N  =  polychromatic : normochromatic 
erythrocyte ratio 
fT he time following the second dose.
The mean at each o f the time points were compared using the least 
significant difference based upon the pooled residual mean 
squares from a factorial analysis o f variance (Snedecor & 
Cochran, 1967): * * P <  0.01, ♦*♦/>< 0.001.
assay, except for an increase in the number of gaps 
in the chromosomes of one animal. Gaps are consid­
ered the most subjective and least biologically 
significant category of aberrations (Anderson & 
Richardson, 1981). The different results found in a 
bone marrow assay in rats and mice may be due to 
a species sensitivity difference. The positive results in 
mice support the findings of previous in vitro experi­
ments in the Ames test (Challis et al. 1985) and in 
Chinese hamster ovary cells (Anderson et al. 1986).
The observations in the dominant lethal assay are 
unusual. Conventionally, statistically significant in­
creases in the number of early deaths are required for 
a positive result (Anderson et al. 1983; Bateman, 1966 
& 1977). However, such a result was only seen in one 
of the studies reported here and it was not re­
producible. The increase in the number of late deaths 
in the absence of a corresponding increase in the
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Table 6. Incidence o f aberrant metaphases (and damage type) in the bone marrow of male rats given ip doses o f APN G  or M M C
M ean no. of: No. of:
Treatment
Dose
(mg/kg)
No. o f cells 
scored Gaps
Chromatid Chromosome 
breaks breaks
Cells with 
more than 
ten aberrations
Cells with 
breaks
Cells with 
aberrations
Control 200 0
24-hr sampling time
0 0 0 0 0
APNG 200 200 1 0 0 0 0 1
M M C (positive 3.5 250 34* 35* 2 3 22* 37*
control)
Control 250 4
6-hr sampling time
0 0 0 0 4
A PN G f 50 200 15* 0 0 0 0 14*
APNG =  V-(Af-acetyl-L-propyl)-A-nitrosoglycine M M C =  mitomycin C
fFive ip doses.
The values are means for groups o f ten rats, those marked with an asterisk differ significantly (chi-square test) from those o f the controls; ♦P<0.01.
number of early deaths is surprising; since all females 
mated were apparently in good health the effects 
observed cannot be due to maternal influences. Even 
though the increases in the number of late deaths 
were not dose related, the statistically significant 
increases in all three studies would suggest that the 
late deaths result from genetic damage to the sperm. 
In addition there was some evidence that abnormal­
ities (exencephalic foetuses) were produced. Bateman 
& Epstein (1971) and Gropp et al. (1976) have 
suggested that late deaths may result from trisomie 
genotypes. An abnormal karyotype such as this 
might also be responsible for exencephaly, a high 
incidence of which was seen in the first study and it 
may arise at doses at which dominant lethals are not 
observed (Jenkinson et al. 1987). The possibility that 
late deaths may arise from a genetic event have 
prompted further investigation in this laboratory 
with unscheduled DNA synthesis studies in somatic 
and germ cells. Also further work carried out using 
a host-mediated assay in mice has shown that APNG  
administered orally is mutagenic (Blowers et al. 
1988).
From these results and those reported previously, 
it is evident that APNG causes genetic damage both 
in vitro and in vivo, but the mechanism in vivo is not 
yet clear.
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EFFECTS OF THE NITROSOPEPTIDE Æ-(Æ-ACETYL-L- 
PROLYL)-#-NITROSOGLYCINE ON SALMONELLA 
TYPHIMURIUM TAIOO IN THE HOST-MEDIATED 
ASSAY IN MICE
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Abstract—The A-nitrosopeptide A-(A-acetyl-L-prolyl)-A-nitrosoglycine (APNG) was examined for 
mutagenicity in the mouse host-mediated assay using Salmonella typhimurium strain TAIOO. Adminis­
tration of APNG orally or as a single ip injection was shown to produce an increase in revertants. This 
study provides the first evidence that APNG is absorbed after oral administration in mice and 
demonstrates that the mutagenic product o f APNG is short-lived in vivo.
i n t r o d u c t i o n
The A-nitrosopeptide A-(A-acetyl-L-prolyl)-A- 
nitrosoglycine (APNG) has been shown to be a 
potent direct-acting mutagen in the Ames 
Salmonella/mammalian mutagenicity test (Ames et 
al. 1975) with strains TA1535, TAIOO and TA102, 
which detect base-pair substitution mutations 
(Challis et al. 1985). In addition it has been shown by 
Anderson et al. (1986) that APNG is a direct acting 
mutagen for causing chromosome aberrations, sister 
chromatid exchange and induction of thioguanine- 
resistant variants in an established line of Chinese 
hamster ovarj' cells (CH0-K1-BH4).
Studies of the in vivo genotoxic activity of APNG  
in mice (Blowers & Anderson, 1988; Blowers et al. 
1986) have shown that it produces an increase in the 
number of micronuclei in polychromatic erythrocytes 
and an increase in late embryonic deaths in dominant 
lethal assays. The assays were carried out using ip 
dosing to maximize potential effects.
The studies reported here examine the mutagenic 
potential o f APNG in the host-mediated assay 
(HMA) as described by Arni et al. (1977) and 
modified by Howes (1987). This test has been used to 
discover whether APNG is absorbed after oral ad­
ministration in mice and to determine the length of 
time that APNG or its metabolites remain active in 
vivo.
M ATERIALS AND M ETHODS
Chemicals. APNG was synthesized as described by 
Challis et al. (1985) and was dosed either as a solution 
or suspension in phosphate-buffered saline (PBS) at 
pH 7.4. The Vogel Bonner plates were obtained from 
SafePharm Laboratories Ltd, Derby. The nutrient 
broth and nutrient agar plates were made in-house
Abbreviations: APNG =  A-(A-acetyl-L-prolyl)-A-nitroso- 
glycine; HMA =  host-mediated assay; PBS =  phos­
phate-buffered saline.
using media from Oxoid Ltd, Basingstoke, Hants. All 
other chemicals were obtained from standard 
sources.
Animals. Female CD-I mice (Charles River, 
Margate, Kent) 6-8-wk old (20-25 g) were fed Rat 
and Mouse No. 1. diet ad. lib. (Special Diet Services 
Ltd, Witham, Essex) and had unlimited access to 
mains tap-water. The animals were housed, in 
groups, in plastic and stainless-steel cages with 
moulded solid plastic floors. The mice were kept in 
ventilated rooms at a temperature of 20-25°C and 
a relative humidity 45-75%, and exposed to a 
12-hr light/dark cycle (06.00-18.00 hr/18.00-06.00 hr 
Greenwich mean-time).
HMA dose-response studies. An inoculum of  
Salmonella typhimurium strain TAIOO was incubated 
for 16 hr with nutrient broth in a gently shaking 
water-bath at 37°C. Cells were collected by centrifu­
gation at 1500 g for 15min and the pellet was sus­
pended in one twentieth o f the original volume o f  
PBS (pH 7.4). Cell suspension (0.1 ml) was injected 
into a tail vein of each mouse (not fasted) immedi­
ately before a dose of PBS, or APNG given orally at 
a dose of 100, 200, 300, 400 or 500 mg/kg body 
weight or given by ip injection at 200 or 400 mg/kg 
body weight. Each treatment group consisted o f four 
or six mice. One hour after dose administration the 
mice were killed by cervical dislocation and the 
bacteria were recovered from the mouse livers.
HMA time-course studies. Groups o f four mice 
(not fasted) were administered APNG either as a 
single ip injection (200 mg/kg body weight) at 0, 5, 
10, 15, 30, 45, 60, 75, 90, 120 and 150 min before the 
administration of bacteria, or as an oral dose 
(500 mg/kg body weight) at 0, 5, 10, 15, 20, 30, 40, 
50 or 60 min before the administration of bacteria. 
After 1 hr the mice were killed by cervical dislocation 
and the bacteria were recovered from the mouse 
livers.
Collection and quantification o f revertant bacteria. 
The liver of each mouse was removed and homoge­
nized in 10 ml ice-cold Tris/KCl using an Ultraturrax
F.C.T. 26/11.12—C
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homogenizer. (IKA-labortechnik, Switzerland). Cell 
debris was sedimented by centrifugation for 10 min at 
100 g. The supernatant was then centrifuged at 1700 g 
for 30 min and the sedimented bacterial cells re­
suspended in 1 ml 50mM-Tris/KCl (pH 7.4).
The number of his revertants was determined by 
mixing 0.1 ml bacterial suspension with 2 ml top agar 
(containing 0.05 mM-histidine, 0.05 mM-biotin and 
25^g/ml ampicillin) and pouring the mixture onto 
the Vogel Bonner agar plates. Triplicate plates were 
made for each liver sample. Total numbers of bac­
teria present in each liver were assessed by plating a 
dilution (10“®) of each suspension onto nutrient agar 
plates containing 25 fig/ml ampicillin. The revertants 
on the Vogel Bonner plates were counted after 3 days 
and the total numbers on nutrient agar after I day.
Evaluation o f  results. The data were evaluated 
using a two-level nested analysis o f variance (Sokal & 
Rohlf, 1969) in transformed data. If an effect was 
significant it was investigated using the least 
significant difference method (Snedecor & Cochran, 
1967). Bartlett’s test of homoscedasticity was used to 
check the equality o f the group variances.
RESULTS
APNG induced his^ revertant colonies in strain 
TAIOO isolated from the livers o f CD-I mice after 
both ip and oral administration (Figs 1-3).
In the dose-response study (Fig. 1) significant 
increases in revertants were seen at doses of 200 and 
400 mg/kg body weight (ip) (7- and 9.5-fold increases, 
respectively). After oral administration only the 
500 mg/kg body weight group had a greater than 
twice background increase in revertants; however, 
significant increases in the numbers o f revertants were
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Fig. 1. Effect of oral and ip AGNG administration on S. 
typhimurium in the HMA in mice. *P <0.05; **P <0.01; 
<0.001; analysis of variance with least significant 
difference.
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Fig. 2. Effect of time on mutagenicity of APNG (ip dose; 
200 mg/kg body weight) in the HMA in mice. ***P <  0.001; 
analysis of variance with least significant difference.
seen at doses o f 200 mg/kg body weight and above 
and the effect was clearly dose related.
Figures 2 & 3 show the effect o f administration of 
APNG before iv administration of bacteria, illustrat­
ing the time that the APNG or its metabolites remain 
active in vivo. After ip dosing (Fig. 2) no evidence of 
an increase in revertants was seen after 30 min. After 
oral administration (Fig. 3) the response was lower 
than with the ip treatment and no evidence o f an 
increase in revertants was seen after 40 min.
Statistical analysis o f the data showed that the 
variation in the experiments was primarily due to 
differences between doses (75-87%), differences be­
tween animals within doses (4-19%) and differences 
between plates within animals (2-22% according to 
the experiment).
The numbers of cells recovered from the animals, 
as measured by the viable count, allowed for between 
5x10^ and 5x10® bacteria/plate. When the number 
of cells was less than 5 x 10 /^ml (the equivalent of 
5 X lOVpIate) the mutation value was not included in 
the analysis.
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Fig. 3. Effect of time on mutagenicity of APNG (oral dose; 
500 mg/kg body weight) in the HMA in mice. **P <0.01; 
<0.001; analysis of variance with least significant 
difference.
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DISCUSSION
Previous in vivo studies o f the genotoxic effects o f 
APNG administration (Blowers & Anderson, 1988; 
Blowers et al. 1986) have only used ip dosing and so 
no evidence of oral absorption of APNG has been 
shown. As the standard in vivo mutagenic tests are 
time consuming, expensive and require relatively 
large amounts of chemical, a more efficient assay was 
required to investigate the potential oral absorption 
of the APNG. For this purpose the mouse HMA was 
selected. Observation of the m vivo metabolism of 
APNG using this assay provides some indication of 
the pharmacokinetic profile of the compound.
Results from these studies clearly show that APNG  
(or its product) is mutagenic in the mouse HMA. A 
direct dose-related effect is apparent after dosing by 
both routes, but the effect is greater after ip dosing. 
This may imply that when the compound is adminis­
tered orally, either much of it is inactivated before 
absorption or much of it fails to cross the stomach 
wall. (Preliminary evidence from our laboratory im­
plies that the former is more likely.) Furthermore, the 
animals used in these assays were not fasted and 
much of the APNG may have been bound to the food 
rather than absorbed.
APNG administered by the oral route is absorbed 
more slowly than after ip injection. The difference in 
the half-life, as indicated in the time studies, between 
each administration route is probably due to different 
absorption times. The mutagenic product is removed 
from the blood rapidly irrespective of the route of 
administration.
In previous in vivo studies (Blowers & Anderson, 
1988; Blowers et al. 1986) effects on the bone marrow
and the testis were evident and our present studies
would imply that these effects are initiated rapidly.
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